Cover
Cover - USD ($) | 12 Months Ended | ||
Dec. 31, 2023 | Apr. 01, 2024 | Jun. 30, 2023 | |
Document Information [Line Items] | |||
Document Type | 10-K | ||
Document Annual Report | true | ||
Document Transition Report | false | ||
Document Financial Statement Error Correction [Flag] | false | ||
Entity Interactive Data Current | Yes | ||
ICFR Auditor Attestation Flag | false | ||
Amendment Flag | false | ||
Document Period End Date | Dec. 31, 2023 | ||
Document Fiscal Year Focus | 2023 | ||
Document Fiscal Period Focus | FY | ||
Documents Incorporated by Reference [Text Block] | None | ||
Entity Information [Line Items] | |||
Entity Registrant Name | MITESCO, INC. | ||
Entity Central Index Key | 0000802257 | ||
Entity File Number | 000-53601 | ||
Entity Tax Identification Number | 87-0496850 | ||
Entity Incorporation, State or Country Code | DE | ||
Current Fiscal Year End Date | --12-31 | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Shell Company | false | ||
Entity Filer Category | Non-accelerated Filer | ||
Entity Small Business | true | ||
Entity Emerging Growth Company | false | ||
Entity Public Float | $ 5,571,231 | ||
Entity Contact Personnel [Line Items] | |||
Entity Address, Address Line One | 505 Beachland Blvd., Suite 1377 | ||
Entity Address, City or Town | Vero Beach | ||
Entity Address, State or Province | FL | ||
Entity Address, Postal Zip Code | 32963 | ||
Entity Phone Fax Numbers [Line Items] | |||
City Area Code | 844 | ||
Local Phone Number | 383-8689 | ||
Entity Listings [Line Items] | |||
Title of 12(b) Security | N/A | ||
No Trading Symbol Flag | true | ||
Security Exchange Name | NONE | ||
Entity Common Stock, Shares Outstanding | 5,635,044 |
Audit Information
Audit Information | 12 Months Ended |
Dec. 31, 2023 | |
Auditor [Table] | |
Auditor Name | Accell Audit & Compliance, P.A. |
Auditor Firm ID | 3289 |
Auditor Location | Tampa, Florida |
CONSOLIDATED BALANCE SHEETS
CONSOLIDATED BALANCE SHEETS - USD ($) | Dec. 31, 2023 | Dec. 31, 2022 |
Current assets | ||
Cash and cash equivalents | $ 2,838 | $ 35,623 |
Prepaid expenses | 0 | 51,632 |
Current assets of discontinued operations | 0 | 93,033 |
Total current assets | 2,838 | 180,288 |
Right to use operating leases, net | 0 | 83,810 |
Fixed assets, net | 0 | 44,655 |
Non-current assets of discontinued operations | 0 | 2,293,227 |
Total Assets | 2,838 | 2,601,980 |
Current liabilities | ||
Accounts payable and accrued liabilities | 7,838,112 | 7,353,215 |
Derivative liabilities | 152,945 | 568,912 |
Lease liability - operating leases, current | 99,477 | 442,866 |
SBA loan payable | 421,788 | 460,406 |
Other current liabilities | 121,136 | 96,136 |
Legal settlements | 2,219,886 | 0 |
Current liabilities from discontinued operations | 0 | 2,145,706 |
Total current liabilities | 14,134,595 | 17,802,471 |
Lease Liability- operating leases, non-current | 0 | 3,936,858 |
Total Liabilities | 14,134,595 | 21,739,329 |
Commitments and contingencies | 0 | 0 |
Common stock subscribed | 0 | 36,575 |
Common stock, $0.01 par value, 500,000,000 shares authorized, 5,567,957 and 4,630,372 shares issued and outstanding as of December 31, 2023 and 2022, respectively | 55,680 | 46,305 |
Additional paid-in capital | 47,856,444 | 29,452,514 |
Accumulated deficit | (62,046,824) | (48,714,461) |
Total stockholders' equity (deficit) | (14,131,757) | (19,137,349) |
Total liabilities and stockholders' equity (deficit) | 2,838 | 2,601,980 |
Series A Preferred Stock [Member] | ||
Current liabilities | ||
Preferred stock, Value | 0 | 0 |
Series C Preferred Stock [Member] | ||
Current liabilities | ||
Preferred stock, Value | 0 | 10,476 |
Series D Preferred Stock [Member] | ||
Current liabilities | ||
Preferred stock, Value | 2,500 | 31,000 |
Series E Preferred Stock [Member] | ||
Current liabilities | ||
Preferred stock, Value | 0 | 0 |
Series F Preferred Stock [Member] | ||
Current liabilities | ||
Preferred stock, Value | 201 | |
Series X Preferred Stock [Member] | ||
Current liabilities | ||
Preferred stock, Value | 242 | 242 |
Nonrelated Party [Member] | ||
Current liabilities | ||
Accrued interest | 375,346 | 358,165 |
Notes payable, net of discounts | 1,078,529 | 5,047,995 |
Preferred stock dividends payable | 1,551,833 | 395,407 |
Related Party [Member] | ||
Current liabilities | ||
Accrued interest | 35,267 | 52,643 |
Notes payable, net of discounts | 166,912 | 846,001 |
Preferred stock dividends payable | $ 73,364 | $ 35,019 |
CONSOLIDATED BALANCE SHEETS (Pa
CONSOLIDATED BALANCE SHEETS (Parentheticals) - $ / shares | Dec. 31, 2023 | Apr. 11, 2023 | Mar. 23, 2023 | Jan. 12, 2023 | Dec. 31, 2022 | Dec. 12, 2022 | Dec. 11, 2022 | Nov. 07, 2022 |
Common stock, par value (in Dollars per share) | $ 0.01 | $ 0.01 | $ 0.01 | |||||
Common stock, shares authorized | 500,000,000 | 500,000,000 | ||||||
Common stock, shares issued | 5,567,957 | 4,630,372 | ||||||
Common stock, shares outstanding | 5,567,957 | 4,630,372 | 4,630,372 | 231,374,330 | ||||
Series A Preferred Stock [Member] | ||||||||
Preferred stock, par value (in Dollars per share) | $ 0.01 | $ 0.01 | ||||||
Preferred stock, shares issued | 0 | 0 | ||||||
Preferred stock, shares outstanding | 0 | 0 | ||||||
Series C Preferred Stock [Member] | ||||||||
Preferred stock, par value (in Dollars per share) | $ 0.01 | $ 0.01 | ||||||
Preferred stock, shares issued | 0 | 1,047,619 | 1,047,619 | |||||
Preferred stock, shares outstanding | 0 | 1,047,619 | ||||||
Series D Preferred Stock [Member] | ||||||||
Preferred stock, par value (in Dollars per share) | $ 0.01 | $ 0.01 | ||||||
Preferred stock, shares issued | 250,000 | 3,100,000 | ||||||
Preferred stock, shares outstanding | 250,000 | 3,100,000 | ||||||
Series E Preferred Stock [Member] | ||||||||
Preferred stock, par value (in Dollars per share) | $ 0.01 | $ 0.01 | $ 0.01 | |||||
Preferred stock, shares issued | 0 | 0 | ||||||
Preferred stock, shares outstanding | 0 | 0 | ||||||
Series F Preferred Stock [Member] | ||||||||
Preferred stock, par value (in Dollars per share) | $ 0.01 | $ 0.01 | $ 0.01 | |||||
Preferred stock, shares issued | 20,057 | 0 | ||||||
Preferred stock, shares outstanding | 20,057 | 0 | ||||||
Series X Preferred Stock [Member] | ||||||||
Preferred stock, par value (in Dollars per share) | $ 0.01 | $ 0.01 | ||||||
Preferred stock, shares issued | 24,227 | 24,227 | ||||||
Preferred stock, shares outstanding | 24,227 | 24,227 |
CONSOLIDATED STATEMENTS OF OPER
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Revenue | $ 0 | $ 0 |
Cost of goods sold | 0 | 0 |
Gross (loss) profit | 0 | 0 |
Operating expenses: | ||
General and administrative | 2,454,668 | 4,330,734 |
Impairment of fixed assets | 132,000 | 0 |
Total operating expenses | 2,586,668 | 4,330,734 |
Net Operating Loss | (2,586,668) | (4,330,734) |
Other income (expense): | ||
Equity investment incentives | (7,644,077) | 0 |
Financing costs | (18,617) | 0 |
Loss on legal settlement | (18,759) | 0 |
Loss on true-up shares | (119,370) | (9,007) |
Gain on settlement of accrued salary | 0 | 15,032 |
(Loss) Gain on settlement of accounts payable | 25,000 | (88,235) |
Gain on issuance of shares to service provider | 33,092 | 0 |
Gain on sale of assets | 8,876 | 0 |
(Loss) on conversion of accrued salaries and Series D preferred stock into Series F preferred stock | (25,000) | 0 |
Other Income | 40,622 | 0 |
Loss on revaluation of derivative liabilities | (85,773) | (687,178) |
Total other expense | (9,376,704) | (3,945,962) |
Loss before provision for income taxes | (11,963,372) | (8,276,696) |
Provision for income taxes | 0 | 0 |
Net loss from continuing operations | (11,963,372) | (8,276,696) |
Net loss from discontinued operations | (1,368,991) | (14,959,433) |
Net loss | (13,332,363) | (23,236,129) |
Preferred stock dividends | (1,719,781) | (322,310) |
Net loss available to common shareholders | $ (15,052,144) | $ (23,558,439) |
Net loss per share from continuing operations - basic and diluted (in Dollars per share) | $ (0.97) | $ (2.14) |
Net loss per share from discontinued operations - basic and diluted (in Dollars per share) | (0.07) | (3.15) |
Net loss per share - basic and diluted (in Dollars per share) | $ (1.04) | $ (5.29) |
Weighted average shares outstanding - basic and diluted (in Shares) | 14,440,218 | 4,451,962 |
Nonrelated Party [Member] | ||
Other income (expense): | ||
Interest expense | $ (1,615,591) | $ (3,034,402) |
Gain on waiver and commitment fee shares | 0 | 91,444 |
Gain on conversion of notes and accounts payable into common stock – related party | 37,453 | |
Gain on conversion of notes payable and accounts payable to common stock | 37,453 | |
Preferred stock dividends | (1,600,241) | (249,868) |
Related Party [Member] | ||
Other income (expense): | ||
Interest expense | (109,502) | (314,745) |
Gain on waiver and commitment fee shares | 0 | 81,129 |
Gain on conversion of notes and accounts payable into common stock – related party | 114,942 | 0 |
Gain on conversion of notes payable and accounts payable to common stock | 114,942 | 0 |
Preferred stock dividends | $ (119,540) | $ (72,442) |
CONSOLIDATED STATEMENTS OF CHAN
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($) | Waiver Fee [Member] Common Stock [Member] | Waiver Fee [Member] Additional Paid-in Capital [Member] | Waiver Fee [Member] | Commitments [Member] Common Stock [Member] | Commitments [Member] Additional Paid-in Capital [Member] | Commitments [Member] | Stock issued for dividends payable [Member] Series X Preferred Stock [Member] Common Stock [Member] | Stock issued for dividends payable [Member] Series X Preferred Stock [Member] Additional Paid-in Capital [Member] | Stock issued for dividends payable [Member] Series X Preferred Stock [Member] | Shares Previously Subscribed [Member] Common Stock [Member] | Shares Previously Subscribed [Member] Additional Paid-in Capital [Member] | Shares Previously Subscribed [Member] Stock Subscribed [Member] | Make-Good Agreement [Member] Common Stock [Member] | Make-Good Agreement [Member] Additional Paid-in Capital [Member] | Make-Good Agreement [Member] | Rounding in Reserve Split [Member] Common Stock [Member] | Rounding in Reserve Split [Member] Additional Paid-in Capital [Member] | True-up Agreement [Member] Common Stock [Member] | True-up Agreement [Member] Additional Paid-in Capital [Member] | True-up Agreement [Member] | Series C Preferred Stock [Member] Series C Preferred Stock [Member] Preferred Stock [Member] | Series C Preferred Stock [Member] Series F Preferred Stock [Member] Preferred Stock [Member] | Series C Preferred Stock [Member] Additional Paid-in Capital [Member] | Series C Preferred Stock [Member] | Series D Preferred Stock [Member] Series D Preferred Stock [Member] Preferred Stock [Member] | Series D Preferred Stock [Member] Series F Preferred Stock [Member] Preferred Stock [Member] | Series D Preferred Stock [Member] Additional Paid-in Capital [Member] | Series D Preferred Stock [Member] | Howe [Member] Common Stock [Member] | Howe [Member] Additional Paid-in Capital [Member] | Howe [Member] | Accounts Payable [Member] Series F Preferred Stock [Member] Preferred Stock [Member] | Accounts Payable [Member] Series F Preferred Stock [Member] Additional Paid-in Capital [Member] | Accounts Payable [Member] Series F Preferred Stock [Member] | Accounts Payable [Member] Common Stock [Member] | Accounts Payable [Member] Additional Paid-in Capital [Member] | Accounts Payable [Member] | Convertible Debt [Member] Series F Preferred Stock [Member] Preferred Stock [Member] | Convertible Debt [Member] Series F Preferred Stock [Member] Additional Paid-in Capital [Member] | Convertible Debt [Member] Series F Preferred Stock [Member] | Convertible Debt [Member] Common Stock [Member] | Convertible Debt [Member] Additional Paid-in Capital [Member] | Convertible Debt [Member] | Accounts Payable and Debt [Member] Common Stock [Member] | Accounts Payable and Debt [Member] Additional Paid-in Capital [Member] | Accounts Payable and Debt [Member] | Accrued Salaries [Member] Series D Preferred Stock [Member] Preferred Stock [Member] | Accrued Salaries [Member] Series D Preferred Stock [Member] Additional Paid-in Capital [Member] | Accrued Salaries [Member] Series D Preferred Stock [Member] | Accrued Salaries [Member] Series F Preferred Stock [Member] Preferred Stock [Member] | Debt and Accrued Salaries [Member] Series F Preferred Stock [Member] Preferred Stock [Member] | Debt and Accrued Salaries [Member] Series F Preferred Stock [Member] Additional Paid-in Capital [Member] | Debt and Accrued Salaries [Member] Series F Preferred Stock [Member] | Series C Preferred Stock [Member] Preferred Stock [Member] | Series C Preferred Stock [Member] Additional Paid-in Capital [Member] | Series C Preferred Stock [Member] | Series D Preferred Stock [Member] Preferred Stock [Member] | Series D Preferred Stock [Member] | Series X Preferred Stock [Member] Preferred Stock [Member] | Series X Preferred Stock [Member] Common Stock [Member] | Series X Preferred Stock [Member] Additional Paid-in Capital [Member] | Series X Preferred Stock [Member] | Series A Preferred Stock [Member] Additional Paid-in Capital [Member] | Series A Preferred Stock [Member] | Series F Preferred Stock [Member] Preferred Stock [Member] | Series F Preferred Stock [Member] | Common Stock [Member] | Additional Paid-in Capital [Member] | Stock Subscribed [Member] | Retained Earnings [Member] | Total |
Balance at Dec. 31, 2021 | $ 9,406 | $ 31,000 | $ 242 | $ 42,667 | $ 26,385,728 | $ 132,163 | $ (25,478,332) | $ 1,122,874 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance (in Shares) at Dec. 31, 2021 | 940,644 | 3,100,000 | 24,227 | 4,266,669 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vesting of common stock issued to employees | 4,387 | 4,387 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vesting of stock options issued to employees | 345,578 | 345,578 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common stock issued for services | $ 63 | 101,187 | 101,250 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common stock issued for services (in Shares) | 6,329 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock issued for conversion of debt | $ 82 | $ 86,971 | $ 87,053 | $ 76 | $ 95,512 | $ (95,588) | $ 913 | $ 913,735 | $ 319,648 | $ 29 | $ (29) | $ 636 | $ 577,599 | $ 578,235 | $ 1,070 | $ (1,070) | $ 271 | 180,302 | 180,573 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock issued for conversion of debt (in Shares) | 8,103 | 7,648 | 91,329 | 2,875 | 63,593 | 106,975 | 27,064 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss for the period | (23,236,129) | (23,236,129) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred stock dividends | $ (66,447) | $ (195,299) | $ (60,564) | (322,310) | (322,310) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gain on settlement of accrued payroll | $ (80) | 80 | (88,235) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gain on settlement of accrued payroll (in Shares) | (8,000) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Warrants issued with note payable | 94,672 | 94,672 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fee shares | $ 452 | $ 366,706 | $ 367,158 | $ 1,196 | $ 1,218,466 | $ 1,219,662 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fee shares (in Shares) | 45,235 | 119,527 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance at Dec. 31, 2022 | $ 10,476 | $ 31,000 | $ 242 | $ 46,305 | 29,452,514 | $ 36,575 | (48,714,461) | (19,137,349) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance (in Shares) at Dec. 31, 2022 | 1,047,619 | 3,100,000 | 24,227 | 46,305,375 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vesting of stock options issued to employees | 3,732 | 3,732 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series A dividends previously satisfied | $ 2,454,774,000,000 | $ 2,454,774,000,000 | $ 10,967 | $ 10,967 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common stock issued for services | $ 3,000 | 894,000 | 897,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common stock issued for services (in Shares) | 300,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock issued for conversion of debt | $ (10,476) | $ 22 | $ 1,198,450 | $ 1,187,996 | $ (23,500) | $ 41 | $ 1,610,965 | $ 1,587,506 | $ 2 | $ 146,212 | $ 146,214 | $ 2,476 | $ 77,027 | $ 79,503 | $ 90 | $ 9,523,088 | $ 9,523,178 | $ 571 | 82,885 | 83,456 | $ 1,816 | $ 3,632 | $ 5,448 | $ (5,000) | $ 159,899 | $ 154,906 | $ 65 | $ 22 | $ 2,137,033 | $ 2,137,055 | $ 283 | $ 60,281 | 60,564 | ||||||||||||||||||||||||||||||||||||||
Stock issued for conversion of debt (in Shares) | (1,047,619) | 2,289 | (2,350,000) | 4,055 | 147 | 247,776 | 9,027 | 57,138 | 181,606 | (500,000) | 655 | 2,138 | 28,275 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Forgiveness of related party loans for sale of assets | $ 2,454,774,000,000 | $ 2,454,774,000,000 | $ 10,967 | $ 10,967 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares sold for cash | $ 17 | 1,583,483 | 1,583,500 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares sold for cash (in Shares) | 1,746 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares issued | $ 30 | $ 3,778 | $ 3,808 | $ 30 | $ 36,545 | $ (36,575) | $ 947 | $ 118,423 | $ 119,370 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares issued (in Shares) | 2,952 | 2,926 | 94,738 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Loss for the period | (13,332,363) | (13,332,363) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred stock dividends | $ (85,541) | $ (60,564) | $ (1,566,073) | (1,719,781) | (1,719,781) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gain on settlement of accrued payroll | (24,895) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fee shares | $ 222 | $ 18,537 | $ 18,759 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fee shares (in Shares) | 22,174 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance at Dec. 31, 2023 | $ 2,500 | $ 242 | $ 201 | $ 55,680 | $ 47,856,444 | $ (62,046,824) | $ (14,131,757) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance (in Shares) at Dec. 31, 2023 | 250,000 | 24,227 | 20,507 | 5,567,957 |
CONSOLIDATED STATEMENTS OF CASH
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
CASH FLOWS FROM OPERATING ACTIVITIES | ||
Net loss from continuing operations | $ (11,963,372) | $ (8,276,696) |
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Impairment of assets | 132,000 | 0 |
Depreciation | 0 | 8,916 |
Amortization of right-to-use asset | 0 | 80,379 |
Penalties on notes payable | 1,027,778 | 0 |
Incentive on conversion of Stock | 75,000 | 0 |
Incentive on conversion of debt | 7,644,077 | 0 |
Financing cost - waiver fee shares | 0 | 565,431 |
Gain on waiver fee shares | 0 | (198,273) |
Loss on commitment shares | 119,370 | 34,707 |
(Gain) loss on conversion of accrued salary | 25,000 | (15,032) |
Gain on forgiveness of notes payable | (205,459) | 0 |
(Gain) loss on revaluation of derivative liabilities | 85,773 | 687,178 |
Loss on settlement of accounts payable | 24,895 | 88,235 |
Loss on legal settlement | 18,759 | 0 |
Share-based compensation | 904,540 | 451,215 |
Changes in assets and liabilities: | ||
Prepaid expenses | 51,632 | 165,671 |
Accounts payable and accrued liabilities | 1,491,390 | 2,489,404 |
Operating lease liability, net | (38,948) | (44,033) |
Other current liabilities | 25,000 | (73,286) |
Net cash provided by operating activities – continuing operations | (61,119) | (1,102,415) |
Net cash used in operating activities – discontinued operations | (698,611) | (4,071,425) |
Net cash used in operating activities | (759,730) | (5,173,840) |
CASH FLOWS FROM INVESTING ACTIVITIES | ||
Cash paid for acquisition of fixed assets and construction in progress | 0 | (15,709) |
Net cash used in investing activities – continuing operations | 0 | (15,709) |
Net cash used in investing activities – discontinued operations | 0 | (1,733,117) |
Net cash used in investing activities | 0 | (1,748,826) |
CASH FLOWS FROM FINANCING ACTIVITIES | ||
Proceeds from sales of Series F Preferred Stock, net of fees | 738,500 | 0 |
Principal payments on SBA Loan | (11,555) | 0 |
Principal payments on notes payable related parties | 0 | (235,294) |
Net cash provided by financing activities – continuing operations | 726,945 | 4,822,806 |
Net cash provided by financing activities – discontinued operation | 0 | 971,000 |
Net cash provided by financing activities | 726,945 | 5,793,806 |
Net change in cash and cash equivalents | (32,785) | (1,128,860) |
Cash and cash equivalents at beginning of period | 35,623 | 1,164,483 |
Cash and cash equivalents at end of period | 2,838 | 35,623 |
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: | ||
Interest paid | 0 | 0 |
Income taxes paid | 0 | 0 |
NON-CASH INVESTING AND FINANCING ACTIVITIES: | ||
Preferred stock dividend | 1,719,781 | 322,310 |
Shares issued for Series X dividends | 60,564 | 0 |
Forgiveness of notes for purchase of subsidiary assets | 2,454,774 | 0 |
Discount on notes payable due to warrants | 0 | 94,672 |
(Decrease) Increase in capital expenditures included in accounts payable | 0 | (51,587) |
Stock Subscribed [Member] | ||
NON-CASH INVESTING AND FINANCING ACTIVITIES: | ||
Stock issued for common stock subscribed | 36,575 | 95,512 |
Common Stock [Member] | ||
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Loss on settlement of accounts payable | 80 | |
NON-CASH INVESTING AND FINANCING ACTIVITIES: | ||
Conversion of payable to stock | 5,448 | 0 |
Conversion to Series F Preferred Stock | 981 | |
Series F Preferred Stock [Member] | ||
NON-CASH INVESTING AND FINANCING ACTIVITIES: | ||
Preferred stock dividend | 1,566,073 | |
Series C Preferred Stock [Member] | ||
NON-CASH INVESTING AND FINANCING ACTIVITIES: | ||
Preferred stock dividend | 66,447 | |
Conversion to Series F Preferred Stock | 1,198,472 | 0 |
Series D Preferred Stock [Member] | ||
NON-CASH INVESTING AND FINANCING ACTIVITIES: | ||
Preferred stock dividend | 85,541 | 195,299 |
Conversion of payable to stock | 159,906 | 0 |
Series A accrued dividends reclassified to APIC from prior transactions | 10,967 | 0 |
Conversion to Series F Preferred Stock | 1,611,006 | 0 |
Accounts Payable [Member] | ||
NON-CASH INVESTING AND FINANCING ACTIVITIES: | ||
Conversion of payable to stock | 79,503 | 578,235 |
Accounts Payable [Member] | Series F Preferred Stock [Member] | ||
NON-CASH INVESTING AND FINANCING ACTIVITIES: | ||
Conversion of payable to stock | 146,214 | 0 |
Convertible Notes Payable [Member] | ||
NON-CASH INVESTING AND FINANCING ACTIVITIES: | ||
Conversion of payable to stock | 83,456 | 0 |
Convertible Notes Payable [Member] | Series F Preferred Stock [Member] | ||
NON-CASH INVESTING AND FINANCING ACTIVITIES: | ||
Conversion of payable to stock | 9,523,178 | 0 |
Nonrelated Party [Member] | ||
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Amortization of discount on notes payable | 32,011 | 2,116,194 |
Changes in assets and liabilities: | ||
Accrued interest | 471,564 | 350,508 |
CASH FLOWS FROM FINANCING ACTIVITIES | ||
Proceeds from notes payable, net of discounts | 0 | 4,359,350 |
NON-CASH INVESTING AND FINANCING ACTIVITIES: | ||
Preferred stock dividend | 1,600,241 | 249,868 |
Related Party [Member] | ||
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Amortization of discount on notes payable | 19,587 | 264,385 |
Changes in assets and liabilities: | ||
Accrued interest | (1,716) | 202,682 |
CASH FLOWS FROM FINANCING ACTIVITIES | ||
Proceeds from notes payable, net of discounts | 0 | 698,750 |
NON-CASH INVESTING AND FINANCING ACTIVITIES: | ||
Preferred stock dividend | 119,540 | 72,442 |
Related Party [Member] | Series F Preferred Stock [Member] | ||
NON-CASH INVESTING AND FINANCING ACTIVITIES: | ||
Conversion of payable to stock | $ 2,137,055 | $ 0 |
Description of Business
Description of Business | 12 Months Ended |
Dec. 31, 2023 | |
Accounting Policies [Abstract] | |
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] | Note 1: Description of Business Company Overview Mitesco, Inc. (the “Company,” “we,” “us,” or “our”) was formed in the state of Delaware on January 18, 2012. On December 9, 2015, we restructured our operations and acquired Newco4pharmacy, LLC, a development stage company which sought to acquire compounding pharmacy businesses. As a part of the restructuring, we completed a “spin out” of our former business line. On April 24, 2020, we changed our name to Mitesco, Inc. In October 2023, the Company completed a move of its corporate status to Nevada from Delaware in order to effect reduced costs. The details can be found at: https://www.sec.gov/ix?doc=/Archives/edgar/data/0000802257/000118518523001074/mitesco20231016_8k.htm From 2020 through 2022, our operations were focused on establishing medical clinics utilizing Nurse Practitioners under The Good Clinic name and development and acquisition of telemedicine technology. In March of 2020, we formed an owned subsidiary, Mitesco NA LLC, which holds The Good Clinic LLC, a Colorado limited liability company for our clinic business. The Company had previously established a strategy to address opportunities in Europe seeking technology solutions, or financing situations, through a Dublin based subsidiary, Acelerar Healthcare Holdings Ltd. After a review of its near-term opportunities in North America, the Board of Directors has determined that any efforts in the European community should be discontinued so that it can best focus on its North American operations. We opened our first The Good Clinic in Minneapolis, Minnesota in the first quarter of 2021 and had six operating clinics during the year ended December 31, 2022, with two additional sites under contract. In the fourth quarter of fiscal 2022, we made the strategic decision to reduce our capital needs by closing our clinic operations and releasing our staff. We are a holding company seeking to provide products, services and technology. We have a number of near-term opportunities that we hope to pursue, assuming the capital markets make sufficient funding available at reasonable rates. |
Going Concern
Going Concern | 12 Months Ended |
Dec. 31, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Substantial Doubt about Going Concern [Text Block] | Note 2: Going Concern The accompanying consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts classified as liabilities that might be necessary should the Company be forced to take any such actions. The COVID-19 pandemic, decades-high inflation and concerns about an economic recession in the United States or other major markets has resulted in, among other things, volatility in the capital markets that may have the effect of reducing the Company’s ability to access capital, which could in the future negatively affect the Company’s liquidity. In addition, a recession or market correction due to these factors could materially affect the Company’s business and the value of its common stock. |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 12 Months Ended |
Dec. 31, 2023 | |
Accounting Policies [Abstract] | |
Significant Accounting Policies [Text Block] | Note 3: Summary of Significant Accounting Policies Basis of Accounting Principles of Consolidation Use of Estimates - Cash - Property and Equipment - Years Office equipment 3 to 5 Furniture & fixtures 3 to 7 Machinery & equipment 3 to 10 Leasehold improvements Term of lease Revenue Recognition For changes in credit issues assessed at the date of service, the Company will prospectively recognize those amounts in other operating expenses on the statement of operations. For periods prior to the adoption of ASC 606, the provision for bad debts has been presented consistent with the previous revenue recognition standards that required it to be presented separately as a component of net operating revenues. Our revenues generally relate to net patient fees received from various payers and patients themselves under contracts in which our performance obligations are to provide services to the patients. Revenues are recorded during the period our obligations to provide services are satisfied. The contractual relationships with patients, in most cases, also involve a third-party payer (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed care health plans and commercial insurance companies) the third-party payers. The payment arrangements with third-party payers for the services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates for services or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals. Stock-Based Compensation - Equity instruments issued to those other than employees are recognized pursuant to FASB issued ASU 2018-07, Compensation – Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting. This ASU relates to the accounting for non-employee share-based payments. The amendment in this update expands the scope of Topic 718 to include all share-based payment transactions in which a grantor acquired goods or services to be used or consumed in a grantor’s own operations by issuing share-based payment awards. The ASU excludes share-based payment awards that relate to: (1) financing to the issuer; or (2) awards granted in conjunction with selling goods or services to customers as part of a contract accounted for under Topic 606, Revenue from Contracts from Customers. The share-based payments are to be measured at grant-date fair value of the equity instruments that the entity is obligated to issue when the goods or service has been delivered or rendered and all other conditions necessary to earn the right to benefit from the equity instruments have been satisfied. Convertible Instruments Derivative Financial Instruments Common Stock Purchase Warrants - Per Share Data - Income Taxes - Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all the deferred tax assets will not be realized. The Company has determined that a valuation allowance is needed due to recent taxable net operating losses and the limited taxable income in the carry back periods. The effect on deferred tax assets and liabilities of a change in tax rates is recognized as income or expense in the period that includes the enactment date. Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes and certain tax loss carryforwards, less any valuation allowance. The Company accounts for uncertain tax positions as required in that a position taken or expected to be taken in a tax return is recognized in the consolidated financial statements when it is more likely than not (i.e., a likelihood of more than 50%) that the position would be sustained upon examination by tax authorities. A recognized tax position is then measured at the largest amount of benefit that is greater than 50% of being realized upon ultimate settlement. The Company does not have any material unrecognized tax benefits. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as components of interest expense and other expense, respectively, in arriving at pretax income or loss. The Company does not have any interest and penalties accrued. The Company is no longer subject to U.S. federal, state, and local income tax examinations for the years before 2012. Impairment of Long-Lived Assets - Financial Instruments and Fair Values - Level 1 – inputs include exchange quoted prices for identical instruments and are the most observable. Level 2 – inputs include brokered and/or quoted prices for similar assets and observable inputs such as interest rates. Level 3 – inputs include data not observable in the market and reflect management judgment about the assumptions market participants would use in pricing the asset or liability. The use of observable and unobservable inputs and their significance in measuring fair value are reflected in our hierarchy assessment. The carrying amount of cash, prepaid assets, accounts payable and accrued liabilities approximate fair value due to the short-term maturities of these instruments. Because cash and cash equivalents are readily liquidated, management classifies these values as Level 1. The fair value of the derivative liabilities approximates their book value as the instruments are short-term in nature and contain market rates of interest. Because there is no ready market or observable transactions, management classifies the derivative liabilities as Level 3. Recent Accounting Standards ASU 2023-07 Segment Reporting ( Topic 280 Improvements to Reportable Segment Disclosures, In December 2023, the FASB issued ASU 2023-09 Income Taxes ( Topic 740 Improvements to Income Tax Disclosures, There are various other updates recently issued, most of which represent technical corrections to the accounting literature or application to specific industries and are not expected to a have a material impact on the Company’s consolidated financial position, results of operations or cash flows. |
Discontinued Operations
Discontinued Operations | 12 Months Ended |
Dec. 31, 2023 | |
Discontinued Operations and Disposal Groups [Abstract] | |
Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] | Note 4: Discontinued Operations On December 8, 2023, the Company sold the remaining assets of The Good Clinic, LLC to Leading Primary Care LLC, a company organized by Michael C. Howe, the former CEO of The Good Clinic, LLC for total consideration of approximately $2.5 million. ASC 360-10-45-9 requires that a long-lived asset (disposal group) to be sold shall be classified as held for sale in the period in which a set of criteria have been met, including criteria that the sale of the asset (disposal group) is probable and actions required to complete the plan indicate that it is unlikely that significant changes to the plan will be made or that the plan will be withdrawn. This criteria was achieved on December 8, 2023. Additionally, the discontinued operations are comprised of the entirety of The Good Clinic, LLC. For comparability purposes certain prior period line items relating to the assets held for sale have been reclassified and presented as discontinued operations for all periods presented in the accompanying condensed consolidated statements of net loss and comprehensive loss and the condensed consolidated balance sheets. The following information presents the major classes of line item of assets and liabilities included as part of discontinued operations in the consolidated balance sheets: December 31, December 31, 2023 2022 Current assets - discontinued operations: Accounts receivable - 30,943 Prepaid expenses and deposits - 62,090 Total current assets - discontinued operations $ - $ 93,033 Noncurrent assets - discontinued operations: Property and equipment $ - $ 1,832,973 Right-of-use assets - 460,254 Total noncurrent assets - discontinued operations $ - $ 2,293,227 Accrued interest – related party - 150,039 Note payable – related party - 1,995,667 Total current liabilities - discontinued operations $ - $ 2,145,706 The following information presents the major classes of line items constituting the after-tax loss from discontinued operations in the consolidated statements of operations: Year Ended December 31, December 31, 2023 2022 Revenue $ 181,012 $ 690,533 Cost of goods sold - 76,530 Gross margin 181,012 614,003 Selling, general, and administrative expenses (1,166,121 ) (7,046,984 ) Impairment of assets (2,211,462 ) (7,597,558 ) Other (income) expense: Interest expense (306,032 ) (1,105,256 ) Gain on sale of assets 11,268 - Gain on settlement of accounts payable 81,263 - Gain on settlement of operating lease 2,041,080 - Loss from discontinued operations, net of tax $ (1,368,991 ) $ (14,959,433 ) The following information presents the major classes of line items constituting significant operating and investing cash flow activities in the consolidated statements of cash flows relating to discontinued operations: Year Ended December 31, December 31, 2023 2022 Depreciation expense $ 81,765 $ 804,882 Cash used for construction in progress and fixed assets $ - $ (1,733,117 ) Impairment of RTU assets $ 544,063 $ - Impairment of property and equipment $ 1,667,399 $ - |
Related Party Transactions
Related Party Transactions | 12 Months Ended |
Dec. 31, 2023 | |
Related Party Transactions [Abstract] | |
Related Party Transactions Disclosure [Text Block] | Note 5: Related Party Transactions The Company was involved in a significant number of fundraising transactions with related parties during the years ended December 31, 2023 and 2022. See notes 10 and 12. |
Accounts Payable and Accrued Li
Accounts Payable and Accrued Liabilities | 12 Months Ended |
Dec. 31, 2023 | |
Payables and Accruals [Abstract] | |
Accounts Payable and Accrued Liabilities Disclosure [Text Block] | Note 6: Accounts Payable and Accrued Liabilities Accounts payable and accrued liabilities consisted of the following at December 31, 2023 and 2022: December 31, December 31, 2023 2022 Trade accounts payable $ 7,094,334 $ 6,761,793 Accrued payroll and payroll taxes 743,778 590,915 Other - 507 Total accounts payable and accrued liabilities $ 7,838,112 $ 7,353,215 Accounts Payable Exchanged for Common Stock On January 5, 2022, we entered into an exchange agreement with Gardner Builders Holdings, LLC (“Gardner”, the “Gardner Agreement”). Pursuant to the Gardner Agreement, we have authorized the issuance of shares of the Company’s restricted common stock to Gardner in exchange for the certain accounts payable and additional amounts due to Gardner as defined below. The Gardner Agreement settles certain amounts owed by us to Gardner (the “Accounts Payable Amount”) as well as upcoming amounts that will become due between the date of the Gardner Agreement and April 1, 2022. The Gardner Agreement also settled incurred interest and penalties on the amounts owed through January 5, 2022, as well as future interest payments on amounts to be incurred in the first quarter of 2022 (collectively, the “Additional Costs”, and combined with the Accounts Payable Amount, the “Company Debt Obligations”). The Accounts Payable Amount is $500,000, the Additional Costs is $294,913 and the conversion price is $12.50. As a result, 63,593 Restricted Shares were authorized to be issued. Our Board of Directors approved the Gardner Agreement on January 5, 2022. |
Right to Use Assets and Lease L
Right to Use Assets and Lease Liabilities – Operating Leases | 12 Months Ended |
Dec. 31, 2023 | |
Disclosure Text Block [Abstract] | |
Lessee, Operating Leases [Text Block] | Note 7: Right to Use Assets and Lease Liabilities Operating Leases The Company had operating leases for its clinics for which the Company is currently in negotiations with the Lessors to settle the remaining amounts owed after closing the clinic facilities. The Company’s lease expense was entirely comprised of operating leases and is reported as a component of discontinued operations as a result closing of the clinics and the subsequent sale of the assets. During the year ended December 31, 2022, the Company recognized an impairment of RTU assets in the amount of $3,185,591 in connection with the closing of its clinics during the period. During the year ended December 31, 2023, the Company recognized an additional impairment in the amount of $0.5 million in connection with its remaining leased properties. Right to use assets – operating leases are summarized below: December 31, 2023 December 31, 2022 Right to use assets, net $ - $ 83,810 Operating lease liabilities are summarized below: December 31, 2023 December 31, 2022 Lease liability $ 99,477 $ 4,379,724 Less: current portion (99,477 ) (442,866 ) Lease liability, non-current $ - $ 3,936,858 As a result of closing the facilities, the Company has made no further lease payments during the year ending December 31, 2023. As of December 31, 2023 the Company has either settled amounts owed or entered in into default judgements for all leases except for the office lease. For all leases for which a legal settlement have been entered into, all amounts have been reclassified to legal settlements as of December 31, 2023. For the period ended December 31, 2024 $ 99,477 For the period ended December 31, 2025 - For the period ended December 31, 2026 - For the period ended December 31, 2027 - For the period ended December 31, 2028 - Thereafter - Total $ 99,477 Less: Present value discount - Lease liability $ 99,477 As of December 31, 2023, the Company has entered into settlement agreements for certain of our lease in the amount of $2,219,886 which is recorded as Legal Settlements |
SBA Loan Payable
SBA Loan Payable | 12 Months Ended |
Dec. 31, 2023 | |
Small Business Administration Loan Payable Abstract | |
Small Business Administration Loan Payable [Text Block] | Note 8: SBA Loan Payable PPP Loan Conversion to SBA Loan During March 2020, in response to the COVID-19 crisis, the federal government announced plans to offer loans to small businesses in various forms, including the Payroll Protection Program, or “PPP”, established as part of the Corona Virus Aid, Relief and Economic Security Act (“CARES Act”) and administered by the U.S. Small Business Administration (the “SBA”). On April 25, 2020, the Company entered an unsecured Promissory Note with Bank of America for a loan in the original principal amount of $460,400, and the Company received the full amount of the loan proceeds on May 4, 2020 (the “PPP Loan”). The PPP Loan bears interest at the rate of 1% per year. During the year ended December 31, 2022, the Company accrued interest in the amount of $4,632. On July 12, 2023, the Company received confirmation of a payment plan arrangement from the SBA. Pursuant to this payment plan, the Company agreed to pay a minimum of $2,595 each month until the loan is paid in full in July 2028. The SBA confirmed the balance due on the loan, including principal and interest, was $467,117. The Company will amortize the balance due on the loan including interest at the original PPP loan rate of 1% per annum; a gain on restructure of debt in the amount of $40,622 was recorded on this transaction during the year ended December 31, 2023, and the balance of the loan was recorded at the amount of $433,343 representing the net cash flows discounted at 1%. During the year ended December 31, 2023, the Company made principal payments of $11,555 on this loan and recorded interest in the amount of $5,719. |
Notes Payable
Notes Payable | 12 Months Ended |
Dec. 31, 2023 | |
Notes Payable [Line Items] | |
Debt Disclosure [Text Block] | Note 9: Notes Payable The following table summarizes the outstanding notes payable as of December 31, 2023 and 2022, respectively: December 31, 2023 December 31, 2022 AJB Note $ - $ 750,000 Anson Investments note - 562,500 Anson East note - 187,500 GS Capital note - 277,777 Kishon Note 431,666 277,777 Finnegan Note 1 51,765 51,765 Finnegan Note 2 32,353 32,353 Dragon Note - 647,059 Mackay Note - 323,530 Schrier Note 25,882 25,882 Nommsen Note 64,705 64,705 Caplan Note 64,705 64,705 Finnegan Note 3 32,353 32,353 Enright Note - 132,000 Mitchell Note 78,100 78,100 Lightmas Note 66,000 66,000 Lewis Note 33,000 33,000 Goff Note 33,000 33,000 Hagan Note 110,000 110,000 Darling Note - 220,000 Leath Note 55,000 55,000 Cavalry Note - 500,000 Mercer Note 1 - 300,000 Pinz Note - 30,000 Mercer Note 2 - 100,000 Mercer Note 3 - 125,000 Notes Payable $ 1,078,529 $ 5,080,006 Less: Discount - (32,010 ) Notes payable - net of discount $ 1,078,529 $ 5,047,996 Current Portion, net of discount $ 1,078,529 $ 5,047,996 Long-term portion, net of discount $ - $ - AJB Note On March 18, 2022, the Company entered into a Securities Purchase Agreement (the “AJB Agreement”) with AJB Capital Investments, LLC (“AJB”) with respect to the sale and issuance to AJB of: (i) an initial commitment fee in the amount of $430,000 in the form of 34,400 shares (the “AJB Commitment Fee Shares”) of the Company’s Common Stock, (ii) a promissory note in the aggregate principal amount of $750,000 (the “AJB Note”), and (iii) Common Stock Purchase Warrants to purchase 15,000 shares of the Company’s Common Stock (the “AJB Warrants”). The AJB Note and AJB Warrants were issued on March 17, 2022 and were held in escrow pending effectiveness of the AJB Agreement. Should AJB receive net proceeds of less than $430,000 from the sale of the AJB Commitment Fee Shares, the Company will issue additional shares to AJB or pay the shortfall amount to AJB in cash (the “AJB True-up Obligation”. The terms of the AJB Agreement resulted in the Company recording a derivative liability in the initial amount of $106,608. On November 18, 2022, the Company issued 91,328 shares of common stock to AJB and recorded a loss in the amount of $9,007 in connection with the settlement of the AJB True-up Obligation. See notes 12 and 14. The AJB Note was issued in the principal amount of $750,000 for a purchase price of $675,000, resulting in an original issue discount of $75,000, and has a due date, as extended, of March 17, 2023. The AJB Note bears interest at the rate of 10% per year for the first six months and 12% thereafter. In the event of default as defined in the AJB Note this rate will increase to 18% and the AJB Note will become convertible at a price per share equal to the lowest trading price during the previous twenty trading days prior to the conversion date. The AJB Note entered default status on October 6, 2022. The AJB Commitment Fee Shares and AJB Warrants resulted in a discount to the AJB Note in the amount of $349,914. The Company charged the amount of $62,000 to interest on the AJB Note during the year ended December 31, 2022. Discounts in the amount of $424,914 were amortized to interest expense during the year ended December 31, 2022, and total discounts in the amount of $0 remained outstanding at December 31, 2022. Principal and accrued interest in the amounts $750,000 and $22,833, respectively, were due on the AJB Note at December 31, 2022. During the year ended December 31, 2023, a default penalty in the amount of $375,000 and an additional fee in the amount of $15,000 were added to the principal amount of the AJB note. During the year ended December 31, 2023, interest in the amount of $69,167 was accrued on the AJB Note. On April 11, 2023, an equity investment incentive in the amount of $800,800 representing 65% of the total amount due under the AJB Note, along with original principal of $750,000, the default penalty of $375,000, the fee of $15,000, and accrued interest of $92,000 (a total of $2,032,800) was converted to 2,033 shares of the Company’s Series F Preferred Stock. Other than the equity investment incentive of $800,800, there was no additional gain or loss recognized on this transaction as the Series F Preferred Stock was issued at its face value of $1,000 per share. At December 31, 2023, there were no amounts due under the AJB Note. Anson Investments Note On April 6, 2022, the Company entered into a Securities Purchase Agreement (the “Anson Investments Agreement”) with Anson Investments Master Fund LP (“Anson Investments”) with respect to the sale and issuance to Anson Investments of: (i) an initial commitment fee in the amount of $322,500 in the form of 25,800 shares (the “Anson Investments Commitment Fee Shares”) of the Company’s Common Stock, (ii) a promissory note in the aggregate principal amount of $562,500 (the “Anson Investments Note”), and (iii) Common Stock Purchase Warrants to purchase 11,250 shares of the Common Stock (the “Anson Investments Warrants”). Should Anson Investments receive net proceeds of less than $322,500 from the sale of the Anson Investments Commitment Fee Shares, the Company will issue additional shares to Anson Investments or pay the shortfall amount to Anson Investments in cash. The terms of the Anson Investments Agreement resulted in the Company recording a derivative liability in the initial amount of $27,040. The Anson Investments Note was issued in the principal amount of $562,500 for a purchase price of $506,250 resulting in an original issue discount of $56,250. The Anson Investments Note has a due date of October 6, 2022 and bears interest at the rate of 10% per year for the first six months and 12% thereafter. In the event of default as defined in the Anson Investments Note this rate will increase to 18% and the Anson Investment Note will become convertible at a price per share equal to the lowest trading price during the previous twenty trading days prior to the conversion date. The Anson Investments Note entered default status on October 6, 2022. The Anson Investments Commitment Fee Shares and Anson Investments Warrants resulted in a discount to the Anson Investments Note in the amount of $416,375. The Company charged the amount of $68,844 to interest on the Anson Investments note during the year ended December 31, 2022. Discounts in the amount of $472,625 were amortized to interest expense during the year ended December 31, 2022, and total discounts in the amount of $0 remained outstanding at December 31, 2022. Principal and accrued interest in the amounts $562,500 and $41,500, respectively, were due on the AJB Note at December 31, 2022. During the year ended December 31, 2023, a default penalty in the amount of $281,250 and an additional fee in the amount of $15,000 were added to the principal amount of the Anson Investments Note. During the year ended December 31, 2023, interest in the amount of $ $27,157 was accrued on the Anson Investments Note. On April 11, 2023, an equity investment incentive in the amount of $602,815 representing 65% of the total amount due under the Anson Investments Note, along with original principal of $562,500, the default penalty of $281,250, the fee of $15,000, and accrued interest of $68,657 (a total of $1,530,222) was converted to 1,531 shares of the Company’s Series F Preferred Stock. Other than the equity investment incentive of $602,815, there was no gain or loss recognized on this transaction as the Series F Preferred Stock was issued at its face value of $1,000 per share. At December 31, 2023, there were no amounts due under the Anson Investments Note. Anson East Note On April 6, 2022, the Company entered into a Securities Purchase Agreement (the “Anson East Agreement”) with Anson East Master Fund LP (“Anson East”) with respect to the sale and issuance to Anson East of: (i) an initial commitment fee in the amount of $107,500 in the form of 8,600 shares (the “Anson East Commitment Fee Shares”) of the Company’s Common Stock, (ii) a promissory note in the aggregate principal amount of $187,500 (the “Anson East Note”), and (iii) Common Stock Purchase Warrants to purchase 3,750 shares of the Company’s common stock (the “Anson East Warrants”). Should Anson East receive net proceeds of less than $107,500 from the sale of the Anson East Commitment Fee Shares, the Company will issue additional shares to Anson East or pay the shortfall amount to Anson East in cash. The terms of the Anson East Agreement resulted in the Company recording a derivative liability in the initial amount of $9,014. The Anson East Note was issued in the principal amount of $187,500 for a purchase price of $168,750 resulting in an original issue discount of $18,750. The Anson East Note has a due date of October 6, 2022 and bears interest at the rate of 10% per year for the first six months and 12% thereafter. In the event of default as defined in the Anson East Note this rate will increase to 18%, and the Anson East Note will become convertible at a price per share equal to the lowest trading price during the previous twenty trading days prior to the conversion date. The Anson East Note entered default status on October 6, 2022. The Anson East Commitment Fee Shares and Anson East Warrants resulted in a discount to the Anson East Note in the amount of $147,290. The Company charged the amount of $22,948 to interest on the Anson Investments note during the year ended December 31, 2022. Discounts in the amount of $166,040 were amortized to interest expense during the year ended December 31, 2022, and total discounts in the amount of $0 remained outstanding at December 31, 2022. Principal and accrued interest in the amounts $187,500 and $13,833, respectively, were due on the Anson East Note at December 31, 2022. During the year ended December 31, 2023, a default penalty in the amount of $93,750 and an additional fee in the amount of $15,000 were added to the principal amount of the Anson East Note. During the year ended December 31, 2023, the amount of $9,552 was accrued on the Anson East Note. On April 11, 2023, an equity investment incentive in the amount of $207,763 representing 65% of the total amount due under the Anson East Note, along with original principal of $187,500, the default penalty of $93,750, the fee of $15,000, and accrued interest of $23,385 (a total of $527,398) was converted to 528 shares of the Company’s Series F Preferred Stock. Other than the equity investment incentive of $207,763, there was no gain or loss recognized on this transaction as the Series F Preferred Stock was issued at its face value of $1,000 per share. At December 31, 2023, there were no amounts due under the Anson East Note. GS Capital Note On April 18, 2022, the Company entered into a Securities Purchase Agreement (the “GS Capital Agreement”) with GS Capital Investments, LLC (“GS Capital”) with respect to the sale and issuance to GS Capital of: (i) an initial commitment fee in the amount of $159,259 in the form of 12,741 shares (the “GS Capital Commitment Fee Shares”) of the Company’s Common Stock, (ii) a promissory note in the aggregate principal amount of $277,777 (the “GS Capital Note”), and (iii) Common Stock Purchase Warrants to purchase 5,556 shares of the Company’s common stock (the “GS Capital Warrants”). Should GS Capital receive net proceeds of less than $159,259 from the sale of the GS Capital Commitment Fee Shares, the Company will issue additional shares to GS Capital or pay the shortfall amount to GS Capital in cash. The terms of the GS Capital Agreement resulted in the Company recording a derivative liability in the initial amount of $21,920. The GS Capital Note was issued in the principal amount of $277,777 for a purchase price of $250,000 resulting in an original issue discount of $27,777. The GS Capital Note has a due date of November 10, 2022 and bears interest at the rate of 10% per year for the first six months and 12% thereafter. In the event of default as defined in the GS Capital Note this rate will increase to 18%, and the GS Capital Note will become convertible at a price per share equal to the lowest trading price during the previous twenty trading days prior to the conversion date. The GS Capital Note entered default status on October 19, 2022. The GS Capital Commitment Fee Shares and GS Capital Warrants resulted in a discount to the GS Capital Note in the amount of $162,158. The Company charged the amount of $32,155 to interest on the GS Capital Note during the year ended December 31, 2022. Discounts in the amount of $212,435 were amortized to interest expense during the year ended December 31, 2022, and total discounts in the amount of $0 remained outstanding at December 31, 2022. Principal and accrued interest in the amounts $277,777 and $19,578, respectively, were due on the GS Capital Note at December 31, 2022. During the year ended December 31, 2023, GS Capital converted an aggregate amount of $72,777 of principal and $8,679 of accrued interest in the GS Capital Note into an aggregate of 57,140 shares of the Company’s common stock at an average price of $1.46 per share. These conversions were made pursuant to the terms of the GS Capital Note, and no gain or loss was recorded on these transactions. During the year ended December 31, 2023, a default penalty in the amount of $138,889 and an additional fee in the amount of $15,000 were added to the principal amount of the GS Capital Note. During the year ended December 31, 2023, interest in the amount $13,965 was accrued on the GS Capital Note. On April 11, 2023, an equity investment incentive in the amount of $249,439 representing 65% of the total amount due under the GS Capital Note, along with original principal of $205,000, the default penalty of $138,889, the fee of $15,000, and accrued interest of $24,864 (a total of $633,192) was converted to 634 shares of the Company’s Series F Preferred Stock. Other than the equity investment incentive of $249,439, there was no gain or loss recognized on this transaction as the Series F Preferred Stock was issued at its face value of $1,000 per share. At December 31, 2023, there were no amounts due under the GS Capital Note. Kishon Note On May 10, 2022, the Company entered into a Securities Purchase Agreement (the “Kishon Agreement”) with Kishon Investments, LLC (“Kishon”) with respect to the sale and issuance to Kishon of: (i) an initial commitment fee in the amount of $159,259 in the form of 12,741 shares (the “Kishon Commitment Fee Shares”) of the Company’s Common Stock, (ii) a promissory note in the aggregate principal amount of $277,777 (the “Kishon Note”), and (iii) Common Stock Purchase Warrants to purchase 5,556 shares of the Company’s common stock (the “Kishon Warrants”). Should Kishon receive net proceeds of less than $159,259 from the sale of the Kishon Commitment Fee Shares, the Company will issue additional shares to Kishon or pay the shortfall amount to Kishon in cash. The terms of the Kishon Agreement resulted in the Company recording a derivative liability in the initial amount of $27,793. The Kishon Note was issued in the principal amount of $277,777 for a purchase price of $250,000 resulting in an original issue discount of $27,777. The Kishon Note has a due date of November 10, 2022 and bears interest at the rate of 10% per year for the first six months and 12% thereafter. In the event of default as defined in the Kishon Note this rate will increase to 18%, and the Kishon Note will become convertible at a price per share equal to the lowest trading price during the previous twenty trading days prior to the conversion date. The Kishon Note entered default status on November 11, 2022. The Kishon Commitment Fee Shares and Kishon Warrants resulted in a discount to the Kishon Note in the amount of $138,492. The Company charged the amount of $28,624 to interest on the Kishon Note during the year ended December 31, 2022. Discounts in the amount of $181,269 were amortized to interest expense during the year ended December 31, 2022, and total discounts in the amount of $0 remained outstanding at December 31, 2022. Principal and accrued interest in the amounts $277,777 and $17,822, respectively, were due on the Kishon Note at December 31, 2022. During the year ended December 31, 2023, a default penalty in the amount of $138,889 and an additional fee in the amount of $15,000 were added to the principal amount of the Kishon Note. During the year ended December 31, 2023, interest in the amount of $71,087 was accrued on the Kishon Note. At December 31, 2023, principal and interest in the amount of $431,666 and $88,909, respectively, were due on the Kishon Note. This note was in default at December 31, 2023 and 2022. Finnegan Note 1 On May 23, 2022, the Company issued a 10% Promissory Note in the principal amount of $47,059 to Jessica Finnegan (the “Finnegan Note 1”). The Finnegan Note 1 bears interest at the rate of 10% per annum accrued monthly and has a maturity date that is the earlier of (i) November 20, 2022, as extended, or (ii) five (5) business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE. The purchase price of the Finnegan Note 1 was $40,000; the amount payable at maturity will be $47,059 plus 10% of that amount plus any accrued and unpaid interest. Following an event of default as defined in the Finnegan Note 1, the principal amount shall bear interest for each day until paid at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The Finnegan Note 1 entered default status on November 21, 2022, and the interest rate increased to 18%. The Finnegan Note 1 contains a “most favored nations” clause that provides that, so long as the note is outstanding, if the Company issues any new security which Ms. Finnegan reasonably believes contains a term that is more favorable than those in the Finnegan Note 1, the Company shall notify Ms. Finnegan of such term, and such term, at the option of Ms. Finnegan, shall become a part of the Finnegan Note 1. In addition, Ms. Finnegan received five-year warrants to purchase 386 shares of common stock at a price of $25.00 per share with a fair value of $2,000 at the date of issuance, and 1,930 shares of common stock with a value of $3,240; these amounts were recorded as discounts to the Finnegan Note 1. Interest in the amount of $3,285 was accrued on the Finnegan Note 1 during the year ended December 31, 2022. Discounts in the amount of $17,005 were amortized to interest expense during the year ended December 31, 2022, and total discounts in the amount of $0 remained outstanding at December 31, 2022. Principal and accrued interest in the amounts $51,765 and $3,285, respectively, were due on the Finnegan Note 1 at December 31, 2022. During the year ended December 31, 2023, interest in the amount of $8,604 was accrued on the Finnegan Note 1; principal and accrued interest in the amount of $51,765 and $11,889, respectively, were due on this note at December 31, 2023. This note was in default at December 31, 2023. Finnegan Note 2 On May 26, 2022, the Company issued a 10% Promissory Note in the principal amount of $29,412 to Jessica Finnegan (the “Finnegan Note 2”). The Finnegan Note 2 bears interest at the rate of 10% per annum accrued monthly and has a maturity date that is the earlier of (i) November 30, 2022, or (ii) five business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE. The purchase price of the Finnegan Note 2 was $25,000; the amount payable at maturity will be $29,412 plus 10% of that amount plus any accrued and unpaid interest. Following an event of default as defined in the Finnegan Note 2, the principal amount shall bear interest for each day until paid at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The Finnegan Note 2 entered default status on December 1, 2022, and the interest rate increased to 18%. The Finnegan Note 2 contains a “most favored nations” clause that provides that, so long as the note is outstanding, if the Company issues any new security which Ms. Finnegan reasonably believes contains a term that is more favorable than those in the Finnegan Note 2, the Company shall notify Ms. Finnegan of such term, and such term, at the option of Ms. Finnegan, shall become a part of the Finnegan Note 2. In addition, Ms. Finnegan received five-year warrants to purchase 242 shares of common stock at a price of $25.00 per share with a fair value of $1,250 at the date of issuance, and 242 shares of common stock with a value of $2,025; these amounts were recorded as discounts to the Finnegan Note 2. Interest in the amount of $1,965 was accrued on the Finnegan Note 2 during the year ended December 31, 2022. Discounts in the amount of $10,625 were amortized to interest expense during the year ended December 31, 2022, and total discounts in the amount of $0 remained outstanding at December 31, 2022. Principal and accrued interest in the amounts $32,353 and $1,965, respectively, were due on the Finnegan Note 2 at December 31, 2022. During the year ended December 31, 2023, interest in the amount of $5,376 was accrued on the Finnegan Note 2; principal and accrued interest in the amount of $32,353 and $7,341, respectively, were due on this note at December 31, 2023. This note was in default at December 31, 2023. Dragon Note On June 9, 2022, the Company issued a 10% Promissory Note in the principal amount of $588,235 (the “Dragon Note”) to Dragon Dynamic Funds Platform Ltd (“Dragon Dynamic”). The Dragon Note bears interest at the rate of 10% per annum accrued monthly and has a maturity date that is the earlier of (i) December 9, 2022, or (ii) five business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE. The purchase price of the Dragon Note was $500,000; the amount payable at maturity will be $588,235 plus 10% of that amount plus any accrued and unpaid interest. Costs in the amount of $47,500 were charged to discount on the Dragon Note. Following an event of default as defined in the Dragon Note, the principal amount shall bear interest for each day until paid at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The Dragon Note entered default status on December 10, 2022, and the interest rate increased to 18%. The Dragon Note contains a “most favored nations” clause that provides that, so long as the note is outstanding, if the Company issues any new security which Dragon Dynamic reasonably believes contains a term that is more favorable than those in the Dragon Note, the Company shall notify Dragon Dynamic of such term, and such term, at the option of Dragon Dynamic, shall become a part of the Dragon Note. In addition, Dragon Dynamic received five-year warrants to purchase 4,824 shares of common stock at a price of $25.00 per share with a fair value of $21,500 at the date of issuance, and 4,824 shares of common stock with a value of $44,000; these amounts were recorded as discounts to the Dragon Note. Interest in the amount of $35,874 was accrued on the Dragon Note during the year ended December 31, 2022. Discounts in the amount of $260,059 were amortized to interest expense during the year ended December 31, 2022, and total discounts in the amount of $0 remained outstanding at December 31, 2022. Principal and accrued interest in the amounts $647,059 and $35,874, respectively, were due on the Dragon Note at December 31, 2022. During the year ended December 31, 2023, interest in the amount of $30,204 was accrued on the Dragon Note. On April 11, 2023, an equity investment incentive in the amount of $463,539 representing 65% of the total amount due under the Dragon Note, along with original principal of $647,059 and accrued interest of $66,078 (a total of $1,176,676) was converted to 1,177 shares of the Company’s Series F Preferred Stock. Other than the equity investment incentive of $463,539, there was no gain or loss recognized on this transaction as the Series F Preferred Stock was issued at its face value of $1,000 per share. At December 31, 2023, there were no amounts due under the Dragon Note. Mackay Note On July 7, 2022, the Company issued a 10% Promissory Note in the principal amount of $294,118 to Mackay Investments, LLC (the “Mackay Note”). The Mackay Note bears interest at the rate of 10% per annum accrued monthly and has a maturity date that is the earlier of (i) August 10, 2022, or (ii) five business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE. The purchase price of the Mackay Note was $250,000; the amount payable at maturity will be $294,118 plus 10% of that amount plus any accrued and unpaid interest. Following an event of default as defined in the Mackay Note, the principal amount shall bear interest for each day until paid at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The Mackay Note entered default status on August 11, 2022, and the interest rate increased to 18%. The Mackay Note contains a “most favored nations” clause that provides that, so long as the note is outstanding, if the Company issues any new security which Mackay Investments, LLC reasonably believes contains a term that is more favorable than those in the Mackay Note, the Company shall notify Mackay Investments, LLC of such term, and such term, at the option of Mackay Investments, LLC , shall become a part of the Mackay Note. In addition, Mackay Investments, LLC received five-year warrants to purchase 2,412 shares of common stock at a price of $25.00 per share with a fair value of $10,250 at the date of issuance, and 2,412 shares of common stock with a value of $44,118; these amounts were recorded as discounts to the Mackay Note. Interest in the amount of $20,193 was accrued on the Mackay Note during the year ended December 31, 2022. Discounts in the amount of $96,280 were amortized to interest expense during the year ended December 31, 2022, and total discounts in the amount of $0 remained outstanding at December 31, 2022. Principal and accrued interest in the amounts $323,530 and $20,193, respectively, were due on the Mackay Note at December 31, 2022. During the year ended December 31, 2023, interest in the amount of $43,614 was accrued on the Mackay Note. On September 29, 2023, an equity investment incentive in the amount of $258,269 representing 65% of the total amount due under the Mackay Note, along with original principal of $294,118, premium of $29,412, accrued interest of $63,807, and fee of $10,000 (a total of $655,606) was converted to 656 shares of the Company’s Series F Preferred Stock. Other than the equity investment incentive of $258,269, there was no gain or loss recognized on this transaction as the Series F Preferred Stock was issued at its face value of $1,000 per share. At December 31, 2023, there were no amounts due under the Mackay Note. Schrier Note On July 7, 2022, the Company issued a 10% Promissory Note in the principal amount of $23,259 to Charles Schrier (the “Schrier Note”). The Schrier Note bears interest at the rate of 10% per annum accrued monthly and has a maturity date that is the earlier of (i) January 8, 2023, or (ii) five business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE. The purchase price of the Schrier Note was $20,000; the amount payable at maturity will be $23,529 plus 10% of that amount plus any accrued and unpaid interest. Following an event of default as defined in the Schrier Note, the principal amount shall bear interest for each day until paid at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The Schrier Note contains a “most favored nations” clause that provides that, so long as the note is outstanding, if the Company issues any new security which Mr. Schrier reasonably believes contains a term that is more favorable than those in the Schrier Note, the Company shall notify Mr. Schrier of such term, and such term, at the option of Mr. Schrier, shall become a part of the Schrier Note. In addition, Mr. Schrier received five-year warrants to purchase 193 shares of common stock at a price of $25.00 per share with a fair value of $820 at the date of issuance, and 193 shares of common stock with a value of $1,000; these amounts were recorded as discounts to the Schrier Note. Interest in the amount of $1,141 was accrued on the Schrier Note during the year ended December 31, 2022. Discounts in the amount of $7,367 were amortized to interest expense during the year ended December 31, 2022, and total discounts in the amount of $335 remained outstanding at December 31, 2022. Principal and accrued interest in the amounts $25,882 and $1,141, respectively, were due on the Schrier Note at December 31, 2022. During the year ended December 31, 2023, interest in the amount of $4,242 was accrued on the Schrier Note and $335 of discount was amortized to interest expense; principal and accrued interest in the amount of $25,882 and $5,383, respectively, were due on this note at December 31, 2023. This note was in default at December 31, 2023. Nommsen Note On July 26, 2022, the Company issued a 10% Promissory Note in the principal amount of $58,823 to Eric S. Nommsen (the “Nommsen Note”). The Nommsen Note bears interest at the rate of 10% per annum accrued monthly and has a maturity date that is the earlier of (i) November 30, 2022, as extended, or (ii) five business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE. The purchase price of the Nommsen Note was $50,000; the amount payable at maturity will be $58,823 plus 10% of that amount plus any accrued and unpaid interest. Following an event of default as defined in the Nommsen Note, the principal amount shall bear interest for each day until paid at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The Nommsen Note entered default status on December 1, 2022, and the interest rate increased to 18%. The Nommsen Note contains a “most favored nations” clause that provides that, so long as the note is outstanding, if the Company issues any new security which Mr. Nommsen reasonably believes contains a term that is more favorable than those in the Nommsen Note, the Company shall notify Mr. Nommsen of such term, and such term, at the option of Mr. Nommsen, shall become a part of the Nommsen Note. In addition, Mr. Nommsen received five-year warrants to purchase 483 shares of common stock at a price of $25.00 per share with a fair value of $1,850 at the date of issuance, and 483 shares of common stock with a value of $2,350; these amounts were recorded as discounts to the Nommsen Note. Interest in the amount of $2,946 was accrued on the Nommsen Note during the year ended December 31, 2022. Discounts in the amount of $18,905 were amortized to interest expense during the year ended December 31, 2022, and total discounts in the amount of $0 remained outstanding at December 31, 2022. Principal and accrued interest in the amounts $64,705 and $2,946, respectively, were due on the Nommsen Note at December 31, 2022. During the year ended December 31, 2023, interest in the amount of $10,739 was accrued on the Nommsen Note; principal and accrued interest in the amount of $64,705 and $13,685, respectively, were due on this note at December 31, 2023. This note was in default at December 31, 2023. Caplan Note On July 27, 2022, the Company issued a 10% Promissory Note in the principal amount of $58,823 to James H. Caplan (the “Caplan Note”). The Caplan Note bears interest at the rate of 10% per annum accrued monthly and has a maturity date that is the earlier of (i) January 21, 2023, or (ii) five business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE. The purchase price of the Caplan Note was $50,000; the amount payable at maturity will be $58,823 plus 10% of that amount plus any accrued and unpaid interest. Following an event of default as defined in the Caplan Note, the principal amount shall bear interest for each day until paid at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The Caplan Note contains a “most favored nations” clause that provides that, so long as the note is outstanding, if the Company issues any new security which Mr. Caplan reasonably believes contains a term that is more fa |
Related Party [Member] | |
Notes Payable [Line Items] | |
Debt Disclosure [Text Block] | Note 10: Notes Payable Related Parties The following table summarizes the outstanding related party notes payable as of December 31, 2023 and 2022, respectively December 31, 2023 December 31, 2022 Howe Note 1 $ - $ 1,100,000 Howe Note 2 - 330,000 Howe Note 3 - 330,000 Howe Note 4 - 220,000 Diamond Note 1 - 192,500 Diamond Note 2 - 23,529 Diamond Note 3 - 258,823 Diamond Note 4 - 51,765 Diamond Note 5 - 64,706 M Diamond Note 64,706 64,706 Dobbertin Note 19,412 19,412 Iturregui Note 1 - 32,353 Lindstrom Note 45,294 45,294 November 29, 2022 Notes 37,500 131,250 Notes Payable 166,912 2,864,338 Less: Discount - (22,670 ) Less: Amounts classified as current liabilities of discontinued operations - (1,995,667 ) Notes payable – net of discounts $ 166,912 $ 846,001 Current Portion, net of discount $ 166,912 $ 846,001 Long-term portion, net of discount $ - $ - Howe Note 1 On December 30, 2021, we issued a 10% Promissory Note in the principal amount of $1,000,000 in a related party transaction to the Michael C. Howe Living Trust (the “Howe Note 1”). Michael C. Howe was the Chief Executive Officer of the Good Clinic LLC, one of our subsidiaries. The Howe Note 1 bears interest at the rate of 10% interest rate per annum and has a maturity date that is the earlier of (i) November 30, 2022, as extended, or (ii) five (5) business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE. The purchase price of the Howe Note 1 was $850,000; the amount payable at maturity will be $1,000,000 plus 10% of that amount plus any accrued and unpaid interest. Following an event of default, as defined in the Howe Note 1, the principal amount shall bear interest for each day until paid at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The Howe Note 1 entered delinquent status on December 1, 2022, and the interest rate increased to 18%. The Howe Note 1 contains a “most favored nations” clause that provides that, so long as the note is outstanding, if the Company issues any new security, which Mr. Howe reasonably believes contains a term that is more favorable than those in the Howe Note 1, we shall notify Mr. Howe of such term, and such term, at the option of Mr. Howe, shall become a part of the Howe Note 1. In addition, Mr. Howe five-year warrants to purchase 42,000 shares of common stock at a price of $25.00 per share, and five-year warrants to purchase 42,000 shares of common stock at $37.50 per share with an aggregate fair value of $261,568 at the date of issuance, which was recorded as a discount to this note. Interest in the amount of $106,795 was accrued on the Howe Note 1 during the year ended December 31, 2022. Discounts in the amount of $511,568 were amortized to interest expense during the year ended December 31, 2022, and total discounts in the amount of $0 remained outstanding at December 31, 2022. Principal and accrued interest in the amounts $1,100,000 and $106,795, respectively, were due on the Howe Note 1 at December 31, 2022. During the year ended December 31, 2023, interest in the amount of $168,761, respectively, was accrued on the Howe Note 1; principal and accrued interest in the amount of $0 were due on this note at December 31, 2023. Howe Note 2 On June 9, 2022, the Company issued a 10% Promissory Note in the principal amount of $300,000 in a related party transaction to the Michael C. Howe Living Trust (the “Howe Note 2”). Michael C. Howe was the Chief Executive Officer of the Good Clinic LLC, one of our subsidiaries. The Howe Note 2 bears interest at the rate of 10% per annum accrued monthly and has a maturity date that is the earlier of (i) November 30, 2022, or (ii) five business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE. The purchase price of the Howe Note 2 was $255,000; the amount payable at maturity will be $300,000 plus 10% of that amount plus any accrued and unpaid interest. Following an event of default as defined in the Howe Note 2, the principal amount shall bear interest for each day until paid at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The Howe Note 2 entered default status on December 1, 2022, and the interest rate increased to 18%. The Howe Note 2 contains a “most favored nations” clause that provides that, so long as the note is outstanding, if the Company issues any new security which Mr. Howe reasonably believes contains a term that is more favorable than those in the Howe Note 2, the Company shall notify Mr. Howe of such term, and such term, at the option of Mr. Howe, shall become a part of the Howe Note 2. In addition, Mr. Howe received five-year warrants to purchase 2,460 shares of common stock at a price of $25.00 per share with a fair value of $10,965 at the date of issuance, and 2,460 shares of common stock with a value of $22,440; these amounts were recorded as discounts to the Howe Note 2. Interest in the amount of $18,888 was accrued on the Howe Note 2 during the year ended December 31, 2022. Discounts in the amount of $108,405 were amortized to interest expense during the year ended December 31, 2022, and total discounts in the amount of $0 remained outstanding at December 31, 2022. Principal and accrued interest in the amounts $330,000 and $18,888, respectively, were due on the Howe Note 2 at December 31, 2022. During the year ended December 31, 2023, interest in the amount of $50,362 was accrued on the Howe Note 2; principal and accrued interest in the amount of $0 were due on this note at December 31, 2023. Howe Note 3 On July 21, 2022, the Company issued a 10% Promissory Note in the principal amount of $300,000 in a related party transaction to the Michael C. Howe Living Trust (the “Howe Note 3”). Michael C. Howe was the Chief Executive Officer of the Good Clinic LLC, one of our subsidiaries. The Howe Note 3 bears interest at the rate of 10% per annum accrued monthly and has a maturity date that is the earlier of (i) November 30, 2022, as extended, or (ii) five business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE. The purchase price of the Howe Note 3 was $255,000; the amount payable at maturity will be $300,000 plus 10% of that amount plus any accrued and unpaid interest. Following an event of default as defined in the Howe Note 3, the principal amount shall bear interest for each day until paid at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The Howe Note 3 entered default status on December 1, 2022, and the interest rate increased to 18%. The Howe Note 3 contains a “most favored nations” clause that provides that, so long as the note is outstanding, if the Company issues any new security which Mr. Howe reasonably believes contains a term that is more favorable than those in the Howe Note 3, the Company shall notify Mr. Howe of such term, and such term, at the option of Mr. Howe, shall become a part of the Howe Note 3. In addition, Mr. Howe received five-year warrants to purchase 2,460 shares of common stock at a price of $25.00 per share with a fair value of $9,945 at the date of issuance, and 2,460 shares of common stock with a value of $12,495; these amounts were recorded as discounts to the Howe Note 3. Interest in the amount of $15,436 was accrued on the Howe Note 3 during the year ended December 31, 2022. Discounts in the amount of $97,440 were amortized to interest expense during the year ended December 31, 2022, and total discounts in the amount of $0 remained outstanding at December 31, 2022. Principal and accrued interest in the amounts $330,000 and $15,436, respectively, were due on the Howe Note 3 at December 31, 2022. During the year ended December 31, 2023, interest in the amount of $50,314, respectively, was accrued on the Howe Note 3; principal and accrued interest in the amount of $0 were due on this note at December 31, 2023. Howe Note 4 On August 18, 2022, the Company issued a 10% Promissory Note in the principal amount of $200,000 in a related party transaction to the Michael C. Howe Living Trust (the “Howe Note 4”). Michael C. Howe was the Chief Executive Officer of the Good Clinic LLC, one of our subsidiaries. The Howe Note 4 bears interest at the rate of 10% per annum accrued monthly and has a maturity date that is the earlier of (i) November 30, 2022, or (ii) five business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE. The purchase price of the Howe Note 4 was $170,000; the amount payable at maturity will be $200,000 plus 10% of that amount plus any accrued and unpaid interest. Following an event of default as defined in the Howe Note 4, the principal amount shall bear interest for each day until paid at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The Howe Note 4 entered default status on December 1, 2022, and the interest rate increased to 18%. The Howe Note 4 contains a “most favored nations” clause that provides that, so long as the note is outstanding, if the Company issues any new security which Mr. Howe reasonably believes contains a term that is more favorable than those in the Howe Note 4, the Company shall notify Mr. Howe of such term, and such term, at the option of Mr. Howe, shall become a part of the Howe Note 4. In addition, Mr. Howe received 1,640 shares of common stock with a value of $10,775; this amount was recorded as a discount to the Howe Note 4. Interest in the amount of $8,756 was accrued on the Howe Note 4 during the year ended December 31, 2022. Discounts in the amount of $60,775 were amortized to interest expense during the year ended December 31, 2022, and total discounts in the amount of $0 remained outstanding at December 31, 2022. Principal and accrued interest in the amounts $220,000 and $8,756, respectively, were due on the Howe Note 4 at December 31, 2022. During the year ended December 31, 2023, interest in the amount of 34,077 was accrued on the Howe Note 4; principal and accrued interest in the amount of $0, respectively, were due on this note at December 31, 2023. Howe Debt Exchange Agreement On December 8, 2023, the Company sold the remaining assets of The Good Clinic, LLC to Leading Primary Care LLC, a company organized by Michael C. Howe, the former CEO of The Good Clinic, LLC. As consideration for the transaction, Mr. Howe cancelled the existing notes payable and accrued interest owed to Mr. Howe in the amount of $2,454,821. Diamond Note 1 On February 24, 2022, the Company issued a 10% Promissory Note in the principal amount of $175,000 in a related party transaction to Lawrence Diamond, who was Chief Executive Officer and a member of our Board of Directors (the “Diamond Note 1”). The Diamond Note 1 bears interest at the rate of 10% per annum accrued monthly and has a maturity date that is the earlier of (i) November 30, 2022, as extended, or (ii) five business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE. The purchase price of the Diamond Note 1 was $148,750; the amount payable at maturity will be $175,000 plus 10% of that amount plus any accrued and unpaid interest. Following an event of default as defined in the Diamond Note 1, the principal amount shall bear interest for each day until paid at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The Diamond Note 1 entered default status on December 1, 2022, and the interest rate increased to 18%. The Diamond Note 1 contains a “most favored nations” clause that provides that, so long as the note is outstanding, if the Company issues any new security which Mr. Diamond reasonably believes contains a term that is more favorable than those in the Diamond Note 1, the Company shall notify Mr. Diamond of such term, and such term, at the option of Mr. Diamond, shall become a part of the Diamond Note 2. In addition, Mr. Diamond received five-year warrants to purchase 7,350 shares of common stock at a price of $25.00 per share, and five-year warrants to purchase 7,350 shares of common stock at $37.50 per share with an aggregate fair value of $2,914 at the date of issuance, which was recorded as a discount to this note. Interest in the amount of $16,052 was accrued on the Diamond Note 1 during the year ended December 31, 2022. Discounts in the amount of $46,664 were amortized to interest expense during the year ended December 31, 2022, and total discounts in the amount of $0 remained outstanding at December 31, 2022. Principal and accrued interest in the amounts $192,500 and $16,052, respectively, were due on the Diamond Note 1 at December 31, 2022. During the year ended December 31, 2023, interest in the amount of $24,024 was accrued on the Diamond Note 1. On September 29, 2023, an equity investment incentive in the amount of $151,174 representing 65% of the total amount due under the Diamond Note 1, along with original principal of $175,000, premium of $17,500, and accrued interest of $40,076 (a total of $383,750) was converted to 384 shares of the Company’s Series F Preferred Stock. Other than the equity investment incentive of $151,174, there was no gain or loss recognized on this transaction as the Series F Preferred Stock was issued at its face value of $1,000 per share. At December 31, 2023, there were no amounts due under the Diamond Note 1. Diamond Note 2 On March 18, 2022, the Company issued a 10% Promissory Note in the principal amount of $235,294 in a related party transaction to Lawrence Diamond, who was Chief Executive Officer and a member of our Board of Directors (the “Diamond Note 2). The Diamond Note 2 bears interest at the rate of 10% per annum accrued monthly and has a maturity date that is the earlier of (i) November 30, 2022, as extended, or (ii) five business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE. The purchase price of the Diamond Note 2 was $200,000; the amount payable at maturity will be $235,294 plus 10% of that amount plus any accrued and unpaid interest. Following an event of default as defined in the Diamond Note 2, the principal amount shall bear interest for each day until paid at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The Diamond Note 2 entered default status on December 1, 2022, and the interest rate increased to 18%. The Diamond Note 2 contains a “most favored nations” clause that provides that, so long as the note is outstanding, if the Company issues any new security which Mr. Diamond reasonably believes contains a term that is more favorable than those in the Diamond Note 2, the Company shall notify Mr. Diamond of such term, and such term, at the option of Mr. Diamond, shall become a part of the Diamond Note 2. In addition, Mr. Diamond received five-year warrants to purchase 1,930 shares of common stock at a price of $25.00 per share a fair value of $2,213 at the date of issuance, which was recorded as a discount to this note. Interest in the amount of $1,676 was accrued on the Diamond Note 2 during the year ended December 31, 2022. Principal in the amount of $235,294 was paid on the Diamond Note 2 during the year ended December 31, 2022. Discounts in the amount of $61,036 were amortized to interest expense during the year ended December 31, 2022, and total discounts in the amount of $0 remained outstanding at December 31, 2022. Principal and accrued interest in the amounts $23,529 and $1,676, respectively, were due on the Diamond Note 2 at December 31, 2022. During the year ended December 31, 2023, interest in the amount of $23 was accrued on the Diamond Note 2 On September 29, 2023, an equity investment incentive in the amount of $16,398 representing 65% of the total amount due under the Diamond Note 2, along with the premium of $23,529 and accrued interest of $1,699 (a total of $41,626) was converted to 42 shares of the Company’s Series F Preferred Stock. Other than the equity investment incentive of $16,398, there was no gain or loss recognized on this transaction as the Series F Preferred Stock was issued at its face value of $1,000 per share. At December 31, 2023, there were no amounts due under the Diamond Note 2. Diamond Note 3 On April 27, 2022, the Company issued a 10% Promissory Note in the principal amount of $235,294 in a related party transaction to Lawrence Diamond, who was Chief Executive Officer and a member of our Board of Directors (the “Diamond Note 3”). The Diamond Note 3 bears interest at the rate of 10% per annum accrued monthly and has a maturity date that is the earlier of (i) November 30, 2022, as extended, or (ii) five business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE. The purchase price of the Diamond Note 3 was $200,000; the amount payable at maturity will be $235,294 plus 10% of that amount plus any accrued and unpaid interest. Following an event of default as defined in the Diamond Note 3, the principal amount shall bear interest for each day until paid at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The Diamond Note 3 entered default status on December 1, 2022, and the interest rate increased to 18%. The Diamond Note 3 contains a “most favored nations” clause that provides that, so long as the note is outstanding, if the Company issues any new security which Mr. Diamond reasonably believes contains a term that is more favorable than those in the Diamond Note 3, the Company shall notify Mr. Diamond of such term, and such term, at the option of Mr. Diamond, shall become a part of the Diamond Note 3. In addition, Mr. Diamond received five-year warrants to purchase 1,930 shares of common stock at a price of $25.00 per share with a fair value of $8,800 at the date of issuance, and 1,930 shares of common stock with a value of $16,200; these amounts were recorded as discounts on the Diamond Note 3. Interest in the amount of $17,586 was accrued on the Diamond Note 3 during the year ended December 31, 2022. Discounts in the amount of $83,823 were amortized to interest expense during the year ended December 31, 2022, and total discounts in the amount of $0 remained outstanding at December 31, 2022. Principal and accrued interest in the amounts $258,823 and $17,586, respectively, were due on the Diamond Note 3 at December 31, 2022. During the year ended December 31, 2023, interest in the amount of $32,244 was accrued on the Diamond Note 3. On September 29, 2023, an equity investment incentive in the amount of $200,624 representing 65% of the total amount due under the Diamond Note 3, along with original principal of $235,294, premium of $23,529, and accrued interest of $49,830 (a total of $509,277) was converted to 509 shares of the Company’s Series F Preferred Stock. Other than the equity investment incentive of $200,624, there was no gain or loss recognized on this transaction as the Series F Preferred Stock was issued at its face value of $1,000 per share. At December 31, 2023, there were no amounts due under the Diamond Note 3. Diamond Note 4 On May 18, 2022, the Company issued a 10% Promissory Note in the principal amount of $47,059 in a related party transaction to Lawrence Diamond, who was Chief Executive Officer and a member of our Board of Directors (the “Diamond Note 4”). The Diamond Note 4 bears interest at the rate of 10% per annum accrued monthly and has a maturity date that is the earlier of (i) November 30, 2022, as extended, or (ii) five business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE. The purchase price of the Diamond Note 4 was $40,000; the amount payable at maturity will be $47,059 plus 10% of that amount plus any accrued and unpaid interest. Following an event of default as defined in the Diamond Note 4, the principal amount shall bear interest for each day until paid at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The Diamond Note 4 entered default status on December 1, 2022, and the interest rate increased to 18%. The Diamond Note 4 contains a “most favored nations” clause that provides that, so long as the note is outstanding, if the Company issues any new security which Mr. Diamond reasonably believes contains a term that is more favorable than those in the Diamond Note 4, the Company shall notify Mr. Diamond of such term, and such term, at the option of Mr. Diamond, shall become a part of the Diamond Note 4. In addition, Mr. Diamond received five-year warrants to purchase 386 shares of common stock at a price of $25.00 per share with a fair value of $2,960 at the date of issuance, and 1,930 shares of common stock with a value of $3,160; these amounts were recorded as discounts on the Diamond Note 4. Interest in the amount of $3,245 was accrued on the Diamond Note 4 during the year ended December 31, 2022. Discounts in the amount of $17,885 were amortized to interest expense during the year ended December 31, 2022, and total discounts in the amount of $0 remained outstanding at December 31, 2022. Principal and accrued interest in the amounts $51,765 and $3,245, respectively, were due on the Diamond Note 4 at December 31, 2022. During the year ended December 31, 2023, interest in the amount of $6,446 was accrued on the Diamond Note 4. On September 29, 2023, an equity investment incentive in the amount of $39,946 representing 65% of the total amount due under the Diamond Note 4, along with original principal of $47,059, premium of $4,706, and accrued interest of $9,691 (a total of $101,402) was converted to 101 shares of the Company’s Series F Preferred Stock. Other than the equity investment incentive of $200,624, there was no gain or loss recognized on this transaction as the Series F Preferred Stock was issued at its face value of $1,000 per share. At December 31, 2023, there were no amounts due under the Diamond Note 4. Diamond Note 5 On May 26, 2022, the Company issued a 10% Promissory Note in the principal amount of $58,823 in a related party transaction to Lawrence Diamond, who was Chief Executive Officer and a member of our Board of Directors (the “Diamond Note 5”). The Diamond Note 5 bears interest at the rate of 10% per annum accrued monthly and has a maturity date that is the earlier of (i) November 30, 2022, or (ii) five business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE. The purchase price of the Diamond Note 5 was $50,000; the amount payable at maturity will be $58,823 plus 10% of that amount plus any accrued and unpaid interest. Following an event of default as defined in the Diamond Note 5, the principal amount shall bear interest for each day until paid at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The Diamond Note 5 entered default status on December 1, 2022, and the interest rate increased to 18%. The Diamond Note 5 contains a “most favored nations” clause that provides that, so long as the note is outstanding, if the Company issues any new security which Mr. Diamond reasonably believes contains a term that is more favorable than those in the Diamond Note 5, the Company shall notify Mr. Diamond of such term, and such term, at the option of Mr. Diamond, shall become a part of the Diamond Note 5. In addition, Mr. Diamond received five-year warrants to purchase 483 shares of common stock at a price of $25.00 per share with a fair value of $2,500 at the date of issuance, and 483 shares of common stock with a value of $4,050; these amounts were recorded as discounts to the Diamond Note 5. Interest in the amount of $3,929 was accrued on the Diamond Note 5 during the year ended December 31, 2022. Discounts in the amount of $21,256 were amortized to interest expense during the year ended December 31, 2022, and total discounts in the amount of $0 remained outstanding at December 31, 2022. Principal and accrued interest in the amounts $64,705 and $3,929, respectively, were due on the Diamond Note 5 at December 31, 2022. During the year ended December 31, 2023, interest in the amount of $8,055 was accrued on the Diamond Note 5. On September 29, 2023, an equity investment incentive in the amount of $49,849 representing 65% of the total amount due under the Diamond Note 5, along with original principal of $58,824, premium of $5,882, and accrued interest of $11,984 (a total of $126,539) was converted to 127 shares of the Company’s Series F Preferred Stock. Other than the equity investment incentive of $200,624, there was no gain or loss recognized on this transaction as the Series F Preferred Stock was issued at its face value of $1,000 per share. At December 31, 2023, there were no amounts due under the Diamond Note 5. M Diamond Note On May 26, 2022, the Company issued a 10% Promissory Note in the principal amount of $58,823 to Melissa Diamond (the “M Diamond Note”). Ms. Diamond is the daughter of Larry Diamond, former CEO. The M Diamond Note bears interest at the rate of 10% per annum accrued monthly and has a maturity date that is the earlier of (i) November 30, 2022, or (ii) five business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE. The purchase price of the M Diamond Note was $50,000; the amount payable at maturity will be $58,823 plus 10% of that amount plus any accrued and unpaid interest. Following an event of default as defined in the M Diamond Note, the principal amount shall bear interest for each day until paid at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The M Diamond Note entered default status on December 1, 2022, and the interest rate increased to 18%. The M Diamond Note contains a “most favored nations” clause that provides that, so long as the note is outstanding, if the Company issues any new security which Ms. Diamond reasonably believes contains a term that is more favorable than those in the M Diamond Note, the Company shall notify Ms. Diamond of such term, and such term, at the option of Ms. Diamond, shall become a part of the M Diamond Note. In addition, Ms. Diamond received five-year warrants to purchase 483 shares of common stock at a price of $25.00 per share with a fair value of $2,500 at the date of issuance, and 483 shares of common stock with a value of $4,050; these amounts were recorded as discounts to the M Diamond Note. Interest in the amount of $3,929 was accrued on the M Diamond Note during the year ended December 31, 2022. Discounts in the amount of $21,256 were amortized to interest expense during the year ended December 31, 2022, and total discounts in the amount of $0 remained outstanding at December 31, 2022. Principal and accrued interest in the amounts $64,705 and $3,929, respectively, were due on the M Diamond Note at December 31, 2022. During the year ended December 31, 2023, interest in the amount of $10,753 was accrued on the M Diamond Note; principal and accrued interest in the amount of $64,705 and $14,682, respectively, were due on this note at December 31, 2023. This note was in default at December 31, 2023. Lindstrom Note On May 26, 2022, the Company issued a 10% Promissory Note in the principal amount of $41,176 in a related party transaction to Jenny Lindstrom, who was the Company’s Chief Legal Officer (the “Lindstrom Note 1”). The Lindstrom Note 1 bears interest at the rate of 10% per annum accrued monthly and has a maturity date that is the earlier of (i) November 30, 2022, or (ii) five business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE. The purchase price of the Lindstrom Note 1 was $35,000; the amount payable at maturity will be $41,176 plus 10% of that amount plus any accrued and unpaid interest. Following an event of default as defined in the Lindstrom Note 1, the principal amount shall bear interest for each day until paid at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The Lindstrom Note 1 entered default status on December 1, 2022, and the interest rate increased to 18%. The Lindstrom Note 1 contains a “most favored nations” clause that provides that, so long as the note is outstanding, if the Company issues any new security which Ms. Lindstrom reasonably believes contains a term that is more favorable than those in the Lindstrom Note 1, the Company shall notify Ms. Lindstrom of such term, and such term, at the option of Ms. Lindstrom, shall become a part of the Lindstrom Note 1. In addition, Ms. Lindstrom received five-year warrants to purchase 338 shares of common stock at a price of $25.00 per share with a fair value of $1,750 at the date of issuance, and 338 shares of common stock with a value of $2,835; these amounts were recorded as discounts to the Lindstrom Note 1. Interest in the amount of $2,750 was accrued on the Lindstrom Note 1 during the year ended December 31, 2022. Discounts in the amount of $14,879 were amortized to interest expense during the year ended December 31, 2022, and total discounts in the amount of $0 remained outstanding at December 31, 2022. Principal and accrued interest in the amounts $45,294 and $2,750, respectively, were due on the Lindstrom Note 1 at December 31, 2022. During the year ended December 31, 2023, interest in the amount of $7,527 was accrued on the Lindstrom Note; principal and accrued interest in the amount of $45,294 and $10,277, respectively, were due on this note at December 31, 2023. This note was in default at December 31, 2023. Dobbertin Note On May 26, 2022, the Company issued a 10% Promissory Note in the principal amount of $17,647 in a related party transaction to Alexander Dobbertin (the “Dobbertin Note”). Mr. Dobbertin is the spouse of Jenny Lindstrom, who was the Company’s Chief Legal Officer. The Dobbertin Note bears interest at the rate of 10% per annum accrued monthly and has a maturity date that is the earlier of (i) November 30, 2022, or (ii) five business days after the date on which the Company successfully lists its shares of common stock on Nasdaq or NYSE. The purchase price of the Dobbertin Note was $15,000; the amount payable at maturity will be $17,647 plus 10% of that amount plus any accrued and unpaid interest. Following an event of default as defined in the Dobbertin Note, the principal amount shall bear interest for each day until paid at a rate per annum equal to the lesser of the maximum interest permitted by applicable law and 18%. The Dobbertin Note entered default status on December 1, 2022, and the interest rate increased to 18%. The Dobbertin Note contains a “most favored nations” clause that provides that, so long as the note is outstanding, if the Company issues any new security which Mr. Dobbertin reasonably believes contains a term that is more favorable than those in the Dobbertin Note, the Company shall notify Mr. Dobbertin of such term, and such term, at the option of Mr. Dobbertin, shall become a part of the Dobbertin Note. In addition, Mr. Dobbertin received five-year warrants to purchase 145 shares of common stock at a price of $25.00 per share with a fair value of $750 at the date of issuance, and 145 shares of common stock with a value of $1,215; these amounts were recorded as discounts to the Dobbertin Note. Interest in the amount of $1,179 was accrued on the Dobbertin Note during the year ended December 31, 2022. Discounts in the amount of $6,377 were amortized to interest expense during the year ended December 31, 2022, and total discounts in the amount of $0 remained outstanding at December 31, 2022. Principal and accrued interest in the amounts $19,412 and $1,179, respectively, were due on the Dobbertin Note at December 31, 2022. During the year ended December 31, 2023, interest in the amount of $3,226 was accrued on the Dobbertin Note; principal and accrued interest in the amount of $19,412 and $4,405, respectively, were due on this note at December 31, 2023. This note was in default at December 31, 2023. Iturregui Note 1 On July 21, 2022, the Company issued a 10% Promissory Note in the principal amount of $29,412 in a related party transaction to Juan Carlos Iturregui, who was a member of the Company’s Board of Directors (the “Iturregui Note 1”). The Iturregui Note 1 bears interest at the rate of 10% per annum |
Derivative Liabilities
Derivative Liabilities | 12 Months Ended |
Dec. 31, 2023 | |
Disclosure Text Block [Abstract] | |
Derivatives and Fair Value [Text Block] | Note 11: Derivative Liabilities Certain of the Company’s convertible notes and warrants contain features that create derivative liabilities. The pricing model the Company uses for determining fair value of its derivatives is the Monte Carlo Model. Valuations derived from this model are subject to ongoing internal and external verification and review. The model uses market-sourced inputs such as interest rates and stock price volatilities. Selection of these inputs involves management’s judgment and may impact net income. The derivative components of these notes are valued at issuance, at conversion, at restructure, and at each period end. Derivative liability activity for the years ended December 31, 2023 and 2022 is summarized in the table below: December 31, 2021 $ - True-up features issued 192,375 Settled upon conversion or exercise (310,641 ) Loss on revaluation 687,178 December 31, 2022 $ 568,912 True-up features issued - Settled upon conversion or exercise (501,740 ) Loss on revaluation 85,773 December 31, 2023 $ 152,945 The Company uses a Monte Carlo model to value certain features of its notes payable that create derivative liabilities. The following tables summarize the assumptions for the valuations: December 31, December 31, 2023 2022 Volatility 475.7 % 95.1% to 123.2 % Stock Price $ 0.0250 $ 1.06 to 3.50 Risk-free interest rates 5.21 % 4.35% to 4.37 % Term (years) 0.39 0.73 to 0.86 Certain of our notes payable contain a commitment fee obligation with a true-up feature. The following assumptions were used for the valuation of the derivative liability associated with this obligation: ● The stock price would fluctuate with the Company projected volatility. ● The projected volatility curve from an annualized analysis for each valuation date was based on the historical volatility of the Company and the term remaining for the True-Up obligation. ● The Company expected the note would be repaid 90% of the time by the maturity date, at which point the Company would redeem the 1,000,000 redeemable commitment fee shares for $1. ● In the event the Company did not repay the note in time, the shareholders would sell their shares subject to volume restrictions. ● Discount rates were based on risk free rates in effect based on the remaining term. 50,000 simulations were run for each Monte Carlo simulation. |
Stockholders' Equity (Deficit)
Stockholders' Equity (Deficit) | 12 Months Ended |
Dec. 31, 2023 | |
Stockholders' Equity Note [Abstract] | |
Equity [Text Block] | Note 12: Stockholders Equity (Deficit) Common Stock The Company has authorized 500,000,000 shares of common stock, par value $0.01; 5,567,957 and 4,630,372 shares were issued and outstanding at December 31, 2023 and 2022, respectively. On December 12, 2022, the Company effected one-for-fifty reverse-split of its common stock. The number of shares of common stock outstanding immediately before the reverse-split was 231,374,330; the number of shares of common stock immediately following the reverse-split was 4,630,372, a decrease of 226,743,958 shares. Common Stock Transactions During the Year Ended December 31, 2023 On January 23, 2023, the Company issued 150,000 shares of common stock at the market price of $3.45 per share to a service provider. The aggregate value of $517,500 was charged to operations during the year ended December 31, 2023. On February 21, 2023, the Company issued 150,000 shares of common stock at the market price of $2.53 per share to a service provider. The aggregate value of $379,500 was charged to operations during the year ended December 31, 2023. During the year ended December 31, 2023, GS Capital converted principal and accrued interest in a convertible note payable into shares of common stock as follows: On February 14, 2023, principal of $15,000 and accrued interest of $1,632 were converted at a price of $1.74 per share into 9,846 shares of common stock; on February 28, 2023, principal of $17,777 and accrued interest of $2,057 were converted at a price of $1.50 per share into 13,555 shares of common stock; on March 9, 2023, principal of $20,000 and accrued interest of $2,399 were converted at a price of $1.50 per share into 15,265 shares of common stock; and on March 28, 2023, principal of $20,000 and accrued interest of $2,581 were converted at a price of $1.25 per share into 18,472 shares of common stock. These conversions were made pursuant to the terms of the convertible note agreement and no gain or loss was recognized on these transactions. On March 31, 2023, the Company issued a total of 8,063 shares of common stock for accrued dividends on its Series X Preferred Stock. Of this amount, a total of 1,066 shares were issued to officers and directors, 4,160 were issued to a related party shareholder, and 2,837 were issued to non-related parties. On April 4, 2023, the Company issued 2,952 shares of common stock to a consultant at a price of $1.29 per share as a commission on funds previously raised. The Company recorded a gain in the amount of $33,092 on this transaction. On April 4, 2023, the Company issued 94,738 shares of common stock to GS Capital at an average price of pursuant to a make-whole agreement entered into in connection with the GS Capital Warrants. See note 10. A gain in the amount of $21,506 was recorded on the settlement of this derivative liability. See note 12. On May 5, 2023, the Company issued 2,552 shares of common stock to a vendor at a price of $0.85 per share, and on May 9, 2023, the Company issued 19,622 shares of common stock at a price of $0.85 per share to the Michael C. Howe Living Trust (the “Howe Trust”), an entity controlled by a related party. These shares were issued in satisfaction of a vendor dispute. The shares issued to the Howe Trust were reimbursement for shares previously issued to the vendor by the Howe Trust with regard to this dispute. There was no gain or loss recorded on these transactions. On June 29, 2023, the Company issued a total of 20,212 shares of common stock for accrued dividends on its Series X Preferred Stock. Of this amount, a total of 2,673 shares were issued to officers and directors, 10,426 were issued to a related party shareholder, and 7,113 were issued to non-related parties. Effective June 30, 2023, the Company issued 2,926 shares of common stock at a price of $12.50 to a previous board member for the conversion of accounts payable in the amount of $36,575. These shares had been carried on the Company balance sheet as Common Stock Subscribed. On August 21, 2023, the Company issued 131,362 shares of common stock at a price of $0.80 per share for accounts payable in the amount of $105,089. A gain in the amount of $59,112 was recorded on this transaction. On August 21, 2023, the Company issued 43,750 shares of common stock at a price of $0.80 per share for accounts payable in the amount of $35,000. A gain in the amount of $19,687 was recorded on this transaction. On August 21, 2023, the Company issued 49,226 shares of common stock at a price of $0.80 per share for accounts payable in the amount of $39,380. A gain in the amount of $22,151 was recorded on this transaction. Effective September 29, 2023, the Company’s now former Chief Operating Officer and now former board member converted a note in the amount of $18,750, accrued interest of $2,101, accrued salary of $64,434, and board of director fees of $60,000 (a total of $145,285) at a price of $0.80 per share into 181,606 shares of the Company’s common stock. A gain in the amount of $138,531 was recorded on this transaction. On October 10, 2023, the Company issued 23,438 shares of common stock to a service provider at a price of $0.80 per share for accounts payable in the amount of $18,750. Common Stock Transactions During the Year Ended December 31, 2022 On January 12, 2022, the Company entered into a settlement agreement with an ex-employee. Pursuant to the terms of this agreement, the Company agreed to pay the amount of $19,032 for accrued salary, and the employee returned to the Company for cancellation 8,000 shares of common stock previously issued as compensation. These shares were valued at par value of $0.01 or a total value of $80; the Company recorded a gain on cancellation of these shares in the amount of $15,032. The Company entered into a debt-for-equity exchange agreement with Gardner Builders Holdings, LLC (“Gardner”) on January 7, 2022 (the “Gardner Equity Agreement”). Pursuant to Gardner Equity Agreement, the Company issued shares of restricted common stock to Gardner in exchange for the Company Debt Obligations, as defined below. The Gardner Equity Agreement settled for certain accounts payable amounts owed by the Company to Gardner. The Gardner Equity Agreement also settled accrued interest and penalties on the amounts due through January 5, 2022, as well as interest payments on amounts incurred in the first quarter of 2022 (collectively, the “Additional Costs”, and combined with the Accounts Payable Amount, the “Company Debt Obligations”). The Accounts Payable Amount was $500,000, the Additional Costs were $294,912 and the conversion price was $12.50. As a result, 63,593 Restricted Shares were authorized to be issued. On March 22, 2022 and March 31, 2022, the Company issued an aggregate 30,835 shares of common stock as waiver fees to holders of the Series C and Series D Preferred Stock for their waivers of certain covenants as set forth and defined in the Series C and Series D Certificates of Designations. The Company valued these shares at their contractual price of $12.50 per share and recorded the amount of $385,431 as waiver fees. The Company recorded an aggregate gain upon issuance of these shares in the amount of $198,273 based on the market price of the Company’s common stock on the date of issuance. On March 31, 2022, the Company issued 34,400 Commitment Fee Shares to AJB Capital Investors, LLC. A Monte Carlo model was used to value the warrants and call features, and a probability weighted expected return model was used to value the True-Up Provision. The contractual price of the common stock $12.50 per share; valuation purposes, the common stock was valued at the market price on the date of the transaction of $6.35 per share. The discount on the notes due to the Commitment Fee Shares and warrants was valued at $349,914. The Company recorded the amount of $226,106 to additional paid-in capital pursuant to this transaction. On March 31, 2022, the Company issued 7,648 shares of common stock at a price of $12.50 per share which were previously subscribed for the conversion of accounts payable in the amount of $95,558. On April 27, 2022, the Company issued 14,400 shares of stock to Cavalry Fund 1 LP at a price of $6.35 per share for a total value of $91,440 as compensation for the waiver of certain covenants as set forth in the Series C Certificate of Designation. The Company recorded a gain in the amount of $88,560 on this transaction. On April 27, 2022, the Company issued 1,929 shares of common stock with a contract price of $12.50 per share or $24,118 and a grant date market value of $8.00 or $15,434 to Larry Diamond, it’s Chief Executive as commitment shares as set forth and defined in Diamond Note 3. The Company recorded these shares at their relative fair value of the components of Diamond Note 3, or $16,200, and recorded a loss in the amount of $765 on this transaction. The Company also issued five-year warrants to purchase 1,929 shares of common stock at a price of $12.50 to Mr. Diamond pursuant to Diamond Note 3. On May 1, 2022, the Company issued 15,000 shares of common stock to a service provider at a price of $6.88 per share. On May 10, 2022, the Company entered into a securities purchase agreement with Kishon Investments, LLC with respect to the sale and issuance of: (i) an initial commitment fee in the amount of $159,259 in the form of 12,741 shares of the Company’s common stock, (ii) promissory note in the principal amount of $277,777 due on November 10, 2022, and (iii) warrants to purchase up to 5,556 shares of the common stock. The note and warrants were issued on May 10, 2022 and were held in escrow pending effectiveness of the Purchase Agreement. Pursuant to the terms of the purchase agreement, the initial shares were issued at a value of $159,259, the note was issued in the principal amount of $277,777 for a purchase price of $250,000, resulting in the original issue discount of $27,777; and the warrants were issued, with an initial exercise price of $12.50 per share, subject to adjustment. On May 18, 2022, the Company issued 386 shares of common stock to Larry Diamond, it’s Chief Executive Officer at a contractual price of $12.50 per share and a market price at issuance date of $7.585 per share as commitment shares as set forth and defined in Diamond Note 4. The Company recorded these shares at their relative fair value of the components of Diamond Note 4, or $3,160 and recorded a loss in the amount of $249 on this transaction. The Company also issued five-year warrants to purchase 386 shares of common stock at a price of $12.50 to Mr. Diamond pursuant to Diamond Note 4. On May 23, 2022, the Company issued 386 shares of common stock to Jessica Finnegan at a contractual price of $12.50 per share and a market price at issuance date of $8.97 per share as commitment shares as set forth and defined in Finnegan Note 1. The Company recorded these shares at their relative fair value of the components of Finnegan Note 1, or $3,240, and recorded a gain in the amount of $222 on this transaction. The Company also issued five-year warrants to purchase 386 shares of common stock at a price of $12.50 to Ms. Finnegan pursuant to Finnegan Note 1. On May 26, 2022, the Company issued 1,688 shares of common stock to the May 26 Lenders at a contractual price of $12.50 per share and a market price at issuance date of $7.585 per share as commitment shares as set forth and defined in the May 26, 2022 Notes. The Company recorded these shares at their relative fair value of the components of the May 26 Note, or $14,175, and recorded a loss in the amount of $1,369 on these transactions. The Company also issued five-year warrants to purchase 1,688 shares of common stock at a price of $25.00 to the May 26 Lenders pursuant to the May 26, 2022. On June 7, 2022, the Company issued 8,103 shares of common stock at a price of $12.50 per share to investors for accumulated dividends on Series X Preferred Stock. See Note 12. On June 9, 2022, the Company issued 7,284 shares of common stock to the June 9 Lenders at a contractual price of $12.50 per share and a market price at issuance date of $7,425 per share as commitment shares as set forth and defined in the June 9 Notes. The Company recorded these shares at the relative fair value of the components of June 9 Notes, or $66,400, and recorded an aggregate loss in the amount of $9,356 on these transactions. The Company also issued five-year warrants to purchase 7,284 shares of common stock at a price of $25.00 to the May 26 Lenders pursuant to the June 9 notes. On June 22, 2022, the Company issued 4,824 shares of common stock at fair value of $10.45 per share to Dragon Dynamic at a fair value of $10.45 per share as a commitment fee. On June 22, 2022, the Company issued 12,741 shares of common stock at fair value of $10.45 per share to GS Capital at a fair value of $10.45 per share as a commitment fee. On June 22, 2022, the Company issued 8,600 shares of common stock at fair value of $10.45 per share to Anson East and an additional 25,800 shares of common stock at a fair value of $10.45 per share to Anson Investments as a commitment fee. On July 7, 2022, the Company issued 2,412 shares of common stock to William Mackay at a contractual price of $12.50 per share and a market price at issuance date of $7.445 per share as commitment shares as set forth and defined in the Mackay Note. The Company recorded these shares at their relative fair value of the components of Mackay Note, or $12,500, and recorded a gain in the amount of $5,456 on this transaction. The Company also issued five-year warrants to purchase 2,412 shares of common stock at a price of $12.50 to Mr. Mackay pursuant to the Mackay Note. On July 7, 2022, the Company issued 193 shares of common stock to Charlies Schrier at a contractual price of $12.50 per share and a market price at issuance date of $7.445 per share as commitment shares as set forth and defined in the Schrier Note. The Company recorded these shares at their relative fair value of the components of Schrier Note, or $1,000, and recorded a gain in the amount of $436 on this transaction. The Company also issued five-year warrants to purchase 193 shares of common stock at a price of $25.00 to Mr. Schrier pursuant to the Schrier Note. On July 21, 2022, the Company issued 241 shares of common stock to Juan Carlos Iturregui, a related party, at a contractual price of $12.50 per share and a market price at issuance date of $7.225 per share as commitment shares as set forth and defined in the Iturregui Note. The Company recorded these shares at their relative fair value of the components of Schrier Note, or $1,225, and recorded a gain in the amount of $518 on this transaction. The Company also issued five-year warrants to purchase 241 shares of common stock at a price of $25.00 to Mr. Iturregui pursuant to the Iturregui Note. On July 21, 2022, the Company issued 2,460 shares of common stock to the Michael C. Howe Living Trust, a related party, at a contractual price of $12.50 per share and a market price at issuance date of $7.225 per share as commitment shares as set forth and defined in the Howe Note 3. The Company recorded these shares at their relative fair value of the components of Howe Note 3, or $12,495, and recorded a gain in the amount of $5,729 on this transaction. The Company also issued five-year warrants to purchase 2,460 shares of common stock at a price of $25.00 to the Michael C. Howe Living Trust pursuant to the Howe Note 3. On July 26, 2022, the Company issued 482 shares of common stock to Eric S. Nommsen at a contractual price of $12.50 per share and a market price at issuance date of $6.84 per share as commitment shares as set forth and defined in the Nommsen Note. The Company recorded these shares at their relative fair value of the components of Nommsen Note, or $2,350, and recorded a gain in the amount of $949 on this transaction. The Company also issued five-year warrants to purchase 482 shares of common stock at a price of $25.00 to Mr. Nommsen pursuant to the Nommsen Note. On July 27, 2022, the Company issued 482 shares of common stock to James H. Caplan at a contractual price of $12.50 per share and a market price at issuance date of $6.935 per share as commitment shares as set forth and defined in the Caplan Note. The Company recorded these shares at their relative fair value of the components of the Caplan Note, or $2,350, and recorded a gain in the amount of $995 on this transaction. The Company also issued five-year warrants to purchase 482 shares of common stock at a price of $25.00 to Mr. Caplan pursuant to the Caplan Note. On August 4, 2022, the Company issued a total of 241 shares of common stock to Jessica, Kevin C., Brody, Isabella, and Jack Finnegan at a contractual price of $25.00 per share and a market price at issuance date of $6.42 per share as commitment shares as set forth and defined in the Finnegan Note 3. The Company recorded these shares at their relative fair value of the components of the Finnegan Note 3, or $1,000, and recorded a gain in the amount of $448 on this transaction. The Company also issued five-year warrants to purchase a total of 241 shares of common stock at a price of $25.00 to the holders of the Finnegan Note 3. On August 4, 2022, the Company issued 984 shares of common stock to Jack Enright at a contractual price of $12.50 per share and a market price at issuance date of $6.42 per share as commitment shares as set forth and defined in the Caplan Note. The Company recorded these shares at their fair value of $6,317. On August 4, 2022, the Company issued 12,064 shares of common stock to a service provider as payment for investor relations services. The transaction was effective August 1, 2022 and has a six month term. The shares were valued at the closing price of the Company’s common stock on August 4, 2022, of $6.42 per share or $77,448. On August 18, 2022, the Company issued 1,640 shares of common stock to the Michael C. Howe Living Trust, a related party, at a contractual price of $12.50 per share and a market price at issuance date of $6.57 per share as commitment shares as set forth and defined in the Howe Note 4. The Company recorded these shares at their fair value of $10,775. On September 2, 2022, the Company issued 582 shares of common stock to John Mitchell at a contractual price of $12.50 per share and a market price at issuance date of $5.365 per share as commitment shares as set forth and defined in the Mitchell Note. The Company recorded these shares at their fair value of $3,124. On September 2, 2022, the Company issued 492 shares of common stock to Frank Lightmas at a contractual price of $12.50 per share and a market price at issuance date of $5.365 per share as commitment shares as set forth and defined in the Lightmas Note. The Company recorded these shares at their fair value of $2,640. On September 2, 2022, the Company issued 246 shares of common stock to Lisa Lewis at a contractual price of $12.50 per share and a market price at issuance date of $5.365 per share as commitment shares as set forth and defined in the Lewis Note. The Company recorded these shares at their fair value of $1,320. On September 2, 2022, the Company issued 246 shares of common stock to Sharon Goff at a contractual price of $12.50 per share and a market price at issuance date of $5.65 per share as commitment shares as set forth and defined in the Goff Note. The Company recorded these shares at their fair value of $1,320. On September 9, 2022, the Company issued 820 shares of common stock to Cliff Hagan at a contractual price of $12.50 per share and a market price at issuance date of $5.75 per share as commitment shares as set forth and defined in the Hagan Note. The Company recorded these shares at their fair value of $4,715. On September 14, 2022, the Company issued 1,640 shares of common stock to Darling Capital at a contractual price of $12.50 per share and a market price at issuance date of $6.60 per share as commitment shares as set forth and defined in the Darling Capital Note. The Company recorded these shares at their fair value of $10,824. On September 15, 2022, the Company issued 410 shares of common stock to Mack Leath at a contractual price of $12.50 per share and a market price at issuance date of $6.995 per share as commitment shares as set forth and defined in the Leath Note. The Company recorded these shares at their fair value of $2,868. On October 1, 2022, the Company issued 6,329 shares of common stock at a price of $16.00 per share to a service provider. On November 18, 2022, the Company issued 91,328 shares of common stock to AJB in settlement of the AJB True-up Obligation. See note 9. Preferred Stock We have authorized to issue 100,000,000 shares of Preferred Stock with such rights designations and preferences as determined by our Board of Directors. We have designated 500,000 shares of series A stock, 3,000,000 shares of Series C Preferred, 10,000,000 shares of Series D Preferred, 10,000 shares of Series E Preferred, and 24,227 shares as Series X Preferred Stock. Series A Preferred Stock The Series A Preferred Stock has a par value of $0.01 per share, no stated maturity, a liquidation preference of $25.00 per share and accrued dividends at the rate of 12% on $25.00 per share. The Company had no shares of Series A Preferred Stock outstanding at December 31, 2023 and 2022. Series C Preferred Stock The Series C Preferred Stock has the following terms: Ranking Pari passu Voting Rights. Conversion. Dividends. Liquidation Rights. Pari passu Rights and Preferences. Redemption Rights. Price Adjustments Protection Preemptive or Similar Rights Fully Paid and Nonassessable Series C Preferred Stock Transactions During the Year Ended December 31, 2023 The Company accrued dividends in the amount of $17,603 on the Series C Preferred Stock. On April 11, 2023, a total of 1,047,619 shares of Series C Preferred Stock with a stated value of $1,100,000, accrued dividends in the amount $171,109, and equity investment incentives in the amount of $1,016,888 were exchanged for 2,289 shares of Series F Preferred Stock. Series C Preferred Stock Transactions During the Year Ended December 31, 2022 During the year ended December 31, 2022, the Company accrued dividends on the Series C Preferred Stock in the amount of $66,447. The Company also adjusted the number of shares of Series C Preferred Stock outstanding by an increase in the amount of 98,064 shares in connection with previous conversions of Series C Preferred Stock to common stock; the amount of $981 was charged to additional paid-in capital pursuant to this adjustment. Series D Preferred Stock The Series D Preferred Stock has the following terms: Ranking Pari passu Voting Rights. Conversion. Dividends. Liquidation Rights. Pari passu Rights and Preferences. Redemption Rights. Price Adjustments Protection Preemptive or Similar Rights Series D Preferred Stock Transactions During the Year Ended December 31, 2023 The Company accrued dividends in the amount of $85,541 on the Series D Preferred Stock. On April 11, 2023, a total of 2,350,000 shares of Series D Preferred Stock with a stated value of $2,467,500, accrued dividends in the amount $215,659, and equity investment incentives in the amount of $1,371,846 were exchanged for 4,055 shares of Series F Preferred Stock. There was no gain or loss recorded in connection with these transactions. On December 8, 2023, Mr. Howe exchanged (i) 500,000 shares of Series D Preferred Stock with a stated value of approximately $0.5 million and accrued dividends of approximately $67,000, and (ii) accrued salary owed to Mr. Howe in the amount of approximately $38,000 plus a conversion incentive of 65% or approximately $25,000 for 655 shares of the Company’s Series F Preferred Stock with a liquidation value of approximately $0.6 million. Other than the conversion of incentive of the approximately $25,000, there was no gain or loss recorded on this transaction. Series D Preferred Stock Transactions During the Year Ended December 31, 2022 During the year ended December 31, 2022, the Company accrued dividends on the Series D Preferred Stock in the amount of $195,299. Series E Preferred Stock On November 7, 2022, the Company filed a Certificate of Designations, Preferences and Rights of Series E Convertible Perpetual Preferred Stock (the “Series E”) with the Delaware Secretary of State. The number of shares of Series E designated is 10,000 and each share of Series E has a stated value equal to $1,000. Each share of Series E Preferred Stock shall have a par value of $0.01. There are 0 shares of Series E Preferred Stock outstanding at December 31, 2023 and 2022. No shares of Series E Preferred Stock have ever been issued. As long as any shares of Series E are outstanding, the Company shall not, without the affirmative vote of the holders of a majority of the then outstanding shares of the Series E, (a) alter or change the preferences, rights, privileges or powers given to the Series E or alter or amend the Certificate of Incorporation or bylaws, (b) increase or decrease (other than by conversion) the number of authorized shares of Series E, or (c) create or authorize any new class of shares that has a preference over Series E. Unless previously converted into shares of Common Stock, any shares of Series E issued and outstanding, shall be redeemable at the option of the Company for cash at a redemption price per share equal to 110% of the initial issuance price, or $1,100, plus all dividends declared thereon. Each share of Series E shall become convertible, at the option of the holder, commencing on the date of issuance, into such number of fully paid and non-assessable shares of Common Stock. The conversion price shall be, as of the conversion date, (a) prior to the date of the qualified offering the average VWAP per share of the Common Stock for the five (5) trading days prior to the date of conversion and (b) on or following the date of the qualified offering, the qualified offering price (the “Conversion Price”). Immediately following the 120th day following the qualified offering, the Conversion Price shall be adjusted to the lesser of (a) the average VWAP per share of the Common Stock for the five (5) trading days immediately following the 120th day following the qualified offering and (b) the Conversion Price on such date, which shall in no event be less than $0.05. Series E Exchange Agreements During the year ended December 31, 2022, the Company entered into the following agreements to exchange certain debt and equity amounts for shares of Series E Preferred Stock (see notes 9, 10, and 16): On October 5, 2022, the Company entered into the Cavalry Exchange Agreement, pursuant to which Cavalry shall exchange (a) 1,000,000 shares of the Company’s Series C Convertible Preferred Stock (b) 750,000 shares of the Company’s Series D Convertible Preferred Stock and (c) amounts owing under the Cavalry Note, for a number of Series E Convertible Preferred Stock (the “Series E Shares”) equal to 150% of the principal amount of the Cavalry Note, plus 150% of the stated value of the Series C Shares and Series D Shares (the “Series E Exchange Value”). No transactions occurred pursuant to the Cavalry Exchange Agreement during the year ended December 31, 2022. See note 9 and 16. On October 7, 2022, the Company entered into the Mercer Exchange Agreement whereby Mercer shall exchange (a) 47,619 shares of the Company’s Series C Convertible Preferred Stock, (b) 750,000 shares of the Company’s Series D Convertible Preferred Stock, and (c) amounts owing under the Mercer Note, for a number of Series E Convertible Preferred Stock (the “Series E Shares”) equal to 150% of the principal amount of the Mercer Note, plus 150% of the stated value of the Series C Shares and Series D Shares (the “Series E Exchange Value”). No transactions occurred pursuant to the Mercer Exchange Agreement during the year ended December 31, 2022. See note 9. Amounts due under the Mercer Note 2 will also convert pursuant to the terms of the Mercer Exchange Agreement into shares of the Company’s series E Preferred Stock. See note 9 and 16. On October 10, 2022, the Company entered into the Pinz Exchange Agreement whereby Pinz shall exchange (a) 100,000 shares of the Company’s Series D Convertible Preferred Stock, and (b) amounts owing under the Pinz Note, for a number of Series E Convertible Preferred Stock equal to 150% of the principal amount of the Pinz Note, plus 150% of the stated value of the Series D Shares. No transactions occurred pursuant to the Pinz Exchange Agreement during the year ended December 31, 2022. See note 9 and 16. On October 18, 2022, the Company entered into separate exchange agreements with each of Anson East Master Fund LP and Anson Investments Master Fund LP (collectively, “Ansons”), (the “Ansons Exchange Agreements”). Pursuant to the Ansons Exchange Agreements, Ansons shall exchange an aggregate of 750,000 shares of the Company’s Series D Stock for a number of Series E Convertible Preferred Stock (the “Series E Shares”) equal to 150% of the stated value of the Series D Shares (the "Series E Exchange Value"), and the Funds have agreed to invest no less than an aggregate amount of $375,000 into the uplisting offering. No transactions occurred pursuant to the terms of the Ansons Exchange Agreements during the year ended December 31, 2022. See notes 9 and 16. On November 29, 2022, the Company entered into the November 29 Notes Exchange Agreements whereby amounts due under the November 29 Notes will be exchanged for a number Series E Convertible Preferred Stock equal to 150% of the principal amount of the Notes. No transactions occurred pursuant to the November 29 Notes Exchange Agreements during the year ended December 31, 2022. See notes 10 and 16. Series F Preferred Stock On March 23, 2023, the Company filed a Certificate of Designations, Preferences and Rights of Series F 12% PIK $0.01 par value Convertible Perpetual Preferred Stock with the Delaware Secretary of State. The number of shares of Series F Preferred Stock designated is 140,000 and each share of Series F Preferred Stock has a liquidation preference of $1,000. The Series F Preferred Stock will rank senior to the Corporation’s Common Stock and on parity with all Preferred Stock of the Corporation with terms specifically providing that such Preferred Stock rank on parity with the Series F Preferred Stock with respect to rights to the distribution of assets upon any liquidation, dissolution or winding up of the Corporation; and (iii) junior to all Preferred Stock of the Corporation with terms specifically providing that such Preferred Stock rank senior to the Series F Preferred Stock with respect to rights to the distribution of assets upon any liquidation, dissolution or winding up of the Company. Holders of shares of the Series F Preferred Stock are entitled to receive payment-in-kind dividends payable only in additional shares of Series F Preferred Stock (“PIK Dividends”) at rate of 12% per annum. The Series F Preferred Stock will be convertible into common stock of the Company upon the listing of the Company’s stock on any of the following trading markets: the NYSE, the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, or the Nasdaq Global Select Market. The conversion price will be calculated as 65% of the volume-weighted average price of the Company’s common stock on the conversion date. The number of shares issuable upon conversion will be calculated as the liquidation preference of the Series F Preferred stock plus any accrued but unpaid dividends divided by the conversion price. Series F Preferred Stock Transactions During the Year Ended December 31, 2023 On April 11, 2023, the Company issued a total of 8,116 shares of Series F Preferred Stock at its liquidation value of $1,000 per share to nine investors upon the conversion of notes payable. The total amount converted was $8,111,334, consisting of principal $3,602,059, default penalties of $888,889, fees of $60,000, accrued interest of $365,012, and equity investment incentives of $3,195,374. Other than the equity investment incentive, there were no gains or losses recorded in connection with these transactions. See note 10. On April 11, 2023, the Company issued a total of 2,289 shares of Series F Preferred Stock at its liquidation value of $1,000 per share to two investors upon the conversion of Series C Preferred Stock. The total amount converted was $2,287,997, consisting of the Series C Preferred Stock stated value of $1,100,000, accrued dividends of $171,109, and e |
Income Taxes
Income Taxes | 12 Months Ended |
Dec. 31, 2023 | |
Income Tax Disclosure [Abstract] | |
Income Tax Disclosure [Text Block] | Note 13: Income Taxes Deferred income taxes result from the temporary differences primarily attributable to amortization of intangible assets and debt discount and an accumulation of net operating loss carryforwards for income tax purposes with a valuation allowance against the carryforwards for book purposes. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. Included in deferred tax assets are Federal and State net operating loss carryforwards of approximately $13.5 million and $1.6 million, respectively, which will expire through 2040. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and tax planning strategies in making this assessment. Due to significant changes in the Company’s ownership, the Company’s future use of its existing net operating losses may be limited. For the years ended December 31, 2023 and 2022, the expected tax expense (benefit) based on the U. S. federal statutory rate is reconciled with the actual tax provision (benefit) as follows: For the Years Ended December 31, 2023 2022 Expected tax at statutory rates $ (3,463,000 ) 21 % $ (4,879,000 ) 21 % Permanent Differences 7,000 0 % 1,610,000 (7 )% State Income Tax, Net of Federal benefit (418,000 ) 1 % (380,000 ) 2 % Other (95,000 ) 2 % 286,000 (1 )% Current Year Change in Valuation Allowance 3,969,000 (24 )% 2,611,000 (9 )% Prior Year True-Ups - 0 % 752,000 (6 )% Income tax expense $ - 0 % $ - 0 % Deferred income taxes reflect the tax impact of temporary differences between the amounts of assets and liabilities for financial reporting purposes and such amounts as measured by tax laws and regulations. Deferred income taxes include the net tax effects of net operating loss (NOL) carryforwards and the temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. As of December 31, 2023, and 2022 significant components of the Company’s deferred tax assets are as follows: For the Years Ended December 31, 2023 2022 Deferred Tax Assets (Liabilities): Accrued payroll $ 141,000 $ 112,000 ASC842-ROU Asset - (68,000 ) ASC842-ROU (Liability) 822,000 830,000 Loss from derivatives (16,000 ) (130,000 ) Waiver and commitment fee shares - (32,000 ) Stock based compensation (171,000 ) (85,000 ) Depreciation 3,000 33,000 Net operating loss 13,529,000 9,679,000 Net deferred tax assets (liabilities) 14,308,000 10,339,000 Valuation allowance (14,308,000 ) (10,339,000 ) Net deferred tax assets (liabilities) $ - $ - |
Fair Value of Financial Instrum
Fair Value of Financial Instruments | 12 Months Ended |
Dec. 31, 2023 | |
Fair Value Disclosures [Abstract] | |
Fair Value Disclosures [Text Block] | Note 14: Fair Value of Financial Instruments The following summarizes the Company’s derivative financial liabilities that are recorded at fair value on a recurring basis at December 31, 2023 and 2022. December 31, 2023 Level 1 Level 2 Level 3 Total Liabilities Derivative liabilities $ - $ - $ 152,945 $ 152,945 December 31, 2022 Level 1 Level 2 Level 3 Total Liabilities Derivative liabilities $ - $ - $ 568,912 $ 568,912 |
Commitments and Contingencies
Commitments and Contingencies | 12 Months Ended |
Dec. 31, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies Disclosure [Text Block] | Note 15: Commitments and Contingencies Legal From time to time, we may become involved in legal proceedings or be subject to claims arising in the ordinary course of our business. On June 23, 2022, The Good Clinic LLC was notified that a former employee had filed a lawsuit for wrongful termination. The Good Clinic believes the lawsuit is without merit. Mitesco (Company) was not named in the suit. We have settled this matter as of January 11, 2024 for total consideration consisting of a cash payment of $3,000. On June 23, 2022, The Good Clinic LLC was notified that a former employee had filed a lawsuit for wrongful termination. The Good Clinic believes the lawsuit is without merit. Mitesco (Company) was not named in the suit. We have settled this matter as of January 11, 2024 for total consideration consisting of a cash payment of $3,000. On October 25, 2022, the Company was notified that a vendor filed a lawsuit related to a contract dispute naming both The Good Clinic and The CEO of the Good Clinic. This suit was settled on May 5, 2023, and dismissed with prejudice on May 12, 2023. The settlement included the issuance of the Company’s restricted common stock. As a part of the settlement the Company issued 2,552 shares of its restricted common stock to the plaintiff and it issued to the CEO of The Good Clinic 19,622 of its restricted common stock, plus $3,000 in cash for reimbursement of expenses related to settling the suit with the vendor. The Company has a number of legal situations involved with the winding down of its clinic business activities. These include claims regarding certain construction contracts and cancellation of leases as noted below: Nordhaus Clinic On November 1, 2020, we entered into an agreement to open a clinic in Minneapolis, Minnesota. The initial lease term is eight years. Fixed rent payments under the initial term are approximately $511,000. On November 6, 2023, the Company received a termination notice from the landlord indicating the lease had been terminated. No additional claims have been received by the landlord and the Company believes no additional amounts are owed. Egan Clinic a.k.a Vikings On October 14, 2021, we entered into an agreement to open a clinic in Eagan, Minnesota, which began operations in the fourth quarter of 2021. The initial lease term is for 96 months. Fixed rent payments under the initial term are approximately $767,000. A Summary Judgment was granted on December 4, 2023, in the amount of $488,491, and the entry of final judgment was entered on December 15, 2023 and the Company has released the property back to the leaseholder. St. Paul Clinic a.k.a. The Grove On August 31, 2021, we entered into an agreement to open a clinic in St. Paul, Minnesota, which began operations in the fourth quarter of 2021. The initial lease term is for 114 months. Fixed rent payments under the initial term are approximately $1,153,000. A stipulation for Judgment was filed on December 21, 2023 in the amount of $415,266. The stipulated judgment includes $178,542 in unpaid back rent, $172,124 in resolution of mechanics’ liens, and $64,600 in attorneys’ fees. Final entry of judgment by the Court was entered against the Company on January 19, 2024, and the Company has released the property back to the leaseholder. St. Louis Park Clinic a.k.a Excelsior & Grand On May 24, 2021, we entered into an agreement to open a clinic in St. Louis Park, Minnesota, which began operations in the third quarter of 2021. The initial lease term is seven years. Fixed rent payments under the initial term are approximately $673,000. The Company agreed to and executed a Confession of Judgment in the amount of $425,351 on April 2, 2024 and has released the property back to the leaseholder. We received the fully executed and recorded judgement on April 10, 2024. Eden Prairie Clinic a.k.a TP Elevate On June 8, 2021, we entered into an agreement to open a clinic in Eden Prairie, Minnesota, which began operation in the third quarter of 2021. The initial lease term is eight years. Fixed rent payments under the initial term are approximately $620,000. The Company has surrendered possession of the property and is currently in negotiations the amounts owed and is in the process of settling the remaining amounts owed. Maple Grove Clinic a.k.a Arbor Lakes On October 8, 2021, we entered into an agreement to open a clinic in Maple Grove, Minnesota which began operation in the fourth quarter of 2021. The initial lease term is for 108 months. Fixed rent payments under the initial term are approximately $1,153,127. On October 22, 2022, the Company entered into a settlement agreement with the leaseholder for $219,576 and the Company has released the property back to the leaseholder. Radiant Clinic a.k.a LMC Welton On September 9, 2021, we entered into an agreement to open a clinic in Denver, Colorado, which was expected to begin operation in the first quarter of 2023 but possession of which has been relinquished to the landlords. The initial lease term is for 90 months. Fixed rent payments under the initial term are approximately $782,000. As of April 10, 2024, the Company has settled the amounts owed to the leaseholder and full resolution of all liens for approximately $530,000 and the Company has released the property back to the leaseholder. Quincy Clinic a.k.a 1776 Curtis On September 28, 2021, we entered into an agreement to open a clinic in Denver, Colorado, which was expected to begin operation in the first quarter of 2023 but possession of which has been relinquished to the landlords. The initial lease term is for 94 months. Fixed rent payments under the initial term are approximately $1,079,000. A Final Judgment was granted on November 14, 2023, in the amount of $348,764 including interest, fees and other costs. The Company has released the property back to the leaseholder. The following table summarizes the status of our property settlements as noted above and the total settlement amounts as of the date of the filing: LOCATION ALSO KNOWN AS: PROPERTY NAME/OWNER ORIGINAL OBLIGATION (NOT INC. CAPX) SETTLEMENT AMOUNT TYPE OF SETTLEMENT MINNEAPOLIS, MN NORDHAUS LENNAR $ 511,000 $ - N.A. WAYZETTA, MN PROMINADE WAZETTA BAY $ 407,000 $ 25,000 CASH PAYMENT OBLIGATION EAGAN, MN EAGAN CLINIC VIKINGS $ 767,000 $ 488,491 DEFAULT JUDGEMENT ST. LOUIS PARK, MN EXCELSIOR & GRAND EXCELSIOR $ 673,000 $ 425,350 DEFAULT JUDGEMENT ST. PAUL, MN THE GROVE CONTINENTAL 560 $ 1,153,000 $ 415,606 DEFAULT JUDGEMENT EDEN PRARIE ELEVATE TP ELEVATE $ 620,000 $ - IN PROCESS MAPLE GROVE, MN ARBOR LAKES BUTTNICK $ 1,153,127 $ 219,575 SETTLEMENT AGREE DENVER, CO LMC WELTON RADIANT $ 782,000 $ 530,000 DEFAULT JUDGEMENT DENVER, CO 1776 CURTIS QUINCY $ 1,079,000 $ 348,764 DEFAULT JUDGEMENT TOTAL $ 7,145,127 $ 2,452,768 Administrative offices On June 24, 2021, we entered into an agreement to open an administrative office in St. Louis Park, Minnesota. The initial lease term is 2.5 years. Fixed rent payments under the initial term are approximately $244,000. We have not entered into a settlement agreement on this site as of the date of this filing but expect to shortly. |
Subsequent Events
Subsequent Events | 12 Months Ended |
Dec. 31, 2023 | |
Subsequent Events [Abstract] | |
Subsequent Events [Text Block] | Note 16: Subsequent Events On January 17, 2024, because of the substantially lower price realized on the OTC Expert Market the holders of the Series X Preferred shares have modified their policy on pricing of the restricted common stock used for the dividend payments. Until further notice the number of dividend shares will be determined using a price per share of $.80 in computing the number of shares to be issued. This represents a 20% discount to the average closing price immediately before the trading of the common stock was moved onto the OTC Expert Market. On January 24, 2024 the Company received funding after entering into a lending agreement with each of two (2) of its historical institutional investors, Cavalry Fund and Mercer Street Capital (“the Lenders”). The notes provide $25,000 of proceeds each, are for 12-month period, and earn interest at ten percent (10%) per year. The Lenders and the Company have agreed that the use of the proceeds are intended to fund compliance related costs such as SEC reporting, audit, legal and accounting related. On February 9, 2024, the Company issued 41,057 shares of common stock for dividends payable on its Series X Preferred Stock for the period from July 2023 through December 31, 2023. On February 20, 2024 the Board of Directors of Mitesco unanimously voted to terminate a previously approved authorization for a reverse split of its common stock at a ratio of up to 4:1, previously disclosed on January 4, 2023. On March 20, 2024, the Company issued a total of 25,013 shares of restricted common stock for the payment of dividends due for its Series X Preferred stock during the first quarter of 2024 using the $.80 price per share as noted above. Effective April 1, 2024 the Company intends to return to the dividend payment terms as defined in the Certificate of Designation for the Series X Preferred stock, as such the share price used in future dividend payment shall be determined using the closing price of the common stock on the 15 th Advisory Board The Board of Directors recently authorized the creation of a new Advisory Board whose participants shall include subject matter experts in certain business areas under consideration by the Company. These positions are “non-executive” and as such are not governed by Section 16 of the Securities Act. The compensation for the participants shall be $60,000 per year paid through the issuance of restricted common stock. The per share valuation to be used shall be determined by the Board of Directors based on the market of the Company’s common stock at the time of the appointment. On March 19, 2024, the Company announced its first participants to that Board. Each will receive $60,000 of restricted common stock for their services over the next 12 months. The Board has determined that the price per share for the restricted stock shall be $.80, the same pricing used for the payment of dividends to Series X Preferred shareholders. This results in the issuance of 75,000 shares for each member, in aggregate 225,000 shares of restricted common stock. Issuance of Series X Preferred share dividends The Series X Preferred shares accrue dividends at a rate of 10% annually and may be paid in cash or the issuance of restricted common stock. To date the dividends have only been paid through the issuance of restricted common stock. While the documented policy for determining the share price used in such dividend payment states the closing price of the common stock on the 15 th On February 27, 2024 the Company entered into a lending agreements with each of three (3) of its historical institutional investors, Cavalry Fund, AJB and Mercer Street Capital (“the Lenders”). The notes provide $50,000 of proceeds each, are for 12-month period, and earn interest at ten percent (10%) per year. On March 20, 2024, the Company issued a total of 25,013 shares of restricted common stock for the payment of dividends during the first quarter of 2024 using the $.80 price per share as noted above. |
Pay vs Performance Disclosure
Pay vs Performance Disclosure - USD ($) | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Pay vs Performance Disclosure | ||
Net Income (Loss) | $ (13,332,363) | $ (23,236,129) |
Insider Trading Arrangements
Insider Trading Arrangements | 12 Months Ended |
Dec. 31, 2023 | |
Trading Arrangements, by Individual | |
Rule 10b5-1 Arrangement Adopted | false |
Non-Rule 10b5-1 Arrangement Adopted | false |
Rule 10b5-1 Arrangement Terminated | false |
Non-Rule 10b5-1 Arrangement Terminated | false |
Accounting Policies, by Policy
Accounting Policies, by Policy (Policies) | 12 Months Ended |
Dec. 31, 2023 | |
Accounting Policies [Abstract] | |
Basis of Accounting, Policy [Policy Text Block] | Basis of Accounting |
Consolidation, Policy [Policy Text Block] | Principles of Consolidation |
Use of Estimates, Policy [Policy Text Block] | Use of Estimates - |
Cash and Cash Equivalents, Policy [Policy Text Block] | Cash - |
Property, Plant and Equipment, Policy [Policy Text Block] | Property and Equipment - Years Office equipment 3 to 5 Furniture & fixtures 3 to 7 Machinery & equipment 3 to 10 Leasehold improvements Term of lease |
Revenue [Policy Text Block] | Revenue Recognition For changes in credit issues assessed at the date of service, the Company will prospectively recognize those amounts in other operating expenses on the statement of operations. For periods prior to the adoption of ASC 606, the provision for bad debts has been presented consistent with the previous revenue recognition standards that required it to be presented separately as a component of net operating revenues. Our revenues generally relate to net patient fees received from various payers and patients themselves under contracts in which our performance obligations are to provide services to the patients. Revenues are recorded during the period our obligations to provide services are satisfied. The contractual relationships with patients, in most cases, also involve a third-party payer (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed care health plans and commercial insurance companies) the third-party payers. The payment arrangements with third-party payers for the services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates for services or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals. |
Share-Based Payment Arrangement [Policy Text Block] | Stock-Based Compensation - Equity instruments issued to those other than employees are recognized pursuant to FASB issued ASU 2018-07, Compensation – Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting. This ASU relates to the accounting for non-employee share-based payments. The amendment in this update expands the scope of Topic 718 to include all share-based payment transactions in which a grantor acquired goods or services to be used or consumed in a grantor’s own operations by issuing share-based payment awards. The ASU excludes share-based payment awards that relate to: (1) financing to the issuer; or (2) awards granted in conjunction with selling goods or services to customers as part of a contract accounted for under Topic 606, Revenue from Contracts from Customers. The share-based payments are to be measured at grant-date fair value of the equity instruments that the entity is obligated to issue when the goods or service has been delivered or rendered and all other conditions necessary to earn the right to benefit from the equity instruments have been satisfied. |
Convertible Instruments Policy Policy Text Block | Convertible Instruments |
Derivatives, Policy [Policy Text Block] | Derivative Financial Instruments |
Warrants Policy Policy Text Block | Common Stock Purchase Warrants - |
Earnings Per Share, Policy [Policy Text Block] | Per Share Data - |
Income Tax, Policy [Policy Text Block] | Income Taxes - Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all the deferred tax assets will not be realized. The Company has determined that a valuation allowance is needed due to recent taxable net operating losses and the limited taxable income in the carry back periods. The effect on deferred tax assets and liabilities of a change in tax rates is recognized as income or expense in the period that includes the enactment date. Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes and certain tax loss carryforwards, less any valuation allowance. The Company accounts for uncertain tax positions as required in that a position taken or expected to be taken in a tax return is recognized in the consolidated financial statements when it is more likely than not (i.e., a likelihood of more than 50%) that the position would be sustained upon examination by tax authorities. A recognized tax position is then measured at the largest amount of benefit that is greater than 50% of being realized upon ultimate settlement. The Company does not have any material unrecognized tax benefits. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as components of interest expense and other expense, respectively, in arriving at pretax income or loss. The Company does not have any interest and penalties accrued. The Company is no longer subject to U.S. federal, state, and local income tax examinations for the years before 2012. |
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] | Impairment of Long-Lived Assets - |
Fair Value of Financial Instruments, Policy [Policy Text Block] | Financial Instruments and Fair Values - Level 1 – inputs include exchange quoted prices for identical instruments and are the most observable. Level 2 – inputs include brokered and/or quoted prices for similar assets and observable inputs such as interest rates. Level 3 – inputs include data not observable in the market and reflect management judgment about the assumptions market participants would use in pricing the asset or liability. |
New Accounting Pronouncements, Policy [Policy Text Block] | Recent Accounting Standards ASU 2023-07 Segment Reporting ( Topic 280 Improvements to Reportable Segment Disclosures, In December 2023, the FASB issued ASU 2023-09 Income Taxes ( Topic 740 Improvements to Income Tax Disclosures, There are various other updates recently issued, most of which represent technical corrections to the accounting literature or application to specific industries and are not expected to a have a material impact on the Company’s consolidated financial position, results of operations or cash flows. |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Accounting Policies [Abstract] | |
Property, Plant and Equipment [Table Text Block] | Property acquired in a business combination is recorded at estimated initial fair value. Property and equipment are depreciated using the straight-line method based on the lesser of the estimated useful lives of the assets or the lease term based upon the following life expectancy: Years Office equipment 3 to 5 Furniture & fixtures 3 to 7 Machinery & equipment 3 to 10 Leasehold improvements Term of lease |
Discontinued Operations (Tables
Discontinued Operations (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Discontinued Operations and Disposal Groups [Abstract] | |
Disposal Groups, Including Discontinued Operations [Table Text Block] | The following information presents the major classes of line item of assets and liabilities included as part of discontinued operations in the consolidated balance sheets: December 31, December 31, 2023 2022 Current assets - discontinued operations: Accounts receivable - 30,943 Prepaid expenses and deposits - 62,090 Total current assets - discontinued operations $ - $ 93,033 Noncurrent assets - discontinued operations: Property and equipment $ - $ 1,832,973 Right-of-use assets - 460,254 Total noncurrent assets - discontinued operations $ - $ 2,293,227 Accrued interest – related party - 150,039 Note payable – related party - 1,995,667 Total current liabilities - discontinued operations $ - $ 2,145,706 Year Ended December 31, December 31, 2023 2022 Revenue $ 181,012 $ 690,533 Cost of goods sold - 76,530 Gross margin 181,012 614,003 Selling, general, and administrative expenses (1,166,121 ) (7,046,984 ) Impairment of assets (2,211,462 ) (7,597,558 ) Other (income) expense: Interest expense (306,032 ) (1,105,256 ) Gain on sale of assets 11,268 - Gain on settlement of accounts payable 81,263 - Gain on settlement of operating lease 2,041,080 - Loss from discontinued operations, net of tax $ (1,368,991 ) $ (14,959,433 ) Year Ended December 31, December 31, 2023 2022 Depreciation expense $ 81,765 $ 804,882 Cash used for construction in progress and fixed assets $ - $ (1,733,117 ) Impairment of RTU assets $ 544,063 $ - Impairment of property and equipment $ 1,667,399 $ - |
Accounts Payable and Accrued _2
Accounts Payable and Accrued Liabilities (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Payables and Accruals [Abstract] | |
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] | Accounts payable and accrued liabilities consisted of the following at December 31, 2023 and 2022: December 31, December 31, 2023 2022 Trade accounts payable $ 7,094,334 $ 6,761,793 Accrued payroll and payroll taxes 743,778 590,915 Other - 507 Total accounts payable and accrued liabilities $ 7,838,112 $ 7,353,215 |
Right to Use Assets and Lease_2
Right to Use Assets and Lease Liabilities – Operating Leases (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Disclosure Text Block [Abstract] | |
Lease, Cost [Table Text Block] | Right to use assets – operating leases are summarized below: December 31, 2023 December 31, 2022 Right to use assets, net $ - $ 83,810 December 31, 2023 December 31, 2022 Lease liability $ 99,477 $ 4,379,724 Less: current portion (99,477 ) (442,866 ) Lease liability, non-current $ - $ 3,936,858 |
Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] | For all leases for which a legal settlement have been entered into, all amounts have been reclassified to legal settlements as of December 31, 2023. For the period ended December 31, 2024 $ 99,477 For the period ended December 31, 2025 - For the period ended December 31, 2026 - For the period ended December 31, 2027 - For the period ended December 31, 2028 - Thereafter - Total $ 99,477 Less: Present value discount - Lease liability $ 99,477 |
Notes Payable (Tables)
Notes Payable (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Notes Payable (Tables) [Line Items] | |
Schedule of Debt [Table Text Block] | The following table summarizes the outstanding notes payable as of December 31, 2023 and 2022, respectively: December 31, 2023 December 31, 2022 AJB Note $ - $ 750,000 Anson Investments note - 562,500 Anson East note - 187,500 GS Capital note - 277,777 Kishon Note 431,666 277,777 Finnegan Note 1 51,765 51,765 Finnegan Note 2 32,353 32,353 Dragon Note - 647,059 Mackay Note - 323,530 Schrier Note 25,882 25,882 Nommsen Note 64,705 64,705 Caplan Note 64,705 64,705 Finnegan Note 3 32,353 32,353 Enright Note - 132,000 Mitchell Note 78,100 78,100 Lightmas Note 66,000 66,000 Lewis Note 33,000 33,000 Goff Note 33,000 33,000 Hagan Note 110,000 110,000 Darling Note - 220,000 Leath Note 55,000 55,000 Cavalry Note - 500,000 Mercer Note 1 - 300,000 Pinz Note - 30,000 Mercer Note 2 - 100,000 Mercer Note 3 - 125,000 Notes Payable $ 1,078,529 $ 5,080,006 Less: Discount - (32,010 ) Notes payable - net of discount $ 1,078,529 $ 5,047,996 Current Portion, net of discount $ 1,078,529 $ 5,047,996 Long-term portion, net of discount $ - $ - |
Related Party [Member] | |
Notes Payable (Tables) [Line Items] | |
Schedule of Debt [Table Text Block] | The following table summarizes the outstanding related party notes payable as of December 31, 2023 and 2022, respectively December 31, 2023 December 31, 2022 Howe Note 1 $ - $ 1,100,000 Howe Note 2 - 330,000 Howe Note 3 - 330,000 Howe Note 4 - 220,000 Diamond Note 1 - 192,500 Diamond Note 2 - 23,529 Diamond Note 3 - 258,823 Diamond Note 4 - 51,765 Diamond Note 5 - 64,706 M Diamond Note 64,706 64,706 Dobbertin Note 19,412 19,412 Iturregui Note 1 - 32,353 Lindstrom Note 45,294 45,294 November 29, 2022 Notes 37,500 131,250 Notes Payable 166,912 2,864,338 Less: Discount - (22,670 ) Less: Amounts classified as current liabilities of discontinued operations - (1,995,667 ) Notes payable – net of discounts $ 166,912 $ 846,001 Current Portion, net of discount $ 166,912 $ 846,001 Long-term portion, net of discount $ - $ - |
Derivative Liabilities (Tables)
Derivative Liabilities (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Disclosure Text Block [Abstract] | |
Schedule of Derivative Instruments [Table Text Block] | Derivative liability activity for the years ended December 31, 2023 and 2022 is summarized in the table below: December 31, 2021 $ - True-up features issued 192,375 Settled upon conversion or exercise (310,641 ) Loss on revaluation 687,178 December 31, 2022 $ 568,912 True-up features issued - Settled upon conversion or exercise (501,740 ) Loss on revaluation 85,773 December 31, 2023 $ 152,945 |
Fair Value, Assets and Liabilities Measured on Nonrecurring Basis, Valuation Techniques [Table Text Block] | The Company uses a Monte Carlo model to value certain features of its notes payable that create derivative liabilities. The following tables summarize the assumptions for the valuations: December 31, December 31, 2023 2022 Volatility 475.7 % 95.1% to 123.2 % Stock Price $ 0.0250 $ 1.06 to 3.50 Risk-free interest rates 5.21 % 4.35% to 4.37 % Term (years) 0.39 0.73 to 0.86 |
Stockholders' Equity (Deficit)
Stockholders' Equity (Deficit) (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Stockholders' Equity Note [Abstract] | |
Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block] | The following table summarizes the options outstanding at December 31, 2023 and the related prices for the options to purchase shares of the Company’s common stock: Weighted Weighted Weighted average average average exercise exercise Range of Number of remaining price of Number of price of exercise options contractual outstanding options exercisable prices outstanding life (years) options exercisable options $ 1.50 - 16.00 100,934 7.16 $ 10.05 80,934 $ 9.25 100,934 7.16 $ 10.05 80,934 $ 9.25 |
Share-Based Payment Arrangement, Option, Activity [Table Text Block] | Transactions involving stock options are summarized as follows: Shares Weighted- Average Exercise Price ($) Outstanding at December 31, 2021 366,591 $ 10.29 Granted 4,000 $ 12.50 Cancelled/Expired (59,899 ) $ 12.18 Outstanding at December 31, 2022 310,692 $ 10.01 Granted - - Cancelled/Expired (209,758 ) $ 10.00 Exercised - - Outstanding at December 31, 2023 100,934 $ 10.05 Options vested and exercisable 80,934 $ 9.25 |
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] | The following table summarizes the warrants outstanding on December 31, 2023, and the related prices for the warrants to purchase shares of the Company’s common stock: Shares Weighted- Average Exercise Price ($) Outstanding at December 31, 2021 596,400 $ 31.25 Granted 75,934 $ 26.21 Exercised - $ - Outstanding at December 31, 2022 672,334 $ 30.68 Granted 874 $ 2.50 Exercised - $ - Outstanding at December 31, 2023 673,208 $ 30.64 |
Income Taxes (Tables)
Income Taxes (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Income Tax Disclosure [Abstract] | |
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] | For the years ended December 31, 2023 and 2022, the expected tax expense (benefit) based on the U. S. federal statutory rate is reconciled with the actual tax provision (benefit) as follows: For the Years Ended December 31, 2023 2022 Expected tax at statutory rates $ (3,463,000 ) 21 % $ (4,879,000 ) 21 % Permanent Differences 7,000 0 % 1,610,000 (7 )% State Income Tax, Net of Federal benefit (418,000 ) 1 % (380,000 ) 2 % Other (95,000 ) 2 % 286,000 (1 )% Current Year Change in Valuation Allowance 3,969,000 (24 )% 2,611,000 (9 )% Prior Year True-Ups - 0 % 752,000 (6 )% Income tax expense $ - 0 % $ - 0 % |
Schedule of Deferred Tax Assets and Liabilities [Table Text Block] | As of December 31, 2023, and 2022 significant components of the Company’s deferred tax assets are as follows: For the Years Ended December 31, 2023 2022 Deferred Tax Assets (Liabilities): Accrued payroll $ 141,000 $ 112,000 ASC842-ROU Asset - (68,000 ) ASC842-ROU (Liability) 822,000 830,000 Loss from derivatives (16,000 ) (130,000 ) Waiver and commitment fee shares - (32,000 ) Stock based compensation (171,000 ) (85,000 ) Depreciation 3,000 33,000 Net operating loss 13,529,000 9,679,000 Net deferred tax assets (liabilities) 14,308,000 10,339,000 Valuation allowance (14,308,000 ) (10,339,000 ) Net deferred tax assets (liabilities) $ - $ - |
Fair Value of Financial Instr_2
Fair Value of Financial Instruments (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Fair Value Disclosures [Abstract] | |
Schedule of Derivative Liabilities at Fair Value [Table Text Block] | The following summarizes the Company’s derivative financial liabilities that are recorded at fair value on a recurring basis at December 31, 2023 and 2022. December 31, 2023 Level 1 Level 2 Level 3 Total Liabilities Derivative liabilities $ - $ - $ 152,945 $ 152,945 December 31, 2022 Level 1 Level 2 Level 3 Total Liabilities Derivative liabilities $ - $ - $ 568,912 $ 568,912 |
Commitments and Contingencies (
Commitments and Contingencies (Tables) | 12 Months Ended |
Dec. 31, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
Schedule of Property Settlement Obligations [Table Text Block] | The following table summarizes the status of our property settlements as noted above and the total settlement amounts as of the date of the filing: LOCATION ALSO KNOWN AS: PROPERTY NAME/OWNER ORIGINAL OBLIGATION (NOT INC. CAPX) SETTLEMENT AMOUNT TYPE OF SETTLEMENT MINNEAPOLIS, MN NORDHAUS LENNAR $ 511,000 $ - N.A. WAYZETTA, MN PROMINADE WAZETTA BAY $ 407,000 $ 25,000 CASH PAYMENT OBLIGATION EAGAN, MN EAGAN CLINIC VIKINGS $ 767,000 $ 488,491 DEFAULT JUDGEMENT ST. LOUIS PARK, MN EXCELSIOR & GRAND EXCELSIOR $ 673,000 $ 425,350 DEFAULT JUDGEMENT ST. PAUL, MN THE GROVE CONTINENTAL 560 $ 1,153,000 $ 415,606 DEFAULT JUDGEMENT EDEN PRARIE ELEVATE TP ELEVATE $ 620,000 $ - IN PROCESS MAPLE GROVE, MN ARBOR LAKES BUTTNICK $ 1,153,127 $ 219,575 SETTLEMENT AGREE DENVER, CO LMC WELTON RADIANT $ 782,000 $ 530,000 DEFAULT JUDGEMENT DENVER, CO 1776 CURTIS QUINCY $ 1,079,000 $ 348,764 DEFAULT JUDGEMENT TOTAL $ 7,145,127 $ 2,452,768 |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies (Details) - Property, Plant and Equipment | 12 Months Ended |
Dec. 31, 2023 | |
Office Equipment [Member] | Minimum [Member] | |
Property, Plant and Equipment [Line Items] | |
Property, Plant and Equipment, Useful Life | 3 years |
Office Equipment [Member] | Maximum [Member] | |
Property, Plant and Equipment [Line Items] | |
Property, Plant and Equipment, Useful Life | 5 years |
Furniture and Fixtures [Member] | Minimum [Member] | |
Property, Plant and Equipment [Line Items] | |
Property, Plant and Equipment, Useful Life | 3 years |
Furniture and Fixtures [Member] | Maximum [Member] | |
Property, Plant and Equipment [Line Items] | |
Property, Plant and Equipment, Useful Life | 7 years |
Machinery and Equipment [Member] | Minimum [Member] | |
Property, Plant and Equipment [Line Items] | |
Property, Plant and Equipment, Useful Life | 3 years |
Machinery and Equipment [Member] | Maximum [Member] | |
Property, Plant and Equipment [Line Items] | |
Property, Plant and Equipment, Useful Life | 10 years |
Leasehold Improvements [Member] | |
Property, Plant and Equipment [Line Items] | |
Property Plant And Equipment, Estimated Useful Lives | Term of lease |
Discontinued Operations (Detail
Discontinued Operations (Details) $ in Millions | Dec. 08, 2023 USD ($) |
Discontinued Operations and Disposal Groups [Abstract] | |
Proceeds from Sale of Productive Assets | $ 2.5 |
Discontinued Operations (Deta_2
Discontinued Operations (Details) - Disposal Groups, Including Discontinued Operations - USD ($) | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Disposal Groups Including Discontinued Operations Abstract | ||
Accounts receivable | $ 0 | $ 30,943 |
Prepaid expenses and deposits | 0 | 62,090 |
Total current assets - discontinued operations | 0 | 93,033 |
Property and equipment | 0 | 1,832,973 |
Right-of-use assets | 0 | 460,254 |
Total noncurrent assets - discontinued operations | 0 | 2,293,227 |
Accrued interest – related party | 0 | 150,039 |
Note payable – related party | 0 | 1,995,667 |
Total current liabilities - discontinued operations | 0 | 2,145,706 |
Revenue | 181,012 | 690,533 |
Cost of goods sold | 0 | 76,530 |
Gross margin | 181,012 | 614,003 |
Selling, general, and administrative expenses | (1,166,121) | (7,046,984) |
Impairment of assets | (2,211,462) | (7,597,558) |
Interest expense | (306,032) | (1,105,256) |
Gain on sale of assets | 11,268 | 0 |
Gain on settlement of accounts payable | 81,263 | 0 |
Gain on settlement of operating lease | 2,041,080 | 0 |
Loss from discontinued operations, net of tax | (1,368,991) | (14,959,433) |
Depreciation expense | 81,765 | 804,882 |
Cash used for construction in progress and fixed assets | 0 | (1,733,117) |
Impairment of RTU assets | 544,063 | 0 |
Impairment of property and equipment | $ 1,667,399 | $ 0 |
Accounts Payable and Accrued _3
Accounts Payable and Accrued Liabilities (Details) - USD ($) | Sep. 29, 2023 | Jan. 05, 2022 |
Accounts Payable and Accrued Liabilities (Details) [Line Items] | ||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 181,606 | |
Gardner Agreement [Member] | ||
Accounts Payable and Accrued Liabilities (Details) [Line Items] | ||
Debt Instrument, Convertible, Conversion Price (in Dollars per share) | $ 12.5 | |
Restricted Stock [Member] | Gardner Agreement [Member] | ||
Accounts Payable and Accrued Liabilities (Details) [Line Items] | ||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 63,593 | |
Accounts Payable [Member] | ||
Accounts Payable and Accrued Liabilities (Details) [Line Items] | ||
Debt Conversion, Original Debt, Amount | $ 500,000 | |
Fees [Member] | ||
Accounts Payable and Accrued Liabilities (Details) [Line Items] | ||
Debt Conversion, Original Debt, Amount | $ 294,913 |
Accounts Payable and Accrued _4
Accounts Payable and Accrued Liabilities (Details) - Schedule of Accounts Payable and Accrued Liabilities - USD ($) | Dec. 31, 2023 | Dec. 31, 2022 |
Schedule Of Accounts Payable And Accrued Liabilities Abstract | ||
Trade accounts payable | $ 7,094,334 | $ 6,761,793 |
Accrued payroll and payroll taxes | 743,778 | 590,915 |
Other | 0 | 507 |
Total accounts payable and accrued liabilities | $ 7,838,112 | $ 7,353,215 |
Right to Use Assets and Lease_3
Right to Use Assets and Lease Liabilities – Operating Leases (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Disclosure Text Block [Abstract] | ||
Impairment, Lessor Asset under Operating Lease | $ 500,000 | $ 3,185,591 |
Estimated Litigation Liability, Current | $ 2,219,886 | $ 0 |
Right to Use Assets and Lease_4
Right to Use Assets and Lease Liabilities – Operating Leases (Details) - Lease, Cost - USD ($) | Dec. 31, 2023 | Dec. 31, 2022 |
Lease, Cost [Abstract] | ||
Right to use assets, net | $ 0 | $ 83,810 |
Lease liability | 99,477 | 4,379,724 |
Less: current portion | (99,477) | (442,866) |
Lease liability, non-current | $ 0 | $ 3,936,858 |
Right to Use Assets and Lease_5
Right to Use Assets and Lease Liabilities – Operating Leases (Details) - Lessee, Operating Lease, Liability, Maturity - USD ($) | Dec. 31, 2023 | Dec. 15, 2023 | Nov. 14, 2023 | Dec. 31, 2022 | Oct. 14, 2021 | Oct. 08, 2021 | Sep. 28, 2021 | Sep. 21, 2021 | Jun. 08, 2021 | May 04, 2021 | Nov. 01, 2020 |
Lessee Operating Lease Liability Maturity Abstract | |||||||||||
For the period ended December 31, 2024 | $ 99,477 | ||||||||||
For the period ended December 31, 2025 | 0 | ||||||||||
For the period ended December 31, 2026 | 0 | ||||||||||
For the period ended December 31, 2027 | 0 | ||||||||||
For the period ended December 31, 2028 | 0 | ||||||||||
Thereafter | 0 | ||||||||||
Total | 99,477 | $ 1,153,000 | $ 244,000 | $ 767,000 | $ 1,153,127 | $ 1,079,000 | $ 782,000 | $ 620,000 | $ 673,000 | $ 511,000 | |
Less: Present value discount | 0 | ||||||||||
Lease liability | $ 99,477 | $ 4,379,724 |
SBA Loan Payable (Details)
SBA Loan Payable (Details) - USD ($) | 12 Months Ended | ||||
Jul. 12, 2023 | Jan. 12, 2023 | Dec. 31, 2023 | Dec. 31, 2022 | May 04, 2020 | |
SBA Loan Payable (Details) [Line Items] | |||||
Debt Instrument, Periodic Payment | $ 2,595 | ||||
Loans Payable to Bank | $ 467,117 | ||||
Gains (Losses) on Restructuring of Debt | $ 15,032 | $ (25,000) | $ 0 | ||
Notes Payable | $ 1,078,529 | 5,047,996 | |||
PPP Loan [Member] | |||||
SBA Loan Payable (Details) [Line Items] | |||||
Debt Instrument, Face Amount | $ 460,400 | ||||
Debt Instrument, Interest Rate, Effective Percentage | 1% | 1% | |||
Debt Instrument, Increase, Accrued Interest | $ 4,632 | ||||
Gains (Losses) on Restructuring of Debt | $ 40,622 | ||||
Notes Payable | 433,343 | ||||
Repayments of Debt | 11,555 | ||||
PPP Loan [Member] | Accrued Interest [Member] | |||||
SBA Loan Payable (Details) [Line Items] | |||||
Repayments of Debt | $ 5,719 |
Notes Payable (Details)
Notes Payable (Details) - USD ($) | 12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||
Feb. 27, 2024 | Dec. 08, 2023 | Sep. 29, 2023 | Aug. 04, 2023 | Jul. 27, 2023 | Jul. 26, 2023 | Jul. 21, 2023 | Jul. 07, 2023 | May 23, 2023 | May 18, 2023 | Apr. 27, 2023 | Apr. 11, 2023 | Mar. 28, 2023 | Mar. 09, 2023 | Feb. 28, 2023 | Feb. 14, 2023 | Dec. 02, 2022 | Nov. 29, 2022 | Nov. 18, 2022 | Oct. 24, 2022 | Oct. 10, 2022 | Oct. 07, 2022 | Oct. 05, 2022 | Sep. 15, 2022 | Sep. 14, 2022 | Sep. 02, 2022 | Aug. 18, 2022 | Aug. 04, 2022 | Jul. 27, 2022 | Jul. 26, 2022 | Jul. 21, 2022 | Jul. 07, 2022 | Jun. 09, 2022 | May 26, 2022 | May 23, 2022 | May 18, 2022 | May 10, 2022 | Apr. 27, 2022 | Apr. 18, 2022 | Apr. 06, 2022 | Mar. 18, 2022 | Feb. 24, 2022 | Jan. 05, 2022 | Dec. 30, 2021 | Dec. 31, 2023 | Dec. 31, 2022 | Sep. 30, 2023 | Dec. 31, 2021 | |
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 874 | 75,934 | ||||||||||||||||||||||||||||||||||||||||||||||
Derivative Liability, Current | $ 152,945 | $ 568,912 | ||||||||||||||||||||||||||||||||||||||||||||||
Proceeds from Issuance of Debt | $ 50,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 0 | 32,010 | ||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10% | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Related Commitment Fees and Debt Issuance Costs | $ 7,644,077 | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 181,606 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Outstanding (in Shares) | 673,208 | 672,334 | 596,400 | |||||||||||||||||||||||||||||||||||||||||||||
Common Stock, Shares, Issued (in Shares) | 5,567,957 | 4,630,372 | ||||||||||||||||||||||||||||||||||||||||||||||
Common Stock, Value, Issued | $ 55,680 | $ 46,305 | ||||||||||||||||||||||||||||||||||||||||||||||
Gain (Loss) on Extinguishment of Debt | 205,459 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
Interest Expense, Debt | 463,136 | 3,210,763 | ||||||||||||||||||||||||||||||||||||||||||||||
Disposal Group, Including Discontinued Operation, Interest Expense | 306,032 | 1,105,256 | ||||||||||||||||||||||||||||||||||||||||||||||
Fees [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 294,913 | |||||||||||||||||||||||||||||||||||||||||||||||
Investment Incentive [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 1,371,846 | |||||||||||||||||||||||||||||||||||||||||||||||
AJB Capital Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 9,007 | |||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 91,328 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 750,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 15,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Derivative Liability, Current | $ 106,608 | |||||||||||||||||||||||||||||||||||||||||||||||
Proceeds from Issuance of Debt | 675,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | $ 349,914 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Mar. 17, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 12% | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Expense, Long-Term Debt | 62,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | 424,914 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Debt Default, Amount | 750,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Payable | 22,833 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Fee Amount | 15,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 69,167 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Related Commitment Fees and Debt Issuance Costs | 800,800 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 2,032,800 | |||||||||||||||||||||||||||||||||||||||||||||||
AJB Capital Note [Member] | Measurement Input, Default Rate [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 18% | |||||||||||||||||||||||||||||||||||||||||||||||
AJB Capital Note [Member] | Minimum [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10% | |||||||||||||||||||||||||||||||||||||||||||||||
AJB Capital Note [Member] | Principal [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 750,000 | |||||||||||||||||||||||||||||||||||||||||||||||
AJB Capital Note [Member] | Default Penalty [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 375,000 | |||||||||||||||||||||||||||||||||||||||||||||||
AJB Capital Note [Member] | Fees [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 15,000 | |||||||||||||||||||||||||||||||||||||||||||||||
AJB Capital Note [Member] | Accrued Interest [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 92,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Anson Investments Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 322,500 | |||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 25,800 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 562,500 | |||||||||||||||||||||||||||||||||||||||||||||||
Derivative Liability, Current | 27,040 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | $ 416,375 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 12% | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Expense, Long-Term Debt | 68,844 | |||||||||||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | 472,625 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Debt Default, Amount | 562,500 | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Payable | 41,500 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Fee Amount | 15,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 27,157 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Related Commitment Fees and Debt Issuance Costs | 602,815 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 1,530,222 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Outstanding (in Shares) | 11,250 | |||||||||||||||||||||||||||||||||||||||||||||||
Payments to Acquire Debt Securities, Available-for-Sale | $ 506,250 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Expiration or Due Date | Oct. 06, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||
Anson Investments Note [Member] | Measurement Input, Default Rate [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 18% | |||||||||||||||||||||||||||||||||||||||||||||||
Anson Investments Note [Member] | Minimum [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10% | |||||||||||||||||||||||||||||||||||||||||||||||
Anson Investments Note [Member] | Principal [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 562,500 | |||||||||||||||||||||||||||||||||||||||||||||||
Anson Investments Note [Member] | Default Penalty [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 281,250 | |||||||||||||||||||||||||||||||||||||||||||||||
Anson Investments Note [Member] | Fees [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 15,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Anson Investments Note [Member] | Accrued Interest [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 68,657 | |||||||||||||||||||||||||||||||||||||||||||||||
Anson East Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 107,500 | |||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 8,600 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 187,500 | |||||||||||||||||||||||||||||||||||||||||||||||
Derivative Liability, Current | 9,014 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | $ 147,290 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 12% | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Expense, Long-Term Debt | 22,948 | |||||||||||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | 166,040 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Debt Default, Amount | 187,500 | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Payable | 13,833 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Fee Amount | 15,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 9,552 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Related Commitment Fees and Debt Issuance Costs | 207,763 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 527,398 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Outstanding (in Shares) | 3,750 | |||||||||||||||||||||||||||||||||||||||||||||||
Payments to Acquire Debt Securities, Available-for-Sale | $ 168,750 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Expiration or Due Date | Oct. 06, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||
Anson East Note [Member] | Measurement Input, Default Rate [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 18% | |||||||||||||||||||||||||||||||||||||||||||||||
Anson East Note [Member] | Minimum [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10% | |||||||||||||||||||||||||||||||||||||||||||||||
Anson East Note [Member] | Principal [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 187,500 | |||||||||||||||||||||||||||||||||||||||||||||||
Anson East Note [Member] | Default Penalty [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 93,750 | |||||||||||||||||||||||||||||||||||||||||||||||
Anson East Note [Member] | Fees [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 15,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Anson East Note [Member] | Accrued Interest [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 23,385 | |||||||||||||||||||||||||||||||||||||||||||||||
GS Capital Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 159,259 | |||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 12,741 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 277,777 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 5,556 | |||||||||||||||||||||||||||||||||||||||||||||||
Derivative Liability, Current | $ 21,920 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 162,158 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
Interest Expense, Long-Term Debt | 32,155 | |||||||||||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | 212,435 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Debt Default, Amount | 277,777 | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Payable | 19,578 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Fee Amount | 15,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 13,965 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Related Commitment Fees and Debt Issuance Costs | 249,439 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 72,777 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 18,472 | 15,265 | 13,555 | 9,846 | ||||||||||||||||||||||||||||||||||||||||||||
Payments to Acquire Debt Securities, Available-for-Sale | $ 250,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Expiration or Due Date | Nov. 10, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount, Current | $ 27,777 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Convertible, Conversion Price (in Dollars per share) | $ 1.25 | $ 1.5 | $ 1.5 | $ 1.74 | $ 1.46 | |||||||||||||||||||||||||||||||||||||||||||
GS Capital Note [Member] | Measurement Input, Default Rate [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 18% | |||||||||||||||||||||||||||||||||||||||||||||||
GS Capital Note [Member] | Minimum [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10% | |||||||||||||||||||||||||||||||||||||||||||||||
GS Capital Note [Member] | Maximum [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 12% | |||||||||||||||||||||||||||||||||||||||||||||||
GS Capital Note [Member] | Principal [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 205,000 | $ 20,000 | $ 20,000 | $ 17,777 | $ 15,000 | |||||||||||||||||||||||||||||||||||||||||||
GS Capital Note [Member] | Default Penalty [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 138,889 | |||||||||||||||||||||||||||||||||||||||||||||||
GS Capital Note [Member] | Fees [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 15,000 | $ 57,140 | ||||||||||||||||||||||||||||||||||||||||||||||
GS Capital Note [Member] | Accrued Interest [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 2,581 | $ 2,399 | $ 2,057 | $ 1,632 | 8,679 | |||||||||||||||||||||||||||||||||||||||||||
Kishon Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 159,259 | |||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 12,741 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 277,777 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 5,556 | |||||||||||||||||||||||||||||||||||||||||||||||
Derivative Liability, Current | $ 27,793 | |||||||||||||||||||||||||||||||||||||||||||||||
Proceeds from Issuance of Debt | 250,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | $ 138,492 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Nov. 10, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 12% | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Expense, Long-Term Debt | 28,624 | |||||||||||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | 181,269 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Debt Default, Amount | 431,666 | 277,777 | ||||||||||||||||||||||||||||||||||||||||||||||
Interest Payable | 88,909 | 17,822 | ||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Fee Amount | 15,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 71,087 | |||||||||||||||||||||||||||||||||||||||||||||||
Kishon Note [Member] | Measurement Input, Default Rate [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 18% | |||||||||||||||||||||||||||||||||||||||||||||||
Kishon Note [Member] | Minimum [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10% | |||||||||||||||||||||||||||||||||||||||||||||||
Finnegan Note 1 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 3,240 | |||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 1,930 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 47,059 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 386 | |||||||||||||||||||||||||||||||||||||||||||||||
Proceeds from Issuance of Debt | $ 40,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 0 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Nov. 20, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Expense, Long-Term Debt | 3,285 | |||||||||||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | 17,005 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Debt Default, Amount | 51,765 | 51,765 | ||||||||||||||||||||||||||||||||||||||||||||||
Interest Payable | 11,889 | 3,285 | ||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 8,604 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ 12.5 | |||||||||||||||||||||||||||||||||||||||||||||||
Warrants and Rights Outstanding | $ 2,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Finnegan Note 1 [Member] | Measurement Input, Default Rate [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 18% | |||||||||||||||||||||||||||||||||||||||||||||||
Finnegan Note 1 [Member] | Warrants at $25.00 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 386 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ 25 | |||||||||||||||||||||||||||||||||||||||||||||||
Finnegan Note 2 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 2,025 | |||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 242 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 29,412 | |||||||||||||||||||||||||||||||||||||||||||||||
Proceeds from Issuance of Debt | $ 25,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 0 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Nov. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Expense, Long-Term Debt | 1,965 | |||||||||||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | 10,625 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Debt Default, Amount | 32,353 | 32,353 | ||||||||||||||||||||||||||||||||||||||||||||||
Interest Payable | 7,341 | 1,965 | ||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 5,376 | |||||||||||||||||||||||||||||||||||||||||||||||
Warrants and Rights Outstanding | $ 1,250 | |||||||||||||||||||||||||||||||||||||||||||||||
Finnegan Note 2 [Member] | Measurement Input, Default Rate [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 18% | |||||||||||||||||||||||||||||||||||||||||||||||
Finnegan Note 2 [Member] | Warrants at $25.00 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 242 | |||||||||||||||||||||||||||||||||||||||||||||||
Share Price (in Dollars per share) | $ 25 | |||||||||||||||||||||||||||||||||||||||||||||||
Dragon Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 44,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 4,824 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 588,235 | |||||||||||||||||||||||||||||||||||||||||||||||
Proceeds from Issuance of Debt | $ 500,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 0 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Dec. 09, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10% | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Expense, Long-Term Debt | 35,874 | |||||||||||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | 260,059 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Debt Default, Amount | 647,059 | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Payable | 35,874 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 30,204 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Related Commitment Fees and Debt Issuance Costs | 463,539 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 1,176,676 | |||||||||||||||||||||||||||||||||||||||||||||||
Warrants and Rights Outstanding | $ 21,500 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Issuance Costs, Gross | $ 47,500 | |||||||||||||||||||||||||||||||||||||||||||||||
Dragon Note [Member] | Measurement Input, Default Rate [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 18% | |||||||||||||||||||||||||||||||||||||||||||||||
Dragon Note [Member] | Principal [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 647,059 | |||||||||||||||||||||||||||||||||||||||||||||||
Dragon Note [Member] | Accrued Interest [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 66,078 | |||||||||||||||||||||||||||||||||||||||||||||||
Dragon Note [Member] | Warrants at $25.00 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 4,824 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ 25 | |||||||||||||||||||||||||||||||||||||||||||||||
Mackay Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 44,118 | |||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 2,412 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 294,118 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 2,412 | |||||||||||||||||||||||||||||||||||||||||||||||
Proceeds from Issuance of Debt | $ 250,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 0 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Aug. 10, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10% | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Expense, Long-Term Debt | 20,193 | |||||||||||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | 96,280 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Debt Default, Amount | 323,530 | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Payable | 20,193 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 43,614 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Related Commitment Fees and Debt Issuance Costs | $ 258,269 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 655,606 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ 12.5 | |||||||||||||||||||||||||||||||||||||||||||||||
Warrants and Rights Outstanding | $ 10,250 | |||||||||||||||||||||||||||||||||||||||||||||||
Mackay Note [Member] | Measurement Input, Default Rate [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 18% | |||||||||||||||||||||||||||||||||||||||||||||||
Mackay Note [Member] | Fees [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 10,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Mackay Note [Member] | Accrued Interest [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 63,807 | |||||||||||||||||||||||||||||||||||||||||||||||
Mackay Note [Member] | Investment Incentive [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 258,269 | |||||||||||||||||||||||||||||||||||||||||||||||
Mackay Note [Member] | Convertible Notes Payable [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 294,118 | |||||||||||||||||||||||||||||||||||||||||||||||
Mackay Note [Member] | Premium on Notes Payable [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 29,412 | |||||||||||||||||||||||||||||||||||||||||||||||
Mackay Note [Member] | Warrants at $25.00 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 2,412 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ 25 | |||||||||||||||||||||||||||||||||||||||||||||||
Schrier Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 1,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 193 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 23,259 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 193 | 193 | ||||||||||||||||||||||||||||||||||||||||||||||
Proceeds from Issuance of Debt | $ 20,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 335 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Jan. 08, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10% | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Expense, Long-Term Debt | 1,141 | |||||||||||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | 335 | 7,367 | ||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Debt Default, Amount | 25,882 | 25,882 | ||||||||||||||||||||||||||||||||||||||||||||||
Interest Payable | 5,383 | 1,141 | ||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 4,242 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ 25 | |||||||||||||||||||||||||||||||||||||||||||||||
Warrants and Rights Outstanding | $ 820 | |||||||||||||||||||||||||||||||||||||||||||||||
Schrier Note [Member] | Measurement Input, Default Rate [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 18% | |||||||||||||||||||||||||||||||||||||||||||||||
Schrier Note [Member] | Warrants at $25.00 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ 25 | |||||||||||||||||||||||||||||||||||||||||||||||
Nommsen Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 2,350 | |||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 483 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 58,823 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 482 | |||||||||||||||||||||||||||||||||||||||||||||||
Proceeds from Issuance of Debt | $ 50,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 0 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Nov. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10% | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Expense, Long-Term Debt | 2,946 | |||||||||||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | 18,905 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Debt Default, Amount | 64,705 | 64,705 | ||||||||||||||||||||||||||||||||||||||||||||||
Interest Payable | 13,685 | 2,946 | ||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 10,739 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ 25 | |||||||||||||||||||||||||||||||||||||||||||||||
Warrants and Rights Outstanding | $ 1,850 | |||||||||||||||||||||||||||||||||||||||||||||||
Nommsen Note [Member] | Measurement Input, Default Rate [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 18% | |||||||||||||||||||||||||||||||||||||||||||||||
Nommsen Note [Member] | Warrants at $25.00 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 483 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ 25 | |||||||||||||||||||||||||||||||||||||||||||||||
Caplan Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 2,350 | |||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 483 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 58,823 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 482 | |||||||||||||||||||||||||||||||||||||||||||||||
Proceeds from Issuance of Debt | $ 50,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 2,230 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Jan. 21, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10% | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Expense, Long-Term Debt | 2,531 | |||||||||||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | 2,230 | 16,675 | ||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Debt Default, Amount | 64,705 | 64,705 | ||||||||||||||||||||||||||||||||||||||||||||||
Interest Payable | 2,531 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 10,458 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ 25 | |||||||||||||||||||||||||||||||||||||||||||||||
Warrants and Rights Outstanding | $ 1,850 | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Payable, Current | $ 12,989 | |||||||||||||||||||||||||||||||||||||||||||||||
Caplan Note [Member] | Measurement Input, Default Rate [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 18% | |||||||||||||||||||||||||||||||||||||||||||||||
Caplan Note [Member] | Warrants at $25.00 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 483 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ 25 | |||||||||||||||||||||||||||||||||||||||||||||||
Finnegan Note 3 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 1,100 | |||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 242 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 29,412 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 241 | |||||||||||||||||||||||||||||||||||||||||||||||
Proceeds from Issuance of Debt | $ 25,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 1,728 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Feb. 03, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10% | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Expense, Long-Term Debt | 1,200 | |||||||||||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | 7,575 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Debt Default, Amount | 32,353 | 32,353 | ||||||||||||||||||||||||||||||||||||||||||||||
Interest Payable | 6,350 | 1,200 | ||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 5,150 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ 25 | |||||||||||||||||||||||||||||||||||||||||||||||
Warrants and Rights Outstanding | $ 850 | |||||||||||||||||||||||||||||||||||||||||||||||
Finnegan Note 3 [Member] | Measurement Input, Default Rate [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 18% | |||||||||||||||||||||||||||||||||||||||||||||||
Finnegan Note 3 [Member] | Warrants at $25.00 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 242 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ 25 | |||||||||||||||||||||||||||||||||||||||||||||||
Enright Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 6,317 | |||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 984 | 984 | ||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 120,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Proceeds from Issuance of Debt | $ 102,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 6,746 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Feb. 03, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10% | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Expense, Long-Term Debt | 4,899 | |||||||||||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | 29,571 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Debt Default, Amount | 132,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Payable | 4,899 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 15,481 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Related Commitment Fees and Debt Issuance Costs | 102,116 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 254,496 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 255 | |||||||||||||||||||||||||||||||||||||||||||||||
Enright Note [Member] | Measurement Input, Default Rate [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 18% | |||||||||||||||||||||||||||||||||||||||||||||||
Enright Note [Member] | Accrued Interest [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 20,380 | |||||||||||||||||||||||||||||||||||||||||||||||
Enright Note [Member] | Investment Incentive [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 102,116 | |||||||||||||||||||||||||||||||||||||||||||||||
Enright Note [Member] | Convertible Notes Payable [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 120,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Enright Note [Member] | Premium on Notes Payable [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 12,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Mitchell Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 71,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Proceeds from Issuance of Debt | $ 60,350 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 0 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Nov. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10% | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Expense, Long-Term Debt | 2,817 | |||||||||||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | 20,874 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Debt Default, Amount | 78,100 | 78,100 | ||||||||||||||||||||||||||||||||||||||||||||||
Interest Payable | 15,768 | 2,817 | ||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 12,951 | |||||||||||||||||||||||||||||||||||||||||||||||
Common Stock, Shares, Issued (in Shares) | 582 | |||||||||||||||||||||||||||||||||||||||||||||||
Common Stock, Value, Issued | $ 3,124 | |||||||||||||||||||||||||||||||||||||||||||||||
Mitchell Note [Member] | Measurement Input, Default Rate [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 18% | |||||||||||||||||||||||||||||||||||||||||||||||
Lightmas Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 2,640 | |||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 492 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 60,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Proceeds from Issuance of Debt | $ 51,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 0 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Nov. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10% | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Expense, Long-Term Debt | 2,380 | |||||||||||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | 17,640 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Debt Default, Amount | 66,000 | 66,000 | ||||||||||||||||||||||||||||||||||||||||||||||
Interest Payable | 13,325 | 2,380 | ||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 10,945 | |||||||||||||||||||||||||||||||||||||||||||||||
Lightmas Note [Member] | Measurement Input, Default Rate [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 18% | |||||||||||||||||||||||||||||||||||||||||||||||
Lewis Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 1,320 | |||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 246 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 30,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Proceeds from Issuance of Debt | $ 25,500 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 0 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Nov. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10% | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Expense, Long-Term Debt | 1,190 | |||||||||||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | 8,820 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Debt Default, Amount | 33,000 | 33,000 | ||||||||||||||||||||||||||||||||||||||||||||||
Interest Payable | 6,663 | 1,190 | ||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 5,473 | |||||||||||||||||||||||||||||||||||||||||||||||
Lewis Note [Member] | Measurement Input, Default Rate [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 18% | |||||||||||||||||||||||||||||||||||||||||||||||
Goff Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 1,320 | |||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 246 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 30,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Proceeds from Issuance of Debt | $ 25,500 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 0 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Nov. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10% | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Expense, Long-Term Debt | 1,190 | |||||||||||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | 8,820 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Debt Default, Amount | 33,000 | 33,000 | ||||||||||||||||||||||||||||||||||||||||||||||
Interest Payable | 6,663 | 1,190 | ||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 5,473 | |||||||||||||||||||||||||||||||||||||||||||||||
Goff Note [Member] | Measurement Input, Default Rate [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 18% | |||||||||||||||||||||||||||||||||||||||||||||||
Hagan Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 4,715 | |||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 820 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 100,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Proceeds from Issuance of Debt | $ 85,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 0 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Dec. 10, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10% | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Expense, Long-Term Debt | 3,556 | |||||||||||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | 29,715 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Debt Default, Amount | 110,000 | 110,000 | ||||||||||||||||||||||||||||||||||||||||||||||
Interest Payable | 21,793 | 3,556 | ||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 18,237 | |||||||||||||||||||||||||||||||||||||||||||||||
Hagan Note [Member] | Measurement Input, Default Rate [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 18% | |||||||||||||||||||||||||||||||||||||||||||||||
Darling Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 10,824 | |||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 1,640 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 200,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Proceeds from Issuance of Debt | $ 170,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 0 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Dec. 15, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10% | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Expense, Long-Term Debt | 6,619 | |||||||||||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | 60,824 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Debt Default, Amount | 220,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Payable | 6,619 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 10,192 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Related Commitment Fees and Debt Issuance Costs | 153,927 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 390,738 | |||||||||||||||||||||||||||||||||||||||||||||||
Darling Note [Member] | Measurement Input, Default Rate [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 18% | |||||||||||||||||||||||||||||||||||||||||||||||
Darling Note [Member] | Principal [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 220,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Darling Note [Member] | Accrued Interest [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 16,811 | |||||||||||||||||||||||||||||||||||||||||||||||
Leath Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 2,868 | |||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 410 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 50,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Proceeds from Issuance of Debt | $ 42,500 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 0 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Dec. 15, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10% | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Expense, Long-Term Debt | 1,641 | |||||||||||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | 15,368 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Debt Default, Amount | 55,000 | 55,000 | ||||||||||||||||||||||||||||||||||||||||||||||
Interest Payable | 10,757 | 1,641 | ||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 9,116 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Securities, Held-to-Maturity, Fair Value | $ 55,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Leath Note [Member] | Measurement Input, Default Rate [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 18% | |||||||||||||||||||||||||||||||||||||||||||||||
Cavalry Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 500,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 750 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 0 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10% | |||||||||||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | 10,500 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Debt Default, Amount | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Payable | 11,918 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 25,415 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Related Commitment Fees and Debt Issuance Costs | 349,266 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 886,599 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Issuance Costs, Gross | $ 7,500 | |||||||||||||||||||||||||||||||||||||||||||||||
Cavalry Note [Member] | Measurement Input, Default Rate [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 18% | |||||||||||||||||||||||||||||||||||||||||||||||
Cavalry Note [Member] | Principal [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 500,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Cavalry Note [Member] | Accrued Interest [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 37,333 | |||||||||||||||||||||||||||||||||||||||||||||||
Mercer Note 1 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 300,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 750 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 0 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Dec. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10% | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Expense, Long-Term Debt | 6,986 | |||||||||||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | 10,500 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Debt Default, Amount | 300,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Payable | 6,986 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 15,247 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Related Commitment Fees and Debt Issuance Costs | 209,452 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 531,685 | |||||||||||||||||||||||||||||||||||||||||||||||
Mercer Note 1 [Member] | Measurement Input, Default Rate [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 18% | |||||||||||||||||||||||||||||||||||||||||||||||
Mercer Note 1 [Member] | Principal [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 300,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Mercer Note 1 [Member] | Accrued Interest [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 22,233 | |||||||||||||||||||||||||||||||||||||||||||||||
Pinz Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 30,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 0 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Dec. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10% | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Expense, Long-Term Debt | 6,986 | |||||||||||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | 2,100 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Debt Default, Amount | 30,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 15,247 | $ 674 | ||||||||||||||||||||||||||||||||||||||||||||||
Debt Related Commitment Fees and Debt Issuance Costs | 20,929 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 53,127 | |||||||||||||||||||||||||||||||||||||||||||||||
Pinz Note [Member] | Measurement Input, Default Rate [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 18% | |||||||||||||||||||||||||||||||||||||||||||||||
Pinz Note [Member] | Principal [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 30,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Pinz Note [Member] | Accrued Interest [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 2,198 | |||||||||||||||||||||||||||||||||||||||||||||||
Pinz Exchange Agreement [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Convertible, Shares Issuable (in Shares) | 100,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Mercer Note 2 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 100,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 750 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | $ 0 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Dec. 31, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Expense, Long-Term Debt | 1,863 | |||||||||||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | 1,900 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Debt Default, Amount | 100,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 5,076 | 1,863 | ||||||||||||||||||||||||||||||||||||||||||||||
Debt Related Commitment Fees and Debt Issuance Costs | 69,510 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 176,449 | |||||||||||||||||||||||||||||||||||||||||||||||
Mercer Note 2 [Member] | Measurement Input, Default Rate [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 18% | |||||||||||||||||||||||||||||||||||||||||||||||
Mercer Note 2 [Member] | Principal [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 100,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Mercer Note 2 [Member] | Accrued Interest [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 6,939 | |||||||||||||||||||||||||||||||||||||||||||||||
Mercer Note 3 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 125,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 750 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 20,972 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | May 21, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10% | |||||||||||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | 4,028 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Debt Default, Amount | 172,448 | 125,000 | ||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 3,521 | 993 | ||||||||||||||||||||||||||||||||||||||||||||||
Debt Related Commitment Fees and Debt Issuance Costs | 67,934 | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Expense, Debt, Excluding Amortization | 20,972 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Decrease, Forgiveness | 25,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Gain (Loss) on Extinguishment of Debt | 25,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Mercer Note 3 [Member] | Measurement Input, Default Rate [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 18% | |||||||||||||||||||||||||||||||||||||||||||||||
Mercer Note 3 [Member] | Principal [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 100,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Mercer Note 3 [Member] | Accrued Interest [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 4,514 | |||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable, Other Payables [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Interest Payable, Current | 375,346 | 358,165 | ||||||||||||||||||||||||||||||||||||||||||||||
Howe Note1 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 1,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Proceeds from Issuance of Debt | $ 850,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 0 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Nov. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10% | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Expense, Long-Term Debt | 106,795 | |||||||||||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | 511,568 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Debt Default, Amount | 0 | 1,100,000 | ||||||||||||||||||||||||||||||||||||||||||||||
Interest Payable | 0 | 106,795 | ||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 168,761 | |||||||||||||||||||||||||||||||||||||||||||||||
Warrants and Rights Outstanding | $ 261,568 | |||||||||||||||||||||||||||||||||||||||||||||||
Howe Note1 [Member] | Measurement Input, Default Rate [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 18% | |||||||||||||||||||||||||||||||||||||||||||||||
Howe Note 2 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 22,440 | |||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 2,460 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 300,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Proceeds from Issuance of Debt | $ 255,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 0 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Nov. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10% | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Expense, Long-Term Debt | 18,888 | |||||||||||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | 108,405 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Debt Default, Amount | 0 | 330,000 | ||||||||||||||||||||||||||||||||||||||||||||||
Interest Payable | 0 | 18,888 | ||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 50,362 | |||||||||||||||||||||||||||||||||||||||||||||||
Warrants and Rights Outstanding | $ 10,965 | |||||||||||||||||||||||||||||||||||||||||||||||
Howe Note 2 [Member] | Measurement Input, Default Rate [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 18% | |||||||||||||||||||||||||||||||||||||||||||||||
Howe Note 2 [Member] | Warrants at $25.00 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 2,460 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ 25 | |||||||||||||||||||||||||||||||||||||||||||||||
Howe Note 3 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 12,495 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 2,460 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 300,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 2,460 | 2,460 | ||||||||||||||||||||||||||||||||||||||||||||||
Proceeds from Issuance of Debt | $ 255,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Nov. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10% | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Expense, Long-Term Debt | 15,436 | |||||||||||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | 97,440 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Debt Default, Amount | 0 | 330,000 | ||||||||||||||||||||||||||||||||||||||||||||||
Interest Payable | 0 | 15,436 | ||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 50,314 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ 25 | |||||||||||||||||||||||||||||||||||||||||||||||
Warrants and Rights Outstanding | $ 9,945 | |||||||||||||||||||||||||||||||||||||||||||||||
Howe Note 3 [Member] | Measurement Input, Default Rate [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 18% | |||||||||||||||||||||||||||||||||||||||||||||||
Howe Note 3 [Member] | Warrants at $25.00 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ 25 | |||||||||||||||||||||||||||||||||||||||||||||||
Howe Note 4 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 10,775 | |||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 1,640 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 200,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Proceeds from Issuance of Debt | $ 170,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 0 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Nov. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10% | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Expense, Long-Term Debt | 8,756 | |||||||||||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | 60,775 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Debt Default, Amount | 0 | 220,000 | ||||||||||||||||||||||||||||||||||||||||||||||
Interest Payable | 0 | 8,756 | ||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 34,077 | |||||||||||||||||||||||||||||||||||||||||||||||
Howe Note 4 [Member] | Measurement Input, Default Rate [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 18% | |||||||||||||||||||||||||||||||||||||||||||||||
Howe Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Decrease, Forgiveness | 2,454,821 | |||||||||||||||||||||||||||||||||||||||||||||||
Howe Note [Member] | Accrued Interest [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 2,682 | |||||||||||||||||||||||||||||||||||||||||||||||
Howe Note [Member] | Convertible Notes Payable [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 18,750 | |||||||||||||||||||||||||||||||||||||||||||||||
Diamond Note 1 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 175,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Proceeds from Issuance of Debt | $ 148,750 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 0 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Nov. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10% | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Expense, Long-Term Debt | 16,052 | |||||||||||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | 46,664 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Debt Default, Amount | 192,500 | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Payable | 16,052 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 24,024 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Related Commitment Fees and Debt Issuance Costs | 151,174 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 383,750 | |||||||||||||||||||||||||||||||||||||||||||||||
Common Stock, Value, Issued | $ 2,914 | |||||||||||||||||||||||||||||||||||||||||||||||
Diamond Note 1 [Member] | Measurement Input, Default Rate [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 18% | |||||||||||||||||||||||||||||||||||||||||||||||
Diamond Note 1 [Member] | Accrued Interest [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 40,076 | |||||||||||||||||||||||||||||||||||||||||||||||
Diamond Note 1 [Member] | Investment Incentive [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 151,174 | |||||||||||||||||||||||||||||||||||||||||||||||
Diamond Note 1 [Member] | Convertible Notes Payable [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 175,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Diamond Note 1 [Member] | Premium on Notes Payable [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 17,500 | |||||||||||||||||||||||||||||||||||||||||||||||
Diamond Note 2 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 235,294 | |||||||||||||||||||||||||||||||||||||||||||||||
Proceeds from Issuance of Debt | $ 200,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Nov. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10% | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Expense, Long-Term Debt | 1,676 | |||||||||||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | 61,036 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Debt Default, Amount | 23,529 | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Payable | 1,676 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 23 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Related Commitment Fees and Debt Issuance Costs | 16,398 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 41,626 | |||||||||||||||||||||||||||||||||||||||||||||||
Warrants and Rights Outstanding | $ 2,213 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Repaid, Principal | 235,294 | |||||||||||||||||||||||||||||||||||||||||||||||
Diamond Note 2 [Member] | Measurement Input, Default Rate [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 18% | |||||||||||||||||||||||||||||||||||||||||||||||
Diamond Note 2 [Member] | Accrued Interest [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 1,699 | |||||||||||||||||||||||||||||||||||||||||||||||
Diamond Note 2 [Member] | Investment Incentive [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 16,398 | |||||||||||||||||||||||||||||||||||||||||||||||
Diamond Note 2 [Member] | Premium on Notes Payable [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 23,529 | |||||||||||||||||||||||||||||||||||||||||||||||
Diamond Note 2 [Member] | Warrants at $25.00 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 1,930 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ 25 | |||||||||||||||||||||||||||||||||||||||||||||||
Diamond Note 3 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 16,200 | $ 16,200 | ||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 1,929 | 1,930 | ||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 235,294 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 1,929 | |||||||||||||||||||||||||||||||||||||||||||||||
Proceeds from Issuance of Debt | $ 200,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 0 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Nov. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Expense, Long-Term Debt | 17,586 | |||||||||||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | 83,823 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Debt Default, Amount | 258,823 | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Payable | 17,586 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 32,244 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Related Commitment Fees and Debt Issuance Costs | 200,624 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 509,277 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ 12.5 | |||||||||||||||||||||||||||||||||||||||||||||||
Warrants and Rights Outstanding | $ 8,800 | |||||||||||||||||||||||||||||||||||||||||||||||
Diamond Note 3 [Member] | Measurement Input, Default Rate [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 18% | |||||||||||||||||||||||||||||||||||||||||||||||
Diamond Note 3 [Member] | Accrued Interest [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 49,830 | |||||||||||||||||||||||||||||||||||||||||||||||
Diamond Note 3 [Member] | Investment Incentive [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 200,624 | |||||||||||||||||||||||||||||||||||||||||||||||
Diamond Note 3 [Member] | Convertible Notes Payable [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 235,294 | |||||||||||||||||||||||||||||||||||||||||||||||
Diamond Note 3 [Member] | Premium on Notes Payable [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 23,529 | |||||||||||||||||||||||||||||||||||||||||||||||
Diamond Note 4 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 3,160 | |||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 1,930 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 47,059 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 386 | |||||||||||||||||||||||||||||||||||||||||||||||
Proceeds from Issuance of Debt | $ 40,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 0 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Nov. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10% | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Expense, Long-Term Debt | 3,245 | |||||||||||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | 17,885 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Debt Default, Amount | 51,765 | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Payable | 3,245 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 6,446 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Related Commitment Fees and Debt Issuance Costs | 200,624 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 101,402 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ 12.5 | |||||||||||||||||||||||||||||||||||||||||||||||
Warrants and Rights Outstanding | $ 2,960 | |||||||||||||||||||||||||||||||||||||||||||||||
Diamond Note 4 [Member] | Measurement Input, Default Rate [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 18% | |||||||||||||||||||||||||||||||||||||||||||||||
Diamond Note 4 [Member] | Accrued Interest [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 9,691 | |||||||||||||||||||||||||||||||||||||||||||||||
Diamond Note 4 [Member] | Investment Incentive [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 39,946 | |||||||||||||||||||||||||||||||||||||||||||||||
Diamond Note 4 [Member] | Convertible Notes Payable [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 47,059 | |||||||||||||||||||||||||||||||||||||||||||||||
Diamond Note 4 [Member] | Premium on Notes Payable [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 4,706 | |||||||||||||||||||||||||||||||||||||||||||||||
Diamond Note 4 [Member] | Warrants at $25.00 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 386 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ 25 | |||||||||||||||||||||||||||||||||||||||||||||||
Diamond Note 5 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 4,050 | |||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 483 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 58,823 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 483 | |||||||||||||||||||||||||||||||||||||||||||||||
Proceeds from Issuance of Debt | $ 50,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 0 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Nov. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10% | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Expense, Long-Term Debt | 3,929 | |||||||||||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | 21,256 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Debt Default, Amount | 64,705 | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Payable | 3,929 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 8,055 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Related Commitment Fees and Debt Issuance Costs | 200,624 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 126,539 | |||||||||||||||||||||||||||||||||||||||||||||||
Warrants and Rights Outstanding | $ 2,500 | |||||||||||||||||||||||||||||||||||||||||||||||
Diamond Note 5 [Member] | Measurement Input, Default Rate [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 18% | |||||||||||||||||||||||||||||||||||||||||||||||
Diamond Note 5 [Member] | Accrued Interest [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 11,984 | |||||||||||||||||||||||||||||||||||||||||||||||
Diamond Note 5 [Member] | Investment Incentive [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 49,849 | |||||||||||||||||||||||||||||||||||||||||||||||
Diamond Note 5 [Member] | Convertible Notes Payable [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 58,824 | |||||||||||||||||||||||||||||||||||||||||||||||
Diamond Note 5 [Member] | Premium on Notes Payable [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 5,882 | |||||||||||||||||||||||||||||||||||||||||||||||
Diamond Note 5 [Member] | Warrants at $25.00 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ 25 | |||||||||||||||||||||||||||||||||||||||||||||||
M Diamond Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 4,050 | |||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 483 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 58,823 | |||||||||||||||||||||||||||||||||||||||||||||||
Proceeds from Issuance of Debt | $ 50,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 0 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Nov. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10% | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Expense, Long-Term Debt | 3,929 | |||||||||||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | 21,256 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Debt Default, Amount | 64,705 | 64,705 | ||||||||||||||||||||||||||||||||||||||||||||||
Interest Payable | 3,929 | $ 14,682 | ||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 10,753 | |||||||||||||||||||||||||||||||||||||||||||||||
Warrants and Rights Outstanding | $ 2,500 | |||||||||||||||||||||||||||||||||||||||||||||||
M Diamond Note [Member] | Measurement Input, Default Rate [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 18% | |||||||||||||||||||||||||||||||||||||||||||||||
M Diamond Note [Member] | Warrants at $25.00 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 483 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ 25 | |||||||||||||||||||||||||||||||||||||||||||||||
Lindstrom Note 1 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 2,835 | |||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 338 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 41,176 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 338 | |||||||||||||||||||||||||||||||||||||||||||||||
Proceeds from Issuance of Debt | $ 35,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 0 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Nov. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10% | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Expense, Long-Term Debt | 2,750 | |||||||||||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | 14,879 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Debt Default, Amount | 45,294 | 45,294 | ||||||||||||||||||||||||||||||||||||||||||||||
Interest Payable | 10,277 | 2,750 | ||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 7,527 | |||||||||||||||||||||||||||||||||||||||||||||||
Warrants and Rights Outstanding | $ 1,750 | |||||||||||||||||||||||||||||||||||||||||||||||
Lindstrom Note 1 [Member] | Measurement Input, Default Rate [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 18% | |||||||||||||||||||||||||||||||||||||||||||||||
Lindstrom Note 1 [Member] | Warrants at $25.00 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ 25 | |||||||||||||||||||||||||||||||||||||||||||||||
Dobbertin Note 1 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 1,215 | |||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 145 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 17,647 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 145 | |||||||||||||||||||||||||||||||||||||||||||||||
Proceeds from Issuance of Debt | $ 15,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 0 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Nov. 30, 2022 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10% | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Expense, Long-Term Debt | 1,179 | |||||||||||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | 6,377 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Debt Default, Amount | 19,412 | 19,412 | ||||||||||||||||||||||||||||||||||||||||||||||
Interest Payable | 4,405 | 1,179 | ||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 3,226 | |||||||||||||||||||||||||||||||||||||||||||||||
Warrants and Rights Outstanding | $ 750 | |||||||||||||||||||||||||||||||||||||||||||||||
Dobbertin Note 1 [Member] | Measurement Input, Default Rate [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 18% | |||||||||||||||||||||||||||||||||||||||||||||||
Dobbertin Note 1 [Member] | Warrants at $25.00 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ 25 | |||||||||||||||||||||||||||||||||||||||||||||||
Iturregui Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 1,225 | |||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 241 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | 29,412 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 241 | |||||||||||||||||||||||||||||||||||||||||||||||
Proceeds from Issuance of Debt | $ 25,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 1,089 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Jan. 21, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10% | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Expense, Long-Term Debt | 1,313 | |||||||||||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | 8,464 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Debt Default, Amount | 32,353 | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Payable | 1,313 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 3,881 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Related Commitment Fees and Debt Issuance Costs | 24,406 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 61,953 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ 25 | |||||||||||||||||||||||||||||||||||||||||||||||
Warrants and Rights Outstanding | $ 975 | |||||||||||||||||||||||||||||||||||||||||||||||
Iturregui Note [Member] | Measurement Input, Default Rate [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 18% | |||||||||||||||||||||||||||||||||||||||||||||||
Iturregui Note [Member] | Accrued Interest [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 5,194 | |||||||||||||||||||||||||||||||||||||||||||||||
Iturregui Note [Member] | Investment Incentive [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 24,406 | |||||||||||||||||||||||||||||||||||||||||||||||
Iturregui Note [Member] | Convertible Notes Payable [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 29,412 | |||||||||||||||||||||||||||||||||||||||||||||||
Iturregui Note [Member] | Premium on Notes Payable [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 2,941 | |||||||||||||||||||||||||||||||||||||||||||||||
Iturregui Note [Member] | Warrants at $25.00 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 242 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ 25 | |||||||||||||||||||||||||||||||||||||||||||||||
November 29, 2022 Notes [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 750 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 3,083 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | May 28, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | 667 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Debt Default, Amount | 18,750 | |||||||||||||||||||||||||||||||||||||||||||||||
Interest Payable | 164 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Increase, Accrued Interest | 11,967 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Related Commitment Fees and Debt Issuance Costs | $ 13,553 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 26,064 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Convertible, Conversion Price (in Dollars per share) | $ 0.8 | |||||||||||||||||||||||||||||||||||||||||||||||
Convertible Notes Payable | 37,500 | $ 5,903 | ||||||||||||||||||||||||||||||||||||||||||||||
November 29, 2022 Notes [Member] | Measurement Input, Default Rate [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 18% | |||||||||||||||||||||||||||||||||||||||||||||||
November 29, 2022 Notes [Member] | Accrued Interest [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 2,101 | |||||||||||||||||||||||||||||||||||||||||||||||
November 29, 2022 Notes [Member] | Investment Incentive [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 13,553 | |||||||||||||||||||||||||||||||||||||||||||||||
November 29, 2022 Notes [Member] | Convertible Notes Payable [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 18,750 | |||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 911 | 8,116 | ||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | Default Penalty [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 888,889 | |||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | Fees [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 10,000 | 60,000 | ||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | Accrued Interest [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 84,187 | 365,012 | ||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | Investment Incentive [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 360,385 | $ 3,195,374 | ||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | Convertible Notes Payable [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 414,118 | |||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | Premium on Notes Payable [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 41,412 | |||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | AJB Capital Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 2,033 | |||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | Anson Investments Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 1,531 | |||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | Anson East Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 528 | |||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | GS Capital Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 633,192 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 634 | |||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | GS Capital Note [Member] | Accrued Interest [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 24,864 | |||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | Dragon Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 1,177 | |||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | Mackay Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 656 | |||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | Darling Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 391 | |||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | Cavalry Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 887 | |||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | Mercer Note 1 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 531 | |||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | Pinz Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 54 | |||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | Mercer Note 2 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 177 | |||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | Mercer Note 3 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 173 | |||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | Diamond Note 1 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 384 | |||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | Diamond Note 2 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 42 | |||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | Diamond Note 3 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 509 | |||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | Diamond Note 4 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 101 | |||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | Diamond Note 5 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 127 | |||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | Iturregui Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 62 | |||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | November 29, 2022 Notes [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 34,404 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 34 | |||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | November 29, 2022 Notes [Member] | Accrued Interest [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 2,101 | |||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | November 29, 2022 Notes [Member] | Convertible Notes Payable [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 18,750 | |||||||||||||||||||||||||||||||||||||||||||||||
Series C Preferred Stock [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Related Commitment Fees and Debt Issuance Costs | $ 1,016,888 | |||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 2,289 | |||||||||||||||||||||||||||||||||||||||||||||||
Series C Preferred Stock [Member] | Cavalry Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Convertible, Shares Issuable (in Shares) | 1,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Series C Preferred Stock [Member] | Cavalry Exchange Agreement [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Convertible, Shares Issuable (in Shares) | 1,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Series C Preferred Stock [Member] | Mercer Note 1 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Convertible, Shares Issuable (in Shares) | 47,619 | |||||||||||||||||||||||||||||||||||||||||||||||
Series C Preferred Stock [Member] | Mercer Exchange Agreement [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Convertible, Shares Issuable (in Shares) | 47,619 | |||||||||||||||||||||||||||||||||||||||||||||||
Series D Preferred Stock [Member] | Cavalry Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Convertible, Shares Issuable (in Shares) | 750,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Series D Preferred Stock [Member] | Cavalry Exchange Agreement [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Convertible, Shares Issuable (in Shares) | 750,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Series D Preferred Stock [Member] | Mercer Note 1 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Convertible, Shares Issuable (in Shares) | 750,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Series D Preferred Stock [Member] | Mercer Exchange Agreement [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Convertible, Shares Issuable (in Shares) | 750,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Series D Preferred Stock [Member] | Pinz Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Convertible, Shares Issuable (in Shares) | 100,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Warrants at $25.00 [Member] | Howe Note1 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 42,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ 25 | |||||||||||||||||||||||||||||||||||||||||||||||
Warrants at $25.00 [Member] | Diamond Note 1 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 7,350 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ 25 | |||||||||||||||||||||||||||||||||||||||||||||||
Warrants at $25.00 [Member] | Diamond Note 3 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 1,930 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ 25 | |||||||||||||||||||||||||||||||||||||||||||||||
Warrants at $37.50 [Member] | Howe Note1 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 42,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ 37.5 | |||||||||||||||||||||||||||||||||||||||||||||||
Warrants at $37.50 [Member] | Diamond Note 1 [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 7,350 | |||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ 37.5 | |||||||||||||||||||||||||||||||||||||||||||||||
Commitments [Member] | AJB Capital Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 430,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 34,400 | |||||||||||||||||||||||||||||||||||||||||||||||
Commitments [Member] | Iturregui Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 242 | |||||||||||||||||||||||||||||||||||||||||||||||
Original Issue Discount [Member] | AJB Capital Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | $ 75,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Original Issue Discount [Member] | Anson Investments Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | $ 56,250 | |||||||||||||||||||||||||||||||||||||||||||||||
Original Issue Discount [Member] | Anson East Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | $ 18,750 | |||||||||||||||||||||||||||||||||||||||||||||||
Original Issue Discount [Member] | Kishon Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | $ 27,777 | |||||||||||||||||||||||||||||||||||||||||||||||
Default Penalty [Member] | AJB Capital Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Fee Amount | 375,000 | |||||||||||||||||||||||||||||||||||||||||||||||
Default Penalty [Member] | Anson Investments Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Fee Amount | 281,250 | |||||||||||||||||||||||||||||||||||||||||||||||
Default Penalty [Member] | Anson East Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Fee Amount | 93,750 | |||||||||||||||||||||||||||||||||||||||||||||||
Default Penalty [Member] | GS Capital Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Fee Amount | 138,889 | |||||||||||||||||||||||||||||||||||||||||||||||
Default Penalty [Member] | Kishon Note [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Fee Amount | 138,889 | |||||||||||||||||||||||||||||||||||||||||||||||
Related Party [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||
Notes Payable (Details) [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||
Proceeds from Issuance of Debt | 0 | $ 698,750 | ||||||||||||||||||||||||||||||||||||||||||||||
Amortization of Debt Discount (Premium) | 19,587 | 264,385 | ||||||||||||||||||||||||||||||||||||||||||||||
Interest Payable | 35,267 | 52,643 | ||||||||||||||||||||||||||||||||||||||||||||||
Interest Payable, Current | 35,267 | 52,643 | ||||||||||||||||||||||||||||||||||||||||||||||
Interest Expense, Debt | 404,781 | 1,243,639 | ||||||||||||||||||||||||||||||||||||||||||||||
Disposal Group, Including Discontinued Operation, Interest Expense | $ 306,032 | $ 928,894 |
Notes Payable (Details) - Sche
Notes Payable (Details) - Schedule of Debt - USD ($) | Dec. 31, 2023 | Dec. 31, 2022 | May 10, 2022 | Apr. 18, 2022 | Apr. 06, 2022 | Mar. 18, 2022 |
Notes Payable (Details) - Schedule of Debt [Line Items] | ||||||
Notes Payable | $ 1,078,529 | $ 5,080,006 | ||||
Less: Discount | 0 | (32,010) | ||||
Notes payable - net of discount | 1,078,529 | 5,047,996 | ||||
Current Portion, net of discount | 1,078,529 | 5,047,996 | ||||
Long-term portion, net of discount | 0 | 0 | ||||
AJB Capital Note [Member] | ||||||
Notes Payable (Details) - Schedule of Debt [Line Items] | ||||||
Notes Payable | 0 | 750,000 | ||||
Less: Discount | 0 | $ (349,914) | ||||
Anson Investments Note [Member] | ||||||
Notes Payable (Details) - Schedule of Debt [Line Items] | ||||||
Notes Payable | 0 | 562,500 | ||||
Less: Discount | 0 | $ (416,375) | ||||
Anson East Note [Member] | ||||||
Notes Payable (Details) - Schedule of Debt [Line Items] | ||||||
Notes Payable | 0 | 187,500 | ||||
Less: Discount | 0 | $ (147,290) | ||||
GS Capital Note [Member] | ||||||
Notes Payable (Details) - Schedule of Debt [Line Items] | ||||||
Notes Payable | 0 | 277,777 | ||||
Less: Discount | 0 | $ (162,158) | ||||
Kishon Note [Member] | ||||||
Notes Payable (Details) - Schedule of Debt [Line Items] | ||||||
Notes Payable | 431,666 | 277,777 | ||||
Less: Discount | 0 | $ (138,492) | ||||
Finnegan Note 1 [Member] | ||||||
Notes Payable (Details) - Schedule of Debt [Line Items] | ||||||
Notes Payable | 51,765 | 51,765 | ||||
Less: Discount | 0 | |||||
Finnegan Note 2 [Member] | ||||||
Notes Payable (Details) - Schedule of Debt [Line Items] | ||||||
Notes Payable | 32,353 | 32,353 | ||||
Less: Discount | 0 | |||||
Dragon Note [Member] | ||||||
Notes Payable (Details) - Schedule of Debt [Line Items] | ||||||
Notes Payable | 0 | 647,059 | ||||
Less: Discount | 0 | |||||
Mackay Note [Member] | ||||||
Notes Payable (Details) - Schedule of Debt [Line Items] | ||||||
Notes Payable | 0 | 323,530 | ||||
Less: Discount | 0 | |||||
Schrier Note [Member] | ||||||
Notes Payable (Details) - Schedule of Debt [Line Items] | ||||||
Notes Payable | 25,882 | 25,882 | ||||
Less: Discount | (335) | |||||
Nommsen Note [Member] | ||||||
Notes Payable (Details) - Schedule of Debt [Line Items] | ||||||
Notes Payable | 64,705 | 64,705 | ||||
Less: Discount | 0 | |||||
Caplan Note [Member] | ||||||
Notes Payable (Details) - Schedule of Debt [Line Items] | ||||||
Notes Payable | 64,705 | 64,705 | ||||
Less: Discount | (2,230) | |||||
Finnegan Note 3 [Member] | ||||||
Notes Payable (Details) - Schedule of Debt [Line Items] | ||||||
Notes Payable | 32,353 | 32,353 | ||||
Less: Discount | (1,728) | |||||
Enright Note [Member] | ||||||
Notes Payable (Details) - Schedule of Debt [Line Items] | ||||||
Notes Payable | 0 | 132,000 | ||||
Less: Discount | (6,746) | |||||
Mitchell Note [Member] | ||||||
Notes Payable (Details) - Schedule of Debt [Line Items] | ||||||
Notes Payable | 78,100 | 78,100 | ||||
Less: Discount | 0 | |||||
Lightmas Note [Member] | ||||||
Notes Payable (Details) - Schedule of Debt [Line Items] | ||||||
Notes Payable | 66,000 | 66,000 | ||||
Less: Discount | 0 | |||||
Lewis Note [Member] | ||||||
Notes Payable (Details) - Schedule of Debt [Line Items] | ||||||
Notes Payable | 33,000 | 33,000 | ||||
Less: Discount | 0 | |||||
Goff Note [Member] | ||||||
Notes Payable (Details) - Schedule of Debt [Line Items] | ||||||
Notes Payable | 33,000 | 33,000 | ||||
Less: Discount | 0 | |||||
Hagan Note [Member] | ||||||
Notes Payable (Details) - Schedule of Debt [Line Items] | ||||||
Notes Payable | 110,000 | 110,000 | ||||
Less: Discount | 0 | |||||
Darling Note [Member] | ||||||
Notes Payable (Details) - Schedule of Debt [Line Items] | ||||||
Notes Payable | 0 | 220,000 | ||||
Less: Discount | 0 | |||||
Leath Note [Member] | ||||||
Notes Payable (Details) - Schedule of Debt [Line Items] | ||||||
Notes Payable | 55,000 | 55,000 | ||||
Less: Discount | 0 | |||||
Cavalry Note [Member] | ||||||
Notes Payable (Details) - Schedule of Debt [Line Items] | ||||||
Notes Payable | 0 | 500,000 | ||||
Less: Discount | 0 | |||||
Mercer Note 1 [Member] | ||||||
Notes Payable (Details) - Schedule of Debt [Line Items] | ||||||
Notes Payable | 0 | 300,000 | ||||
Less: Discount | 0 | |||||
Pinz Note [Member] | ||||||
Notes Payable (Details) - Schedule of Debt [Line Items] | ||||||
Notes Payable | 0 | 30,000 | ||||
Less: Discount | 0 | |||||
Mercer Note 2 [Member] | ||||||
Notes Payable (Details) - Schedule of Debt [Line Items] | ||||||
Notes Payable | 0 | 100,000 | ||||
Less: Discount | 0 | |||||
Mercer Note 3 [Member] | ||||||
Notes Payable (Details) - Schedule of Debt [Line Items] | ||||||
Notes Payable | $ 0 | 125,000 | ||||
Less: Discount | $ (20,972) |
Notes Payable _ Related Parties
Notes Payable – Related Parties (Details) - Schedule of Debt, Related Parties - Related Party [Member] - USD ($) | Dec. 31, 2023 | Dec. 31, 2022 |
Howe Note1 [Member] | ||
Notes Payable – Related Parties (Details) - Schedule of Debt, Related Parties [Line Items] | ||
Notes Payable | $ 0 | $ 1,100,000 |
Howe Note 2 [Member] | ||
Notes Payable – Related Parties (Details) - Schedule of Debt, Related Parties [Line Items] | ||
Notes Payable | 0 | 330,000 |
Howe Note 3 [Member] | ||
Notes Payable – Related Parties (Details) - Schedule of Debt, Related Parties [Line Items] | ||
Notes Payable | 0 | 330,000 |
Howe Note 4 [Member] | ||
Notes Payable – Related Parties (Details) - Schedule of Debt, Related Parties [Line Items] | ||
Notes Payable | 0 | 220,000 |
Diamond Note 1 [Member] | ||
Notes Payable – Related Parties (Details) - Schedule of Debt, Related Parties [Line Items] | ||
Notes Payable | 0 | 192,500 |
Diamond Note 2 [Member] | ||
Notes Payable – Related Parties (Details) - Schedule of Debt, Related Parties [Line Items] | ||
Notes Payable | 0 | 23,529 |
Diamond Note 3 [Member] | ||
Notes Payable – Related Parties (Details) - Schedule of Debt, Related Parties [Line Items] | ||
Notes Payable | 0 | 258,823 |
Diamond Note 4 [Member] | ||
Notes Payable – Related Parties (Details) - Schedule of Debt, Related Parties [Line Items] | ||
Notes Payable | 0 | 51,765 |
Diamond Note 5 [Member] | ||
Notes Payable – Related Parties (Details) - Schedule of Debt, Related Parties [Line Items] | ||
Notes Payable | 0 | 64,706 |
M Diamond Note [Member] | ||
Notes Payable – Related Parties (Details) - Schedule of Debt, Related Parties [Line Items] | ||
Notes Payable | 64,706 | 64,706 |
Dobbertin Note 1 [Member] | ||
Notes Payable – Related Parties (Details) - Schedule of Debt, Related Parties [Line Items] | ||
Notes Payable | 19,412 | 19,412 |
Iturregui Note [Member] | ||
Notes Payable – Related Parties (Details) - Schedule of Debt, Related Parties [Line Items] | ||
Notes Payable | 0 | 32,353 |
Lindstrom Note 1 [Member] | ||
Notes Payable – Related Parties (Details) - Schedule of Debt, Related Parties [Line Items] | ||
Notes Payable | 45,294 | 45,294 |
November 29, 2022 Notes [Member] | ||
Notes Payable – Related Parties (Details) - Schedule of Debt, Related Parties [Line Items] | ||
Notes Payable | 37,500 | 131,250 |
Related Party [Member] | ||
Notes Payable – Related Parties (Details) - Schedule of Debt, Related Parties [Line Items] | ||
Notes Payable | 166,912 | 2,864,338 |
Less: Discount | 0 | (22,670) |
Less: Amounts classified as current liabilities of discontinued operations | 0 | (1,995,667) |
Notes payable – net of discounts | 166,912 | 846,001 |
Current Portion, net of discount | 166,912 | 846,001 |
Long-term portion, net of discount | $ 0 | $ 0 |
Derivative Liabilities (Details
Derivative Liabilities (Details) - Schedule of Derivative Liability Acitivity - USD ($) | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Schedule Of Derivative Liability Acitivity Abstract | ||
Balance | $ 568,912 | $ 0 |
True-up features issued | 0 | 192,375 |
Settled upon conversion or exercise | $ (501,740) | $ (310,641) |
Loss on revaluation | Derivative Liability, Current | Derivative Liability, Current |
Balance | $ 152,945 | $ 568,912 |
Derivative Liabilities (Detai_2
Derivative Liabilities (Details) - Schedule of Valuation Assumptions - $ / shares | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Derivative Liabilities (Details) - Schedule of Valuation Assumptions [Line Items] | ||
Volatility | 475.70% | |
Stock Price (in Dollars per share) | $ 0.025 | |
Risk-free interest rates | 5.21% | |
Term (years) | 4 months 20 days | |
Minimum [Member] | ||
Derivative Liabilities (Details) - Schedule of Valuation Assumptions [Line Items] | ||
Volatility | 95.10% | |
Stock Price (in Dollars per share) | $ 1.06 | |
Risk-free interest rates | 4.35% | |
Term (years) | 8 months 23 days | |
Maximum [Member] | ||
Derivative Liabilities (Details) - Schedule of Valuation Assumptions [Line Items] | ||
Volatility | 123.20% | |
Stock Price (in Dollars per share) | $ 3.5 | |
Risk-free interest rates | 4.37% | |
Term (years) | 10 months 9 days |
Stockholders' Equity (Deficit_2
Stockholders' Equity (Deficit) (Details) - USD ($) | 12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dec. 08, 2023 | Nov. 18, 2023 | Oct. 01, 2023 | Sep. 29, 2023 | Sep. 15, 2023 | Sep. 14, 2023 | Sep. 09, 2023 | Sep. 02, 2023 | Aug. 21, 2023 | Aug. 18, 2023 | Aug. 04, 2023 | Jul. 27, 2023 | Jul. 26, 2023 | Jul. 21, 2023 | Jul. 07, 2023 | Jul. 01, 2023 | Jun. 30, 2023 | Jun. 29, 2023 | Jun. 22, 2023 | Jun. 09, 2023 | Jun. 07, 2023 | May 26, 2023 | May 23, 2023 | May 18, 2023 | May 10, 2023 | May 09, 2023 | May 05, 2023 | May 01, 2023 | Apr. 27, 2023 | Apr. 11, 2023 | Apr. 04, 2023 | Mar. 31, 2023 | Mar. 28, 2023 | Mar. 22, 2023 | Mar. 09, 2023 | Feb. 28, 2023 | Feb. 21, 2023 | Feb. 14, 2023 | Jan. 23, 2023 | Jan. 12, 2023 | Jan. 05, 2023 | Nov. 18, 2022 | Nov. 07, 2022 | Sep. 15, 2022 | Sep. 14, 2022 | Sep. 02, 2022 | Aug. 18, 2022 | Aug. 04, 2022 | Jul. 27, 2022 | Jul. 26, 2022 | Jul. 21, 2022 | Jul. 07, 2022 | Jun. 09, 2022 | May 23, 2022 | May 18, 2022 | Apr. 27, 2022 | Apr. 18, 2022 | Apr. 06, 2022 | Mar. 18, 2022 | Feb. 01, 2022 | Jan. 05, 2022 | Dec. 31, 2023 | Dec. 31, 2022 | Oct. 18, 2023 | Oct. 10, 2023 | Oct. 07, 2023 | Oct. 05, 2023 | Mar. 23, 2023 | Dec. 12, 2022 | Dec. 11, 2022 | Dec. 31, 2021 | |
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common Stock, Shares Authorized (in Shares) | 500,000,000 | 500,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common Stock, Par or Stated Value Per Share (in Dollars per share) | $ 0.01 | $ 0.01 | $ 0.01 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common Stock, Shares, Issued (in Shares) | 5,567,957 | 4,630,372 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common Stock, Shares, Outstanding (in Shares) | 5,567,957 | 4,630,372 | 4,630,372 | 231,374,330 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Reverse Stock Splits (in Shares) | 226,743,958 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Issued for Services (in Shares) | 12,064 | 150,000 | 150,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share (in Dollars per share) | $ 0.8 | $ 2.53 | $ 3.45 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-Based Payment Arrangement, Expense | $ 379,500 | $ 517,500 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 181,606 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, New Issues | $ 1,583,500 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common Stock Dividends, Shares (in Shares) | 20,212 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 145,285 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gain on Conversion of Debt | 138,531 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accrued Salaries, Current | $ 19,032 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Shares, Share-Based Payment Arrangement, Forfeited (in Shares) | 8,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Value, Share-Based Payment Arrangement, Forfeited | $ 80 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gains (Losses) on Restructuring of Debt | $ 15,032 | (25,000) | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Accrued Liabilities, Current | 0 | 507 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Noncash Expense | 1,027,778 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gain (Loss) on Waiver Fee Shares | 0 | 198,273 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | $ 0 | $ 32,010 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 874 | 75,934 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Outstanding (in Shares) | 673,208 | 672,334 | 596,400 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Issued for Services | $ 77,448 | $ 897,000 | $ 101,250 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Shares Authorized (in Shares) | 100,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dividends, Preferred Stock | $ 1,719,781 | 322,310 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Related Commitment Fees and Debt Issuance Costs | 7,644,077 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Conversion of Convertible Securities | 180,573 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Proceeds from Issuance of Preferred Stock and Preference Stock | $ 738,500 | $ 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Subscribed [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share (in Dollars per share) | $ 12.5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 7,648 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common Stock [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Issued for Services (in Shares) | 300,000 | 6,329 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 5,448 | $ 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Shares, Share-Based Payment Arrangement, Forfeited (in Shares) | (8,000) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Issued for Services | 3,000 | $ 63 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Conversion of Stock, Amount Issued | 981 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Conversion of Convertible Securities | 271 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Valuation, Market Approach [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share (in Dollars per share) | $ 6.42 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Waiver Fee [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share (in Dollars per share) | $ 12.5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 30,835 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Noncash Expense | 385,431 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gain (Loss) on Waiver Fee Shares | 198,273 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-Based Payment Arrangement, Option [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | 812,621 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accrued Interest [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Amount | 2,101 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounts Payable [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Amount | 79,503 | 578,235 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Conversion of Convertible Securities | 79,503 | 578,235 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounts Payable [Member] | Common Stock [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Conversion of Convertible Securities | 2,476 | 636 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Convertible Notes Payable [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Amount | 18,750 | 83,456 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accrued Salaries [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Amount | 64,434 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accrued Board Fees [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Amount | 60,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Finnegan Note 3 [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitment Shares Value | $ 1,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accrued Dividends [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 215,659 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment Incentive [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 1,371,846 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fees [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 294,913 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Two Investors [Member] | Accrued Dividends [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Conversion of Stock, Amount Converted | 171,109 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Two Investors [Member] | Series C Preferred Stock [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Conversion of Stock, Amount Converted | 1,100,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Two Investors [Member] | Investment Incentive [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Conversion of Stock, Amount Converted | 1,016,888 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Two Investors [Member] | Series D Preferred Stock [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Conversion of Stock, Amount Converted | 2,467,500 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
GS Capital Note [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common Stock, Par or Stated Value Per Share (in Dollars per share) | $ 10.45 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 72,777 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Convertible, Conversion Price (in Dollars per share) | $ 1.25 | $ 1.5 | $ 1.5 | $ 1.74 | $ 1.46 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 18,472 | 15,265 | 13,555 | 9,846 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, New Issues (in Shares) | 12,741 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 12,741 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | $ 162,158 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 159,259 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 5,556 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Fee Amount | $ 15,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 277,777 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Payments to Acquire Debt Securities, Available-for-Sale | $ 250,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitment Fee Per Share (in Dollars per share) | $ 10.45 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Related Commitment Fees and Debt Issuance Costs | 249,439 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
GS Capital Note [Member] | Principal [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 205,000 | $ 20,000 | $ 20,000 | $ 17,777 | $ 15,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
GS Capital Note [Member] | Accrued Interest [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 2,581 | $ 2,399 | $ 2,057 | $ 1,632 | 8,679 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
GS Capital Note [Member] | Default Penalty [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 138,889 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
GS Capital Note [Member] | Fees [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 15,000 | 57,140 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series X Preferred Stock [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common Stock, Par or Stated Value Per Share (in Dollars per share) | $ 12.5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, New Issues (in Shares) | 8,103 | 8,063 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounts Payable 1 [Member] | Accounts Payable [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share (in Dollars per share) | $ 0.8 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 131,362 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 105,089 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gain on Conversion of Debt | $ 59,112 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounts Payable 2 [Member] | Accounts Payable [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share (in Dollars per share) | $ 0.8 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 43,750 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 35,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gain on Conversion of Debt | $ 19,687 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounts Payable 3 [Member] | Accounts Payable [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share (in Dollars per share) | $ 0.8 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 49,226 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 39,380 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gain on Conversion of Debt | $ 22,151 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Private Placement [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Convertible, Conversion Price (in Dollars per share) | $ 18,750 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 23,438 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
AJB Capital Note [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 2,032,800 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 91,328 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | $ 349,914 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 9,007 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 15,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Fee Amount | 15,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 750,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Mar. 17, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Related Commitment Fees and Debt Issuance Costs | 800,800 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
AJB Capital Note [Member] | Principal [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 750,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
AJB Capital Note [Member] | Accrued Interest [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 92,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
AJB Capital Note [Member] | Default Penalty [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 375,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
AJB Capital Note [Member] | Fees [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 15,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounts Payable [Member] | Stock Subscribed [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 95,558 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cavalry Fund 1 [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share (in Dollars per share) | $ 6.35 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 14,400 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deferred Compensation Arrangement with Individual, Fair Value of Shares Issued | $ 91,440 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised | $ 88,560 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Diamond Note 3 [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share (in Dollars per share) | $ 8 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 509,277 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 1,929 | 1,930 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gain (Loss) on Waiver Fee Shares | $ 765 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Contract, Price per share (in Dollars per share) | $ 12.5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Value of contract shares | $ 24,118 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitment Shares Value | 15,434 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 16,200 | $ 16,200 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 1,929 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ 12.5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 235,294 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Nov. 30, 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Warrants and Rights Outstanding | $ 8,800 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Related Commitment Fees and Debt Issuance Costs | 200,624 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Diamond Note 3 [Member] | Accrued Interest [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 49,830 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Diamond Note 3 [Member] | Convertible Notes Payable [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 235,294 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Diamond Note 3 [Member] | Investment Incentive [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 200,624 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Diamond Note 3 [Member] | Premium on Notes Payable [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 23,529 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Diamond Note 4 [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share (in Dollars per share) | $ 7.585 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 101,402 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, New Issues (in Shares) | 386 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 1,930 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gain (Loss) on Waiver Fee Shares | $ 249 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Contract, Price per share (in Dollars per share) | $ 12.5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitment Shares Value | $ 3,160 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 3,160 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 386 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ 12.5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 47,059 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Nov. 30, 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Warrants and Rights Outstanding | $ 2,960 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Related Commitment Fees and Debt Issuance Costs | 200,624 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Diamond Note 4 [Member] | Accrued Interest [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 9,691 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Diamond Note 4 [Member] | Convertible Notes Payable [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 47,059 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Diamond Note 4 [Member] | Investment Incentive [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 39,946 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Diamond Note 4 [Member] | Premium on Notes Payable [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 4,706 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Finnegan Note 1 [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share (in Dollars per share) | $ 8.97 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, New Issues (in Shares) | 386 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 1,930 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gain (Loss) on Waiver Fee Shares | $ 222 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Contract, Price per share (in Dollars per share) | $ 12.5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitment Shares Value | $ 3,240 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 3,240 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 386 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ 12.5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 47,059 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Nov. 20, 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Warrants and Rights Outstanding | $ 2,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
May 26 Notes [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share (in Dollars per share) | $ 7.585 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 1,688 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gain (Loss) on Waiver Fee Shares | $ 1,369 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Contract, Price per share (in Dollars per share) | $ 12.5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitment Shares Value | $ 14,175 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 1,688 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ 25 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
June9 Notes [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common Stock, Par or Stated Value Per Share (in Dollars per share) | $ 10.45 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share (in Dollars per share) | $ 7,425 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 7,284 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gain (Loss) on Waiver Fee Shares | $ 9,356 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Contract, Price per share (in Dollars per share) | $ 12.5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitment Shares Value | $ 66,400 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 7,284 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ 25 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dragon Note [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 1,176,676 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, New Issues (in Shares) | 4,824 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 4,824 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 44,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 588,235 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Dec. 09, 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Warrants and Rights Outstanding | $ 21,500 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitment Fee Per Share (in Dollars per share) | $ 10.45 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Related Commitment Fees and Debt Issuance Costs | 463,539 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dragon Note [Member] | Principal [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 647,059 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dragon Note [Member] | Accrued Interest [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 66,078 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Anson East Note [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common Stock, Par or Stated Value Per Share (in Dollars per share) | $ 10.45 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 527,398 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, New Issues (in Shares) | 8,600 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 8,600 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | $ 147,290 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | 107,500 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Fee Amount | 15,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 187,500 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Outstanding (in Shares) | 3,750 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Payments to Acquire Debt Securities, Available-for-Sale | $ 168,750 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Related Commitment Fees and Debt Issuance Costs | 207,763 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Anson East Note [Member] | Principal [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 187,500 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Anson East Note [Member] | Accrued Interest [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 23,385 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Anson East Note [Member] | Default Penalty [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 93,750 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Anson East Note [Member] | Fees [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 15,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Anson Investments Note [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 1,530,222 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, New Issues (in Shares) | 25,800 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 25,800 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | $ 416,375 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | 322,500 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Fee Amount | 15,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 562,500 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Outstanding (in Shares) | 11,250 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Payments to Acquire Debt Securities, Available-for-Sale | $ 506,250 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitment Fee Per Share (in Dollars per share) | $ 10.45 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Related Commitment Fees and Debt Issuance Costs | 602,815 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Anson Investments Note [Member] | Principal [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 562,500 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Anson Investments Note [Member] | Accrued Interest [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 68,657 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Anson Investments Note [Member] | Default Penalty [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 281,250 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Anson Investments Note [Member] | Fees [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 15,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mackay Note [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 655,606 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, New Issues (in Shares) | 2,412 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 2,412 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gain (Loss) on Waiver Fee Shares | $ 5,456 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Contract, Price per share (in Dollars per share) | $ 12.5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitment Shares Value | $ 12,500 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 44,118 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 2,412 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ 12.5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 294,118 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Aug. 10, 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Warrants and Rights Outstanding | $ 10,250 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitment Fee Per Share (in Dollars per share) | 7.445 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Related Commitment Fees and Debt Issuance Costs | 258,269 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mackay Note [Member] | Accrued Interest [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 63,807 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mackay Note [Member] | Convertible Notes Payable [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 294,118 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mackay Note [Member] | Investment Incentive [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 258,269 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mackay Note [Member] | Fees [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 10,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mackay Note [Member] | Premium on Notes Payable [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 29,412 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schrier Note [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share (in Dollars per share) | $ 7.445 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, New Issues (in Shares) | 193 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 193 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gain (Loss) on Waiver Fee Shares | $ 436 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Contract, Price per share (in Dollars per share) | $ 12.5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 335 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitment Shares Value | $ 1,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 1,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 193 | 193 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ 25 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 23,259 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Jan. 08, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Warrants and Rights Outstanding | $ 820 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Iturregui Note [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share (in Dollars per share) | $ 7.225 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 61,953 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 241 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gain (Loss) on Waiver Fee Shares | $ 518 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Contract, Price per share (in Dollars per share) | $ 12.5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 1,089 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitment Shares Value | $ 1,225 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 1,225 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 241 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ 25 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 29,412 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Jan. 21, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Warrants and Rights Outstanding | $ 975 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Related Commitment Fees and Debt Issuance Costs | 24,406 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Iturregui Note [Member] | Accrued Interest [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 5,194 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Iturregui Note [Member] | Convertible Notes Payable [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 29,412 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Iturregui Note [Member] | Investment Incentive [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 24,406 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Iturregui Note [Member] | Premium on Notes Payable [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 2,941 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Howe Note 3 [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share (in Dollars per share) | $ 7.225 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, New Issues (in Shares) | 2,460 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 2,460 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gain (Loss) on Waiver Fee Shares | $ 5,729 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Contract, Price per share (in Dollars per share) | $ 12.5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitment Shares Value | $ 12,495 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 12,495 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 2,460 | 2,460 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ 25 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 300,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Nov. 30, 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Warrants and Rights Outstanding | $ 9,945 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nommsen Note [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share (in Dollars per share) | $ 6.84 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, New Issues (in Shares) | 482 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 483 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gain (Loss) on Waiver Fee Shares | $ 949 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Contract, Price per share (in Dollars per share) | $ 12.5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitment Shares Value | $ 2,350 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 2,350 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 482 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ 25 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 58,823 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Nov. 30, 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Warrants and Rights Outstanding | $ 1,850 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Caplan Note [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share (in Dollars per share) | $ 6.935 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, New Issues (in Shares) | 482 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 483 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gain (Loss) on Waiver Fee Shares | $ 995 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Contract, Price per share (in Dollars per share) | $ 12.5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 2,230 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitment Shares Value | $ 2,350 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 2,350 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 482 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ 25 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 58,823 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Jan. 21, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Warrants and Rights Outstanding | $ 1,850 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Finnegan Note 3 [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share (in Dollars per share) | $ 6.42 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, New Issues (in Shares) | 241 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 242 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gain (Loss) on Waiver Fee Shares | $ 448 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Contract, Price per share (in Dollars per share) | $ 25 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 1,728 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 1,100 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Rights, Granted (in Shares) | 241 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ 25 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 29,412 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Feb. 03, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Warrants and Rights Outstanding | $ 850 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Enright Note [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share (in Dollars per share) | $ 6.42 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 254,496 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 255 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 984 | 984 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Contract, Price per share (in Dollars per share) | $ 12.5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 6,746 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitment Shares Value | $ 6,317 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 6,317 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 120,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Feb. 03, 2023 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Related Commitment Fees and Debt Issuance Costs | $ 102,116 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Enright Note [Member] | Accrued Interest [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 20,380 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Enright Note [Member] | Convertible Notes Payable [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 120,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Enright Note [Member] | Investment Incentive [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 102,116 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Enright Note [Member] | Premium on Notes Payable [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 12,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Howe Note 4 [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share (in Dollars per share) | $ 6.57 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, New Issues (in Shares) | 1,640 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 1,640 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Contract, Price per share (in Dollars per share) | $ 12.5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitment Shares Value | $ 10,775 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 10,775 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 200,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Nov. 30, 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mitchell Note [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common Stock, Shares, Issued (in Shares) | 582 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share (in Dollars per share) | $ 5.365 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, New Issues (in Shares) | 582 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Contract, Price per share (in Dollars per share) | $ 12.5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitment Shares Value | $ 3,124 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 71,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Nov. 30, 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Lightmas Note [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share (in Dollars per share) | $ 5.365 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, New Issues (in Shares) | 492 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 492 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Contract, Price per share (in Dollars per share) | $ 12.5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitment Shares Value | $ 2,640 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 2,640 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 60,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Nov. 30, 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Lewis Note [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share (in Dollars per share) | $ 5.365 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, New Issues (in Shares) | 246 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 246 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Contract, Price per share (in Dollars per share) | $ 12.5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitment Shares Value | $ 1,320 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 1,320 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 30,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Nov. 30, 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goff Note [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share (in Dollars per share) | $ 5.65 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, New Issues (in Shares) | 246 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 246 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Contract, Price per share (in Dollars per share) | $ 12.5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitment Shares Value | $ 1,320 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 1,320 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 30,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Nov. 30, 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hagan Note [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share (in Dollars per share) | $ 5.75 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, New Issues (in Shares) | 820 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 820 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Contract, Price per share (in Dollars per share) | $ 12.5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitment Shares Value | $ 4,715 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 4,715 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 100,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Dec. 10, 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Darling Note [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share (in Dollars per share) | $ 6.6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 390,738 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, New Issues (in Shares) | 1,640 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 1,640 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Contract, Price per share (in Dollars per share) | $ 12.5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitment Shares Value | $ 10,824 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 10,824 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 200,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Dec. 15, 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Related Commitment Fees and Debt Issuance Costs | 153,927 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Darling Note [Member] | Principal [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 220,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Darling Note [Member] | Accrued Interest [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 16,811 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Leath Note [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share (in Dollars per share) | $ 6.995 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, New Issues (in Shares) | 410 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Other (in Shares) | 410 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Contract, Price per share (in Dollars per share) | $ 12.5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | $ 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitment Shares Value | $ 2,868 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Other | $ 2,868 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 50,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Dec. 15, 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Service Provider [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common Stock, Par or Stated Value Per Share (in Dollars per share) | $ 16 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Anson East And Anson Investments Notes [Member] | Uplisting Offering [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Value, Issued | $ 375,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series A Preferred Stock [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Adjustments to Additional Paid in Capital, Other | $ 10,967 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Shares Authorized (in Shares) | 500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Par or Stated Value Per Share (in Dollars per share) | $ 0.01 | $ 0.01 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Liquidation Preference Per Share (in Dollars per share) | $ 25 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Dividend Rate, Percentage | 12% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Dividend Rate, Per-Dollar-Amount (in Dollars per share) | $ 25 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Shares Outstanding (in Shares) | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Shares Issued (in Shares) | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Value, Issued | $ 0 | $ 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series C Preferred Stock [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 2,289 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Shares Authorized (in Shares) | 3,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Par or Stated Value Per Share (in Dollars per share) | $ 0.01 | $ 0.01 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Shares Outstanding (in Shares) | 0 | 1,047,619 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Voting Rights | Voting Rights. Holders of the Series C Preferred Stock have the right to vote on any matter presented to holders of our Common Stock for their action or consideration at any meeting of the stockholders (or by written consent of stockholders in lieu of meeting), each holder of our Series C Preferred Stock shall be entitled to cast the number of votes equal to the number of whole shares of Common Stock into which the shares of Series C preferred Stock held by such holder, as described below, are convertible as of the record date for determining stockholders entitled to vote on (or consent to) such matter, voting with the Common Stock as a single class. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Convertible, Terms | Conversion. Each holder of our Series C Preferred Stock is entitled to convert their shares of Series C Preferred Stock, in whole or in part, at the Conversion Rate, which is determined by dividing the Conversion Amount (the Stated Value of $1.05, plus any accrued but unpaid dividends) by the Conversion Price ($0.25 per share). In addition, upon certain triggering events, the holders of our Series C Preferred Stock have the right to convert their Series C Preferred Stock at the lesser of the Conversion Price or 75% of the average VWAP for the five trading days prior to the date of the notice of conversion. The Conversion Price is subject to adjustment upon certain stock splits and recapitalization as well as upon the sale of Common Stock or Common Stock Equivalents. Each share of the Series C Preferred Stock is convertible at the option of the holder thereof, or automatically or upon the closing of an underwritten offering of at least $10 million of the Company’s securities or upon listing of the Company’s Common Stock on a national securities exchange. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Convertible, Conversion Price (in Dollars per share) | $ 0.25 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Dividend Payment Terms | Dividends. Each share of Series C Preferred Stock accrues dividends on a quarterly basis in arrears, at the rate of 6% per annum of the Stated Value ($1.05 per share plus any accrued but unpaid dividends) and is to be paid within 15 days after the end of each of our fiscal quarters. Each holder of the Series C Preferred Stock is entitled to receive dividends or distributions on each share of the Series C Preferred Stock on an as converted into Common Stock basis when and if dividends are declared on the Common Stock by our Board of Directors. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Redemption Terms | Redemption Rights. Upon receipt of a conversion notice, we have the right (but not the obligation) to redeem all or part of the Series C Preferred Stock (which the applicable holder of the Series C Preferred Stock is seeking to convert) at a price per share equal to the product of 125% of the (1) Stated Value plus (2) the Additional Amount (the “Redemption Price”). If we decide to exercise the redemption right, within one trading day, we shall deliver written notice to such holder(s) of Series C Preferred Stock that the Series C Preferred Stock will be redeemed (the “Redemption Notice”) on the date that is three trading days following the date of the Redemption Notice (such date, the “Redemption Date”). On the Redemption Date, we shall redeem the shares of Series C Preferred Stock specified in such request by paying in cash therefore a sum per share equal to the Redemption Price. In no event shall a Redemption Notice be given if we may not lawfully redeem our capital stock. On or before the Redemption Date, the Redemption Price for such shares shall be paid by wire transfer of immediately available funds to an account designated in writing by the applicable holder. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock Preemptive Rights | Preemptive or Similar Rights Additionally, except for a public offering or certain exempt issuances of our securities, holders of the Series C Preferred Stock shall have the right to participate in any offering of our Common Stock or Common Stock Equivalents (as defined in the COD) in a transaction exempt from registration under the Securities Act in an amount equal to an aggregate of 30% of the financing on the same terms, conditions and price provided to investors in such an offering, such right shall expire on the 15 month anniversary of the issuance date of the Series C Preferred Stock. Further, until the earlier of 18 months from the issuance date of the Series C Preferred Stock and the date that there are less than 20% of the shares of Series C Preferred Stock outstanding, the Investors have most favored nations protection in the event we issue or sell Common Stock or Common Stock Equivalents that the Investors believe are more favorable than the terms and conditions under the Private Placement. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dividends, Preferred Stock | $ 17,603 | $ 66,447 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Shares Issued (in Shares) | 1,047,619 | 0 | 1,047,619 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Conversion of Stock, Amount Converted | $ 1,100,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Related Commitment Fees and Debt Issuance Costs | 1,016,888 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Conversion of Stock, Shares Issued (in Shares) | 98,064 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Conversion of Stock, Amount Issued | $ 1,198,472 | $ 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Value, Issued | 0 | 10,476 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series C Preferred Stock [Member] | Accrued Dividends [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Conversion of Stock, Amount Converted | 171,109 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series C Preferred Stock [Member] | Two Investors [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Conversion of Stock, Amount Converted | 2,287,997 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series C Preferred Stock [Member] | Cavalry Exchange Agreement [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Shares Issued (in Shares) | 1,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series C Preferred Stock [Member] | Mercer Exchange Agreement [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Shares Issued (in Shares) | 47,619 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series D Preferred Stock [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, New Issues (in Shares) | 655 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 159,906 | $ 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Shares Authorized (in Shares) | 10,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Par or Stated Value Per Share (in Dollars per share) | $ 0.01 | $ 0.01 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Dividend Rate, Percentage | 6% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Shares Outstanding (in Shares) | 250,000 | 3,100,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Voting Rights | Voting Rights. Holders of the Series D Preferred Stock have the right to vote on any matter presented to holders of our Common Stock for their action or consideration at any meeting of the stockholders (or by written consent of stockholders in lieu of meeting), each holder of our Series C Preferred Stock shall be entitled to cast the number of votes equal to the number of whole shares of Common Stock into which the shares of Series D preferred Stock held by such holder, as described below, are convertible as of the record date for determining stockholders entitled to vote on (or consent to) such matter, voting with the Common Stock as a single class. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Convertible, Terms | Conversion. Each holder of our Series D Preferred Stock is entitled to convert their shares of Series D Preferred Stock, in whole or in part, at the Conversion Rate, which is determined by dividing the Conversion Amount (the Stated Value of $1.05, plus any accrued but unpaid dividends) by the Conversion Price ($0.25 per share). In addition, upon certain triggering events, the holders of our Series C Preferred Stock have the right to convert their Series D Preferred Stock at the lesser of the Conversion Price or 75% of the average VWAP for the five trading days prior to the date of the notice of conversion. The Conversion Price is subject to adjustment upon certain stock splits and recapitalization as well as upon the sale of Common Stock or Common Stock Equivalents. Each share of the Series D Preferred Stock is convertible at the option of the holder thereof, or automatically or upon the closing of an underwritten offering of at least $10 million of the Company’s securities or upon listing of the Company’s Common Stock on a national securities exchange. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Convertible, Conversion Price (in Dollars per share) | $ 0.25 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Dividend Payment Terms | Dividends. Each share of Series D Preferred Stock accrues dividends on a quarterly basis in arrears, at the rate of 6% per annum of the Stated Value ($1.05 per share plus any accrued but unpaid dividends) and is to be paid within 15 days after the end of each of our fiscal quarters. Each holder of the Series C Preferred Stock is entitled to receive dividends or distributions on each share of the Series D Preferred Stock on an as converted into Common Stock basis when and if dividends are declared on the Common Stock by our Board of Directors. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Redemption Terms | Redemption Rights. Upon receipt of a conversion notice, we have the right (but not the obligation) to redeem all or part of the Series D Preferred Stock (which the applicable holder of the Series D Preferred Stock is seeking to convert) at a price per share equal to the product of 125% of the (1) Stated Value plus (2) the Additional Amount (the “Redemption Price”). If we decide to exercise the redemption right, within one trading day, we shall deliver written notice to such holder(s) of Series D Preferred Stock that the Series D Preferred Stock will be redeemed (the “Redemption Notice”) on the date that is three trading days following the date of the Redemption Notice (such date, the “Redemption Date”). On the Redemption Date, we shall redeem the shares of Series D Preferred Stock specified in such request by paying in cash therefore a sum per share equal to the Redemption Price. In no event shall a Redemption Notice be given if we may not lawfully redeem our capital stock. On or before the Redemption Date, the Redemption Price for such shares shall be paid by wire transfer of immediately available funds to an account designated in writing by the applicable holder. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock Preemptive Rights | Preemptive or Similar Rights Additionally, except for a public offering or certain exempt issuances of our securities, holders of the Series D Preferred Stock shall have the right to participate in any offering of our Common Stock or Common Stock Equivalents (as defined in the COD) in a transaction exempt from registration under the Securities Act in an amount equal to an aggregate of 30% of the financing on the same terms, conditions and price provided to investors in such an offering, such right shall expire on the 15 month anniversary of the issuance date of the Series D Preferred Stock. Further, until the earlier of 18 months from the issuance date of the Series D Preferred Stock and the date that there are less than 20% of the shares of Series D Preferred Stock outstanding, the Investors have most favored nations protection in the event we issue or sell Common Stock or Common Stock equivalents that the Investors believe are more favorable than the terms and conditions under the Private Placement. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dividends, Preferred Stock | $ 85,541 | $ 195,299 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Shares Issued (in Shares) | 250,000 | 3,100,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Conversion of Stock, Amount Converted | $ 500,000 | $ 2,467,500 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Conversion of Stock, Amount Issued | $ 1,611,006 | $ 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Conversion of Stock, Shares Converted (in Shares) | 500,000 | 2,350,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants | $ 600,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Value, Issued | 2,500 | $ 31,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series D Preferred Stock [Member] | Accrued Dividends [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Conversion of Stock, Amount Converted | 67,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series D Preferred Stock [Member] | Accrued Salaries [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Conversion of Convertible Securities | $ 154,906 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series D Preferred Stock [Member] | Accrued Salary [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 38,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Incentive, Amount | 25,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series D Preferred Stock [Member] | Conversion Incentive [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 25,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series D Preferred Stock [Member] | Two Investors [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Conversion of Stock, Amount Converted | $ 4,055,005 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series D Preferred Stock [Member] | Two Investors [Member] | Investment Incentive [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Conversion of Stock, Amount Converted | 1,371,846 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series D Preferred Stock [Member] | Two Investors [Member] | Accrued Dividends [Member] | Accrued Dividends [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Conversion of Stock, Amount Converted | $ 215,659 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series D Preferred Stock [Member] | Cavalry Exchange Agreement [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Shares Issued (in Shares) | 750,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series D Preferred Stock [Member] | Mercer Exchange Agreement [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Shares Issued (in Shares) | 750,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series D Preferred Stock [Member] | Pinz Exchange Agreement [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Shares Issued (in Shares) | 100,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series D Preferred Stock [Member] | Anson East And Anson Investments Notes [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Shares Issued (in Shares) | 750,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series E Preferred Stock [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, New Issues (in Shares) | 10,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, New Issues | $ 1,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Shares Authorized (in Shares) | 10,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Par or Stated Value Per Share (in Dollars per share) | $ 0.01 | $ 0.01 | $ 0.01 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Shares Outstanding (in Shares) | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Convertible, Conversion Price (in Dollars per share) | $ 0.05 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Shares Issued (in Shares) | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Conversion of Convertible Securities | $ 1,100 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Value, Issued | $ 0 | $ 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series X Preferred Stock [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common Stock Dividends, Shares (in Shares) | 28,275 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Shares Authorized (in Shares) | 24,227 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Par or Stated Value Per Share (in Dollars per share) | $ 0.01 | $ 0.01 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Liquidation Preference Per Share (in Dollars per share) | $ 25 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Shares Outstanding (in Shares) | 24,227 | 24,227 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Voting Rights | Each one share of the Series X Preferred Stock is entitled to 400 votes on all matters submitted to a vote of our shareholders. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Dividend Payment Terms | The Company reserves the right to pay the dividends in shares of the Company’s common stock at a price equal to the average closing price over the five days prior to the date of the dividend declaration. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dividends, Preferred Stock | $ 60,564 | $ 60,564 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Shares Issued (in Shares) | 24,227 | 24,227 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Conversion of Convertible Securities | $ 60,564 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Value, Issued | 242 | $ 242 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share Price (in Dollars per share) | $ 0.80 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award, Discount from Market Price, Offering Date | 20% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series X Preferred Stock [Member] | Common Stock [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Conversion of Convertible Securities | $ 283 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 911 | 8,116 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, New Issues (in Shares) | 655 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 8,111,334 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Shares Authorized (in Shares) | 140,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Par or Stated Value Per Share (in Dollars per share) | $ 0.01 | $ 0.01 | $ 0.01 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Liquidation Preference Per Share (in Dollars per share) | $ 1,000 | $ 1,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Shares Outstanding (in Shares) | 20,057 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dividends, Preferred Stock | $ 1,566,073 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Shares Issued (in Shares) | 20,057 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Conversion of Stock, Amount Converted | $ 500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Conversion of Stock, Shares Issued (in Shares) | 4,055 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Conversion of Stock, Shares Converted (in Shares) | 500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants | $ 600,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Value, Issued | $ 201 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Value, Outstanding | $ 1,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | Accrued Dividends [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Conversion of Stock, Amount Converted | 67,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | Accrued Interest [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 84,187 | $ 365,012 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | Accounts Payable [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 146,214 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 147 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Amount | 146,214 | $ 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, Conversion of Convertible Securities | 146,214 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | Convertible Notes Payable [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 414,118 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 9,523,178 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | Investment Incentive [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 360,385 | 3,195,374 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | Accrued Salary [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 38,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Incentive, Amount | 25,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | Conversion Incentive [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 25,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | Default Penalty [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 888,889 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | Fees [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 10,000 | 60,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | Premium on Notes Payable [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 41,412 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | Nine Investors Member | Convertible Notes Payable [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 3,602,059 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | Two Investors [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Liquidation Preference Per Share (in Dollars per share) | $ 1,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | Two Investors [Member] | Series C Preferred Stock [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Liquidation Preference Per Share (in Dollars per share) | $ 1,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Conversion of Stock, Shares Issued (in Shares) | 2,289 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | Two Investors [Member] | Series D Preferred Stock [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Conversion of Stock, Shares Issued (in Shares) | 4,055 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | Three Investors [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, New Issues (in Shares) | 1,746 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Liquidation Preference Per Share (in Dollars per share) | $ 1,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants | $ 1,745,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Proceeds from Issuance of Preferred Stock and Preference Stock | 900,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Payments of Stock Issuance Costs | 161,500 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | Three Investors [Member] | Investment Incentive [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants | 845,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | Two Service Providers [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Preferred Stock, Liquidation Preference Per Share (in Dollars per share) | $ 1,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | GS Capital Note [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 633,192 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 634 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | GS Capital Note [Member] | Accrued Interest [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 24,864 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | AJB Capital Note [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 2,033 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | Diamond Note 3 [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 509 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | Diamond Note 4 [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 101 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | Dragon Note [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 1,177 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | Anson East Note [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 528 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | Anson Investments Note [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 1,531 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | Mackay Note [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 656 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | Iturregui Note [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 62 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Series F Preferred Stock [Member] | Darling Note [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 391 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common Stock [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share Price (in Dollars per share) | $ 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Principal [Member] | Officers And Directors [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common Stock Dividends, Shares (in Shares) | 3,739 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ConsultantMember | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, New Issues (in Shares) | 2,952 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common Stock, Dividends, Per Share, Declared (in Dollars per share) | $ 1.29 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, New Issues | $ 33,092 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
GS Capital Note [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, New Issues (in Shares) | 94,738 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Value, New Issues | $ 21,506 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vendor [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share (in Dollars per share) | $ 0.85 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, New Issues (in Shares) | 2,552 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Howe Trust [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share (in Dollars per share) | $ 0.85 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, New Issues (in Shares) | 19,622 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Chief Executive Officer [Member] | Series F Preferred Stock [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 2,138 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Chief Executive Officer [Member] | Series F Preferred Stock [Member] | Convertible Notes Payable [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 601,839 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Chief Executive Officer [Member] | Series F Preferred Stock [Member] | Premium on Notes Payable [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 78,087 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Related Party [Member] | Series F Preferred Stock [Member] | Accrued Interest [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 124,777 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Related Party [Member] | Series F Preferred Stock [Member] | Accrued Board Fees [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 112,500 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Related Party [Member] | Series F Preferred Stock [Member] | Investment Incentive [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | 843,228 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Related Party [Member] | Series F Preferred Stock [Member] | Accrued Salary [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 376,625 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Majority Shareholder [Member] | Series X Preferred Stock [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common Stock Dividends, Shares (in Shares) | 14,586 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nonrelated Party [Member] | Series X Preferred Stock [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common Stock Dividends, Shares (in Shares) | 9,950 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Officer [Member] | Series X Preferred Stock [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, New Issues (in Shares) | 1,066 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Majority Shareholder [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common Stock Dividends, Shares (in Shares) | 10,426 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Majority Shareholder [Member] | Series X Preferred Stock [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, New Issues (in Shares) | 4,160 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nonrelated Party [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common Stock Dividends, Shares (in Shares) | 7,113 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gain on Conversion of Debt | $ 37,453 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dividends, Preferred Stock | $ 1,600,241 | $ 249,868 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nonrelated Party [Member] | Series X Preferred Stock [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, New Issues (in Shares) | 2,837 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Officers And Directors [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common Stock Dividends, Shares (in Shares) | 2,673 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Board [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 2,926 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Board [Member] | Accounts Payable [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share (in Dollars per share) | $ 12.5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Original Debt, Amount | $ 36,575 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gardner Agreement [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Convertible, Conversion Price (in Dollars per share) | $ 12.5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Amount | $ 500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other Accrued Liabilities, Current | $ 294,912 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gardner Agreement [Member] | Restricted Stock [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Conversion, Converted Instrument, Shares Issued (in Shares) | 63,593 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
AJB Capital Investors [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, New Issues (in Shares) | 91,328 | 34,400 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Contract, Price per share (in Dollars per share) | $ 12.5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Adjustments to Additional Paid in Capital, Other | $ 226,106 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
AJB Capital Investors [Member] | Valuation, Market Approach [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shares Issued, Price Per Share (in Dollars per share) | $ 6.35 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
AJB Capital Investors [Member] | AJB Capital Note [Member] | Warrant and Commitment Fees [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | $ 349,914 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Service Provider [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common Stock, Par or Stated Value Per Share (in Dollars per share) | $ 6.88 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, New Issues (in Shares) | 6,329 | 15,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Kishon Investments SPA [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockholders' Equity (Deficit) (Details) [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, New Issues (in Shares) | 12,741 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Unamortized Discount | $ 27,777 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ 12.5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Fee Amount | $ 159,259 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Face Amount | $ 277,777 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument, Maturity Date | Nov. 10, 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Class of Warrant or Right, Outstanding (in Shares) | 5,556 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Warrants and Rights Outstanding | $ 159,259 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Payments to Acquire Debt Securities, Available-for-Sale | $ 250,000 |
Stockholders' Equity (Deficit_3
Stockholders' Equity (Deficit) (Details) - Share-Based Payment Arrangement, Option, Exercise Price Range - $ / shares | 12 Months Ended | ||
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Share Based Payment Arrangement Option Exercise Price Range Abstract | |||
Range of exercise prices | $ 1.5 | ||
Range of exercise prices | $ 16 | ||
Number of options outstanding (in Shares) (in Shares) | 100,934 | 310,692 | 366,591 |
Weighted average remaining contractual life (years) | 7 years 1 month 28 days | ||
Weighted average exercise price of outstanding options | $ 10.05 | $ 10.01 | $ 10.29 |
Number of options exercisable (in Shares) (in Shares) | 80,934 | ||
Weighted average exercise price of exercisable options | $ 9.25 |
Stockholders' Equity (Deficit_4
Stockholders' Equity (Deficit) (Details) - Share-Based Payment Arrangement, Option, Activity - $ / shares | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Share Based Payment Arrangement Option Activity Abstract | ||
Outstanding, Number of Shares | 310,692 | 366,591 |
Outstanding, Weighted-Average Exercise Price | $ 10.01 | $ 10.29 |
Options Vested and Exercisable, Number of Shares | 80,934 | |
Options Vested and Exercisable, Weighted-Average Exercise Price | $ 9.25 | |
Granted, Number of Shares | 0 | 4,000 |
Granted, Weighted-Average Exercise Price | $ 0 | $ 12.5 |
Cancelled/Expired, Number of Shares | (209,758) | (59,899) |
Cancelled/Expired, Weighted-Average Exercise Price | $ 10 | $ 12.18 |
Exercised, Number of Shares | 0 | |
Exercised, Weighted-Average Exercise Price | $ 0 | |
Outstanding, Number of Shares | 100,934 | 310,692 |
Outstanding, Weighted-Average Exercise Price | $ 10.05 | $ 10.01 |
Stockholders' Equity (Deficit_5
Stockholders' Equity (Deficit) (Details) - Schedule of Stockholders' Equity Note, Warrants or Rights - $ / shares | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Schedule Of Stockholders Equity Note Warrants Or Rights Abstract | ||
Outstanding, Number of Shares | 672,334 | 596,400 |
Outstanding, Weighted Average Exercise Price | $ 30.68 | $ 31.25 |
Granted, Number of Shares | 874 | 75,934 |
Granted, Weighted Average Exercise Price | $ 2.5 | $ 26.21 |
Exercised, Number of Shares | 0 | 0 |
Exercised, Weighted Average Exercise Price | $ 0 | $ 0 |
Outstanding, Number of Shares | 673,208 | 672,334 |
Outstanding, Weighted Average Exercise Price | $ 30.64 | $ 30.68 |
Income Taxes (Details)
Income Taxes (Details) - USD ($) $ in Millions | Dec. 31, 2023 | Dec. 31, 2022 |
Income Tax Disclosure [Abstract] | ||
Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration | $ 13.5 | $ 1.6 |
Income Taxes (Details) - Schedu
Income Taxes (Details) - Schedule of Effective Income Tax Rate Reconciliation - USD ($) | 12 Months Ended | |
Dec. 31, 2023 | Dec. 31, 2022 | |
Schedule Of Effective Income Tax Rate Reconciliation Abstract | ||
Expected tax at statutory rates, Amount | $ (3,463,000) | $ (4,879,000) |
Expected tax at statutory rates, Percent | 21% | 21% |
Permanent Differences, Amount | $ 7,000 | $ 1,610,000 |
Permanent Differences, Percent | 0% | (7.00%) |
State Income Tax, Net of Federal benefit, Amount | $ (418,000) | $ (380,000) |
State Income Tax, Net of Federal benefit, Percent | 1% | 2% |
Other, Amount | $ (95,000) | $ 286,000 |
Other, Percent | 2% | (1.00%) |
Current Year Change in Valuation Allowance, Amount | $ 3,969,000 | $ 2,611,000 |
Current Year Change in Valuation Allowance, Percent | (24.00%) | (9.00%) |
Prior Year True-Ups, Amount | $ 0 | $ 752,000 |
Prior Year True-Ups, Percent | 0% | (6.00%) |
Income tax expense, Amount | $ 0 | $ 0 |
Income tax expense, Percent | 0% | 0% |
Income Taxes (Details) - Sche_2
Income Taxes (Details) - Schedule of Deferred Tax Assets and Liabilities - USD ($) | Dec. 31, 2023 | Dec. 31, 2022 |
Schedule Of Deferred Tax Assets And Liabilities Abstract | ||
Accrued payroll | $ 141,000 | $ 112,000 |
ASC842-ROU Asset | 0 | (68,000) |
ASC842-ROU (Liability) | 822,000 | 830,000 |
Loss from derivatives | (16,000) | (130,000) |
Waiver and commitment fee shares | 0 | (32,000) |
Stock based compensation | (171,000) | (85,000) |
Depreciation | 3,000 | 33,000 |
Net operating loss | 13,529,000 | 9,679,000 |
Net deferred tax assets (liabilities) | 14,308,000 | 10,339,000 |
Valuation allowance | (14,308,000) | (10,339,000) |
Net deferred tax assets (liabilities) | $ 0 | $ 0 |
Fair Value of Financial Instr_3
Fair Value of Financial Instruments (Details) - Schedule of Derivative Financial Liabilities at Fair Value - USD ($) | Dec. 31, 2023 | Dec. 31, 2022 |
Fair Value of Financial Instruments (Details) - Schedule of Derivative Financial Liabilities at Fair Value [Line Items] | ||
Derivative liabilities | $ 152,945 | $ 568,912 |
Fair Value, Inputs, Level 1 [Member] | ||
Fair Value of Financial Instruments (Details) - Schedule of Derivative Financial Liabilities at Fair Value [Line Items] | ||
Derivative liabilities | 0 | 0 |
Fair Value, Inputs, Level 2 [Member] | ||
Fair Value of Financial Instruments (Details) - Schedule of Derivative Financial Liabilities at Fair Value [Line Items] | ||
Derivative liabilities | 0 | 0 |
Fair Value, Inputs, Level 3 [Member] | ||
Fair Value of Financial Instruments (Details) - Schedule of Derivative Financial Liabilities at Fair Value [Line Items] | ||
Derivative liabilities | $ 152,945 | $ 568,912 |
Commitments and Contingencies_2
Commitments and Contingencies (Details) - USD ($) | Apr. 10, 2024 | Apr. 02, 2024 | Dec. 21, 2023 | Dec. 15, 2023 | Nov. 14, 2023 | Oct. 22, 2022 | Jun. 23, 2022 | Dec. 31, 2023 | Oct. 14, 2021 | Oct. 08, 2021 | Sep. 28, 2021 | Sep. 21, 2021 | Jun. 08, 2021 | May 04, 2021 | Nov. 01, 2020 |
Commitments and Contingencies (Details) [Line Items] | |||||||||||||||
Litigation Settlement, Amount Awarded to Other Party | $ 3,000 | ||||||||||||||
Litigation Settlement, Expense | $ 3,000 | ||||||||||||||
Lessee, Operating Lease, Term of Contract | 114 years | 2 years 6 months | 96 years | 108 months | 94 months | 90 months | 8 years | 7 years | 8 years | ||||||
Lessee, Operating Lease, Liability, to be Paid | $ 1,153,000 | $ 244,000 | $ 99,477 | $ 767,000 | $ 1,153,127 | $ 1,079,000 | $ 782,000 | $ 620,000 | $ 673,000 | $ 511,000 | |||||
Settled Litigation [Member] | |||||||||||||||
Commitments and Contingencies (Details) [Line Items] | |||||||||||||||
Litigation Settlement, Amount Awarded to Other Party | $ 530,000 | ||||||||||||||
Judicial Ruling [Member] | |||||||||||||||
Commitments and Contingencies (Details) [Line Items] | |||||||||||||||
Litigation Settlement, Amount Awarded to Other Party | $ 425,351 | $ 488,491 | $ 348,764 | $ 219,576 | |||||||||||
Loss Contingency, Actions Taken by Plaintiff | A stipulation for Judgment was filed on December 21, 2023 in the amount of $415,266. The stipulated judgment includes $178,542 in unpaid back rent, $172,124 in resolution of mechanics’ liens, and $64,600 in attorneys’ fees. | ||||||||||||||
Restricted Stock [Member] | Settled Litigation [Member] | |||||||||||||||
Commitments and Contingencies (Details) [Line Items] | |||||||||||||||
Stock Issued During Period, Shares, New Issues (in Shares) | 2,552 | ||||||||||||||
Restricted Stock [Member] | CEO of The Good Clinic [Member] | Settled Litigation [Member] | |||||||||||||||
Commitments and Contingencies (Details) [Line Items] | |||||||||||||||
Stock Issued During Period, Shares, New Issues (in Shares) | 19,622 |
Commitments and Contingencies_3
Commitments and Contingencies (Details) - Schedule of Property Settlement Obligations - USD ($) | Dec. 31, 2023 | Dec. 31, 2022 |
Commitments and Contingencies (Details) - Schedule of Property Settlement Obligations [Line Items] | ||
ORIGINAL OBLIGATION | $ 7,145,127 | |
SETTLEMENT AMOUNT | 121,136 | $ 96,136 |
Settled Litigation [Member] | ||
Commitments and Contingencies (Details) - Schedule of Property Settlement Obligations [Line Items] | ||
SETTLEMENT AMOUNT | 2,452,768 | |
Nordhaus Minneapolis, MN [Member] | ||
Commitments and Contingencies (Details) - Schedule of Property Settlement Obligations [Line Items] | ||
ORIGINAL OBLIGATION | 511,000 | |
Nordhaus Minneapolis, MN [Member] | Settled Litigation [Member] | ||
Commitments and Contingencies (Details) - Schedule of Property Settlement Obligations [Line Items] | ||
SETTLEMENT AMOUNT | ||
Prominade Wayzetta, MN [Member] | ||
Commitments and Contingencies (Details) - Schedule of Property Settlement Obligations [Line Items] | ||
ORIGINAL OBLIGATION | 407,000 | |
Prominade Wayzetta, MN [Member] | Settled Litigation [Member] | ||
Commitments and Contingencies (Details) - Schedule of Property Settlement Obligations [Line Items] | ||
SETTLEMENT AMOUNT | 25,000 | |
Eagan Clinic Eagan, MN [Member] | ||
Commitments and Contingencies (Details) - Schedule of Property Settlement Obligations [Line Items] | ||
ORIGINAL OBLIGATION | 767,000 | |
Eagan Clinic Eagan, MN [Member] | Settled Litigation [Member] | ||
Commitments and Contingencies (Details) - Schedule of Property Settlement Obligations [Line Items] | ||
SETTLEMENT AMOUNT | 488,491 | |
Excelsior & Grand St. Louis Park, MN [Member] | ||
Commitments and Contingencies (Details) - Schedule of Property Settlement Obligations [Line Items] | ||
ORIGINAL OBLIGATION | 673,000 | |
Excelsior & Grand St. Louis Park, MN [Member] | Settled Litigation [Member] | ||
Commitments and Contingencies (Details) - Schedule of Property Settlement Obligations [Line Items] | ||
SETTLEMENT AMOUNT | 425,350 | |
The Grove St. Paul, MN [Member] | ||
Commitments and Contingencies (Details) - Schedule of Property Settlement Obligations [Line Items] | ||
ORIGINAL OBLIGATION | 1,153,000 | |
The Grove St. Paul, MN [Member] | Settled Litigation [Member] | ||
Commitments and Contingencies (Details) - Schedule of Property Settlement Obligations [Line Items] | ||
SETTLEMENT AMOUNT | 415,606 | |
Elevate Eden Prarie [Member] | ||
Commitments and Contingencies (Details) - Schedule of Property Settlement Obligations [Line Items] | ||
ORIGINAL OBLIGATION | 620,000 | |
Elevate Eden Prarie [Member] | Settled Litigation [Member] | ||
Commitments and Contingencies (Details) - Schedule of Property Settlement Obligations [Line Items] | ||
SETTLEMENT AMOUNT | ||
Arbor Lakes Maple Grave, MN [Member] | ||
Commitments and Contingencies (Details) - Schedule of Property Settlement Obligations [Line Items] | ||
ORIGINAL OBLIGATION | 1,153,127 | |
Arbor Lakes Maple Grave, MN [Member] | Settled Litigation [Member] | ||
Commitments and Contingencies (Details) - Schedule of Property Settlement Obligations [Line Items] | ||
SETTLEMENT AMOUNT | 219,575 | |
LMC Welton Denver, CO [Member] | ||
Commitments and Contingencies (Details) - Schedule of Property Settlement Obligations [Line Items] | ||
ORIGINAL OBLIGATION | 782,000 | |
LMC Welton Denver, CO [Member] | Settled Litigation [Member] | ||
Commitments and Contingencies (Details) - Schedule of Property Settlement Obligations [Line Items] | ||
SETTLEMENT AMOUNT | 530,000 | |
1776 Curtis Denver, CO [Member] | ||
Commitments and Contingencies (Details) - Schedule of Property Settlement Obligations [Line Items] | ||
ORIGINAL OBLIGATION | 1,079,000 | |
1776 Curtis Denver, CO [Member] | Settled Litigation [Member] | ||
Commitments and Contingencies (Details) - Schedule of Property Settlement Obligations [Line Items] | ||
SETTLEMENT AMOUNT | $ 348,764 |
Subsequent Events (Details)
Subsequent Events (Details) - USD ($) | 12 Months Ended | ||||||||
Mar. 20, 2024 | Mar. 19, 2024 | Feb. 27, 2024 | Feb. 20, 2024 | Feb. 09, 2024 | Jan. 24, 2024 | Jan. 17, 2024 | Jun. 29, 2023 | Dec. 31, 2023 | |
Subsequent Events (Details) [Line Items] | |||||||||
Proceeds from Issuance of Debt (in Dollars) | $ 50,000 | ||||||||
Debt Instrument, Term | 12 years | ||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10% | ||||||||
Common Stock Dividends, Shares | 20,212 | ||||||||
Subsequent Event [Member] | |||||||||
Subsequent Events (Details) [Line Items] | |||||||||
Proceeds from Issuance of Debt (in Dollars) | $ 25,000 | ||||||||
Debt Instrument, Term | 12 months | ||||||||
Debt Instrument, Interest Rate, Stated Percentage | 10% | ||||||||
Common Stock Dividends, Shares | 25,013 | 41,057 | |||||||
Stockholders' Equity, Reverse Stock Split | 4:1 | ||||||||
Subsequent Event, Description | Company announced its first participants to that Board. Each will receive $60,000 of restricted common stock for their services over the next 12 months. The Board has determined that the price per share for the restricted stock shall be $.80, the same pricing used for the payment of dividends to Series X Preferred shareholders. This results in the issuance of 75,000 shares for each member, in aggregate 225,000 shares of restricted common stock. | ||||||||
Series X Preferred Stock [Member] | |||||||||
Subsequent Events (Details) [Line Items] | |||||||||
Common Stock Dividends, Shares | 28,275 | ||||||||
Series X Preferred Stock [Member] | Subsequent Event [Member] | |||||||||
Subsequent Events (Details) [Line Items] | |||||||||
Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears (in Dollars per share) | $ 0.80 | ||||||||
Common Stock Dividends, Shares | 25,013 |